
<html lang="en"     class="pb-page"  data-request-id="f643d802-73c5-4d05-a215-bac0bdeb5951"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm801315b;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-8;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration" /></meta><meta name="dc.Creator" content="Nilantha  Sirisoma" /></meta><meta name="dc.Creator" content="Azra  Pervin" /></meta><meta name="dc.Creator" content="Hong  Zhang" /></meta><meta name="dc.Creator" content="Songchun  Jiang" /></meta><meta name="dc.Creator" content="J. Adam  Willardsen" /></meta><meta name="dc.Creator" content="Mark B.  Anderson" /></meta><meta name="dc.Creator" content="Gary  Mather" /></meta><meta name="dc.Creator" content="Christopher M.  Pleiman" /></meta><meta name="dc.Creator" content="Shailaja  Kasibhatla" /></meta><meta name="dc.Creator" content="Ben  Tseng" /></meta><meta name="dc.Creator" content="John  Drewe" /></meta><meta name="dc.Creator" content="Sui Xiong  Cai" /></meta><meta name="dc.Description" content="As a continuation of our structure−activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the repla..." /></meta><meta name="Description" content="As a continuation of our structure−activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the repla..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 18, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm801315b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm801315b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm801315b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm801315b" /></link>
        
    
    

<title>Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm801315b" /></meta><meta property="og:title" content="Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0015.jpeg" /></meta><meta property="og:description" content=" As a continuation of our structure−activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the replacement of the 2-Cl group in our lead compound 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (6b, EP128265, MPI-0441138) by other functional groups. This SAR study and lead optimization resulted in the identification of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine (6h, EP128495, MPC-6827) as an anticancer clinical candidate. Compound 6h was found to be a potent apoptosis inducer with EC50 of 2 nM in our cell-based apoptosis induction assay. It also has excellent blood brain barrier penetration, and is highly efficacious in human MX-1 breast and other mouse xenograft cancer models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm801315b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm801315b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm801315b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm801315b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm801315b&amp;href=/doi/10.1021/jm801315b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 2341-2351</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801228h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm801351u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nilantha++Sirisoma">Nilantha Sirisoma</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Azra++Pervin">Azra Pervin</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhang">Hong Zhang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Songchun++Jiang">Songchun Jiang</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J.+Adam++Willardsen">J. Adam Willardsen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+B.++Anderson">Mark B. Anderson</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Mather">Gary Mather</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+M.++Pleiman">Christopher M. Pleiman</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shailaja++Kasibhatla">Shailaja Kasibhatla</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ben++Tseng">Ben Tseng</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Drewe">John Drewe</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sui+Xiong++Cai">Sui Xiong Cai</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div><div class="corresp-info"><strong>*</strong> Corresponding authors. S.X.C.: EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, CA 92121; tel, 858-202-4006; fax, 858-202-4000; e-mail, <a href="/cdn-cgi/l/email-protection#641707050d2401140d070114104a070b09"><span class="__cf_email__" data-cfemail="245747454d6441544d474154500a474b49">[email protected]</span></a>. J.A.W.: Myriad Pharmaceuticals, 320 Wakara Way, Salt Lake City, UT 84108; tel, 801-883-3846; fax, 801-548-3603; e-mail, <a href="/cdn-cgi/l/email-protection#49282d2824673e202525283b2d3a2c270924303b20282d3921283b2428672a2624"><span class="__cf_email__" data-cfemail="abcacfcac685dcc2c7c7cad9cfd8cec5ebc6d2d9c2cacfdbc3cad9c6ca85c8c4c6">[email protected]</span></a></div><div class="corresp-fn" id="afn3">†EpiCept Corporation.</div><div class="corresp-fn" id="afn4">‡Myriad Pharmaceuticals Inc.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm801315b&amp;href=/doi/10.1021%2Fjm801315b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 2341–2351</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 18, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 October 2008</li><li><span class="item_label"><b>Published</b> online</span>18 March 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm801315b" title="DOI URL">https://doi.org/10.1021/jm801315b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2341%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNilantha%2BSirisoma%252C%2BAzra%2BPervin%252C%2BHong%2BZhang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D8%26contentID%3Djm801315b%26title%3DDiscovery%2Bof%2BN-%25284-Methoxyphenyl%2529-N%252C2-dimethylquinazolin-4-amine%252C%2Ba%2BPotent%2BApoptosis%2BInducer%2Band%2BEfficacious%2BAnticancer%2BAgent%2Bwith%2BHigh%2BBlood%2BBrain%2BBarrier%2BPenetration%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2351%26publicationDate%3DApril%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm801315b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4575</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">81</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm801315b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-(4-Methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a Potent Apoptosis Inducer and Efficacious Anticancer Agent with High Blood Brain Barrier Penetration&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nilantha&quot;,&quot;last_name&quot;:&quot;Sirisoma&quot;},{&quot;first_name&quot;:&quot;Azra&quot;,&quot;last_name&quot;:&quot;Pervin&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Songchun&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Adam Willardsen&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;B. Anderson&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Mather&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;M. Pleiman&quot;},{&quot;first_name&quot;:&quot;Shailaja&quot;,&quot;last_name&quot;:&quot;Kasibhatla&quot;},{&quot;first_name&quot;:&quot;Ben&quot;,&quot;last_name&quot;:&quot;Tseng&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Drewe&quot;},{&quot;first_name&quot;:&quot;Sui&quot;,&quot;last_name&quot;:&quot;Xiong Cai&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;2341-2351&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm801315b&quot;},&quot;abstract&quot;:&quot;As a continuation of our structure−activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the replacement of the 2-Cl group in our lead compound 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine (6b, EP128265, MPI-0441138) by other functional groups. This SAR study and lead optimization resulted in the identification of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine (6h, EP128495, MPC-6827) as an anticancer clinical candidate. Compound 6h was found to be a potent apoptosis inducer with EC50 of 2 nM in our cell-based apoptosis induction assay. It also has excellent blood brain barrier penetration, and is highly efficacious in human MX-1 breast and other mouse xenograft cancer models.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801315b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801315b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801315b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801315b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm801315b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801315b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm801315b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm801315b&amp;href=/doi/10.1021/jm801315b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm801315b" /></input><a href="/doi/pdf/10.1021/jm801315b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (471 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm801315b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm801315b%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DSirisoma%26date%3D2009%26atitle%3DDiscovery%2Bof%2BN-%25284-Methoxyphenyl%2529-N%252C2-dimethylquinazolin-4-amine%252C%2Ba%2BPotent%2BApoptosis%2BInducer%2Band%2BEfficacious%2BAnticancer%2BAgent%2Bwith%2BHigh%2BBlood%2BBrain%2BBarrier%2BPenetration%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D8%26spage%3D2341%26epage%3D2351%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291149" title="Apoptosis">Apoptosis</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0015.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">As a continuation of our structure−activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the replacement of the 2-Cl group in our lead compound 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>6b</b>, EP128265, MPI-0441138) by other functional groups. This SAR study and lead optimization resulted in the identification of <i>N</i>-(4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (<b>6h</b>, EP128495, MPC-6827) as an anticancer clinical candidate. Compound <b>6h</b> was found to be a potent apoptosis inducer with EC<sub>50</sub> of 2 nM in our cell-based apoptosis induction assay. It also has excellent blood brain barrier penetration, and is highly efficacious in human MX-1 breast and other mouse xenograft cancer models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Currently, cancer is the second leading cause of death in the United States and could become the most common cause in the future.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Cancer treatment utilizing chemotherapy agents, including paclitaxel and docetaxel, has been a mainstay.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Recent advancements have come with the discovery and development of small molecule targeted therapies. These include the BCR-ABL kinase inhibitor imatinib for chronic myeloid leukemia (CML) and gastrointestinal stromal tumor (GIST<a class="ref internalNav" href="#fn3" aria-label="a">a</a>),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib for nonsmall cell lung cancer (NSCLC),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> the multikinase inhibitor sorafenib for kidney and liver cancers,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> an inhibitor of EGFR and HER-2 kinases lapatinib ditosylate for breast cancer,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> a multikinase inhibitor sunitinib for advanced renal cell carcinoma (RCC) and imatinib refractory/intolerant GIST,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> a proteasome inhibitor bortezomib for multiple myeloma,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and an inhibitor of mTOR (mammalian target of rapamycin) temsirolimus for advanced kidney cancer.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><div class="NLM_fn" id="fn3">a<p class="last">Abbreviations: SAR, structure−activity relationship; GIST, gastrointestinal stromal tumor; EGFR, epidermal growth factor receptor; BBB, blood brain barrier; CSF, cerebrospinal fluid; ASAP, Anticancer Screening Apoptosis Program; HTS, high throughput screening; iv, intravenous; AUC, area under the concentration−time curves; HBD, hydrogen bond donor; N+O, nitrogen plus oxygen; HBA, hydrogen bond acceptors; ADMET, absorption, distribution, metabolism, excretion and toxicity.</p></div></div><div class="NLM_p">Unfortunately, relatively little progress has been made for the treatment of neurologic cancers. One of the reasons is that the blood brain barrier (BBB) effectively prevents many traditional and newer anticancer drugs from entering the brain parenchyma.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> For example, the EGFR inhibitor erlotinib was reported to have cerebrospinal fluid (CSF) penetration of 7% (CSF/plasma),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and EGFR inhibitors gefitinib and erlotinib have been reported to show limited activity in clinical trials in brain cancers.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, the brain concentration of another kinase inhibitor, lapatinib, was reported to be low as determined by whole-body autoradiography.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Currently, there are only a few treatment options available for malignant glioma including surgery, radiotherapy and DNA-damaging chemotherapies such as temozolomide.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Apoptosis is known to play an important role in tumor biology.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Improper or excessive inhibition of apoptosis could lead to unchecked cell proliferation as well as resistance to cancer treatment.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> It has been well-established that anticancer agents like the camptothecins, such as topotecan and irinotecan,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and vinca alkaloids, such as vincristine and vinblastine,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> kill tumors at least partially through induction of apoptosis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Hence, many novel approaches to activate and promote apoptosis in cancer cells<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> via targeting regulators of apoptosis are currently being explored.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> We therefore have developed a cell-based Anticancer Screening Apoptosis Program (ASAP) high throughput screening (HTS) assay to identify apoptosis inducers through measurement of caspase activation.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a></div><div class="NLM_p">We have previously reported the discovery of several novel series of potent apoptosis inducers, including <i>N</i>-phenyl nicotinamides (<b>1a</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> gambogic acid (<b>1b</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> 4-aryl-4<i>H</i>-chromenes (<b>1c</b>),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> 3-aryl-5-aryl-1,2,4-oxadiazoles (<b>1d</b>),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> 4-anilino-2-(2-pyridyl)pyrimidines (<b>1e</b>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and <i>N</i>-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinolin-4-amines (<b>1f</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> using our HTS assays (Chart <a class="ref internalNav" href="#cht1" aria-label=""></a>). More recently, we reported the discovery of <i>N</i><sup>4</sup>-(4-methoxyphenyl)-<i>N</i><sup>4</sup>-methyl-<i>N</i><sup>2</sup>-((<i>E</i>)-3,7-dimethylocta-2,6-dienyl)quinazoline-2,4-diamine (<b>6a</b>) as a potent apoptosis inducer using our cell- and caspase-based HTS assay and the identification of 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>6b</b>), as a highly potent apoptosis inducer with <i>in vivo</i> anticancer activity and high BBB penetration.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In our quest to optimize this class of anticancer agents, the 2-Cl group in <b>6b</b>, a potential liability due to its chemical reactivity, was replaced by other functional groups. Herein we report that this SAR study and lead optimization resulted in the identification of <i>N</i>-(4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (<b>6h</b>, EP128495, MPC-6827, Azixa), an anticancer clinical candidate with potent apoptosis inducing activity, high BBB penetration, good pharmacokinetics and high efficacies in several <i>in vivo</i> anticancer models.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0001.jpeg" id="gc1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16173" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16173" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Compounds <b>6h−6k</b> were prepared in three steps as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 4-Chloro-2-methyl-quinazoline (<b>4a</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> was prepared via reaction of 2-aminobenzoic acid methyl ester and acetonitrile (<b>2a</b>) in the presence of HCl to produce 2-methyl-quinazolin-4-ol (<b>3a</b>), followed by treatment of <b>3a</b> with freshly distilled POCl<sub>3</sub> in anhydrous toluene and diisopropylethylamine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Reaction of <b>4a</b> with <i>N</i>-methyl-4-methoxyaniline (<b>5a</b>) in anhydrous isopropanol (IPA) in the presence of concentrated HCl produced <i>N</i>-(4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (<b>6h</b>) as its hydrochloride salt. In a similar fashion, compounds <b>6i</b>−<b>6k</b> were prepared in three steps via replacing acetonitrile with propiononitrile, fluoroacetonitrile and chloroacetonitrile, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Compounds <b>6l</b>, <b>6m</b> were prepared via reaction of <b>6k</b> with sodium hydroxy and dimethylamine, respectively (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0006.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) RCN (<b>2</b>), HCl(g); (b) POCl<sub>3</sub>, DIPEA, toluene; (c) 4-MeO-PhNHMe (<b>5a</b>), IPA, HCl; (d) NaOH; (e) NHMe<sub>2</sub>.</p></p></figure><div class="NLM_p">Compounds <b>6c</b>−<b>6f</b> were prepared via displacement of the chloro group in <b>6b</b> with the corresponding nucleophiles (NaOMe, NHMe<sub>2</sub>, NH<sub>2</sub>Me, NH<sub>2</sub>NH<sub>2</sub>); reaction of <b>6e</b> with acetyl chloride subsequently produced the amide <b>6g</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0007.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>6c</b>, NaOMe; <b>6d</b>, NHMe<sub>2</sub>; <b>6e</b>, NH<sub>2</sub>Me; <b>6f</b>, NH<sub>2</sub>NH<sub>2</sub>; (b) AcCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">Compounds <b>7a</b> and <b>7b</b> were prepared from reaction of <b>4a</b> with the corresponding <i>N</i>-Me-aniline <b>5b</b> and <b>5c</b> in the presence of a base such as NaH or NaAc. Compound <b>9a</b> was prepared from reaction of <b>4a</b> with 4-methoxyaniline <b>8a</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0008.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>7a</b>, 4-NO<sub>2</sub>−PhNHMe, NaH, DMF; <b>7b</b>, 4-F-PhNHMe, NaAc, THF/H<sub>2</sub>O; <b>9a</b>, 4-MeO-PhNH<sub>2</sub>, IPA, HCl.</p></p></figure><div class="NLM_p"><i>N</i>-(4-Ethoxyphenyl)-2-methylquinazolin-4-amine (<b>9b</b>) was prepared via reaction of <b>4a</b> with 4-ethoxyaniline <b>8b</b>. Reaction of <b>9b</b> with methyl iodide in the presence of sodium hydride produced <i>N</i>-(4-ethoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (<b>7c</b>) (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). In a similar fashion the following compounds were prepared. Reaction of <b>4a</b> with substituted aniline <b>8c</b>−<b>8g</b>; or substituted pyridyl-amine (<b>8i</b>, <b>8j</b>); or substituted pyrimidyl-amine <b>8k</b> or pyrazinyl-amine <b>8l</b> produced compounds <b>9c</b>−<b>9m</b>. Reaction of <b>9c</b>−<b>9m</b> with methyl iodide in the presence of sodium hydride smoothly produced compounds <b>7d</b>−<b>7f</b> and <b>7l</b>−<b>7s</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, and see Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> for structures). The 4-hydroxyl analogue <b>7h</b> was prepared from demethylation of <b>6h</b> via treatment with boron tribromide.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0009.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) ArNH<sub>2</sub> (<b>8</b>), NaAc, THF/H<sub>2</sub>O; (b) MeI, NaH, DMF.</p></p></figure><div class="NLM_p">4-Amino compound <b>7i</b> was prepared from hydrogenation of 4-nitro analogue <b>7a</b>. Treatment of <b>7i</b> with formaldehyde and sodium cyanoborohydride produced the dimethylamino analogue <b>7g</b>. Reaction of <b>7i</b> with acetic anhydride produced the acetamide <b>7k</b>. The azido analogue <b>7j</b> was prepared via reaction of <b>7i</b> with sodium nitrite in aqueous HCl followed by treatment with sodium azide. The corresponding tritium labeled analogue <b>7v</b> was prepared in three steps. Reaction of <b>7i</b> with bromine produced the dibromo analogue <b>7t</b>, which was treated with tritium gas under hydrogenation conditions to produce the ditritium analogue <b>7u</b>. Diazotization of <b>7u</b> followed by treatment with sodium azide, using procedures similar to the preparation of the cold azido analogue <b>7j</b>, produced tritium analogue <b>7v</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0010.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) H<sub>2</sub>, Pd/C, EtOH; (b) HCHO, sodium cyanoborohydride; (c) Br<sub>2</sub>, AcOH; (d) T<sub>2</sub>, Pd/C, EtOH; (e) NaNO<sub>2</sub>, HCl, then NaN<sub>3</sub>.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> HTS and SAR Studies</h3><div class="NLM_p">The apoptosis inducing activities of 4-anilinoquinozalines were measured using our proprietary cell- and caspase-based HTS assay in human breast cancer cells T47D, human colorectal carcinoma cells HCT116 and hepatocellular carcinoma cancer SNU-398 cells as described previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In brief, the cancer cells were placed in a 384-well microtiter plate containing various concentration of test compound and incubated at 37 °C for 24 h. After incubation, the samples were treated with a fluorogenic substrate <i>N</i>-(Ac-DEVD)-<i>N’</i>-ethoxycarbonyl-R110. The caspase activation activity (EC<sub>50</sub>) is summarized in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>−<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of 4-(4-Methoxyanilino)quinazolines in the Caspase Activation Assay</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0011.gif" alt="" id="gr9" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl1-fn2" aria-label="b">b</a></th></tr><tr valign="top"><th align="center" valign="middle">entry</th><th align="center" valign="middle">R<sub>1</sub></th><th align="center" valign="middle">R<sub>2</sub></th><th align="center" valign="middle" char=".">T47D</th><th align="center" valign="middle" char=".">HCT116</th><th align="center" valign="middle">SNU-398</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6a</b></td><td align="left">Me</td><td align="left">NHR<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></td><td align="char" char=".">0.29 ± 0.020</td><td align="char" char=".">0.46 ± 0.098</td><td align="left">0.27 ± 0.03</td></tr><tr valign="top"><td align="left"><b>6b</b></td><td align="left">Me</td><td align="left">Cl</td><td align="char" char=".">0.002 ± 0.0001</td><td align="char" char=".">0.002 ± 0.0001</td><td align="left">0.002 ± 0.0001</td></tr><tr valign="top"><td align="left"><b>6c</b></td><td align="left">Me</td><td align="left">OMe</td><td align="char" char=".">0.004 ± 0.0002</td><td align="char" char=".">0.004 ± 0.0005</td><td align="left">0.003 ± 0.0002</td></tr><tr valign="top"><td align="left"><b>6d</b></td><td align="left">Me</td><td align="left">NMe<sub>2</sub></td><td align="char" char=".">0.015 ± 0.001</td><td align="char" char=".">0.043 ± 0.006</td><td align="left">0.033 ± 0.004</td></tr><tr valign="top"><td align="left"><b>6e</b></td><td align="left">Me</td><td align="left">NHMe</td><td align="char" char=".">0.008 ± 0.001</td><td align="char" char=".">0.009 ± 0.002</td><td align="left">0.005 ± 0.0003</td></tr><tr valign="top"><td align="left"><b>6f</b></td><td align="left">Me</td><td align="left">NHNH<sub>2</sub></td><td align="char" char=".">0.023 ± 0.004</td><td align="char" char=".">0.036 ± 0.007</td><td align="left">0.020 ± 0.002</td></tr><tr valign="top"><td align="left"><b>6g</b></td><td align="left">Me</td><td align="left">NMeAc</td><td align="char" char=".">0.009 ± 0.0004</td><td align="char" char=".">0.009 ± 0.001</td><td align="left">0.010 ± 0.001</td></tr><tr valign="top"><td align="left"><b>6h</b></td><td align="left">Me</td><td align="left">Me</td><td align="char" char=".">0.002 ± 0.0001</td><td align="char" char=".">0.003 ± 0.0002</td><td align="left">0.002 ± 0.0003</td></tr><tr valign="top"><td align="left"><b>6i</b></td><td align="left">Me</td><td align="left">Et</td><td align="char" char=".">0.009 ± 0.0002</td><td align="char" char=".">0.013 ± 0.001</td><td align="left">0.008 ± 0.001</td></tr><tr valign="top"><td align="left"><b>6j</b></td><td align="left">Me</td><td align="left">CH<sub>2</sub>F</td><td align="char" char=".">0.002 ± 0.0002</td><td align="char" char=".">0.002 ± 0.0001</td><td align="left">0.001 ± 0.0001</td></tr><tr valign="top"><td align="left"><b>6k</b></td><td align="left">Me</td><td align="left">CH<sub>2</sub>Cl</td><td align="char" char=".">0.048 ± 0.007</td><td align="char" char=".">0.048 ± 0.011</td><td align="left">ND<a class="ref internalNav" href="#tbl1-fn3" aria-label="c">c</a></td></tr><tr valign="top"><td align="left"><b>6l</b></td><td align="left">Me</td><td align="left">CH<sub>2</sub>OH</td><td align="char" char=".">0.002 ± 0.0002</td><td align="char" char=".">0.004 ± 0.0001</td><td align="left">0.002 ± 0.0001</td></tr><tr valign="top"><td align="left"><b>6m</b></td><td align="left">Me</td><td align="left">CH<sub>2</sub>NMe<sub>2</sub></td><td align="char" char=".">1.8 ± 0.06</td><td align="char" char=".">2.6 ± 0.02</td><td align="left">2.0 ± 0.09</td></tr><tr valign="top"><td align="left"><b>9a</b></td><td align="left">H</td><td align="left">Me</td><td align="char" char=".">6.4 ± 0.38</td><td align="char" char=".">6.1 ± 0.32</td><td align="left">5.3 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">R = <img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0012.gif" alt="" id="gr10" /></img> .</p></div><div class="footnote" id="tbl1-fn2"><sup>b</sup><p class="last">Data are the mean of three or more experiments and are reported as mean  <b>±</b> standard error of the mean (SEM).</p></div><div class="footnote" id="tbl1-fn3"><sup>c</sup><p class="last">ND, not determined.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of <i>N</i>,2-Dimethyl-4-anilinoquinazolines in the Caspase Activation Assay</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0013.gif" alt="" id="gr6" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="14.265335235378032%" align="left" /></col><col width="14.265335235378032%" align="left" /></col><col width="14.265335235378032%" align="left" /></col><col width="14.265335235378032%" align="left" /></col><col width="14.265335235378032%" align="char" char="." /></col><col width="14.122681883024251%" align="char" char="." /></col><col width="14.550641940085592%" align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">entry</th><th align="center" valign="middle">R<sub>2</sub></th><th align="center" valign="middle">R<sub>3</sub></th><th align="center" valign="middle">R<sub>4</sub></th><th align="center" valign="middle" char=".">T47D</th><th align="center" valign="middle" char=".">HCT116</th><th align="center" valign="middle" char=".">SNU-398</th></tr></thead><tbody><tr valign="top"><td align="left"><b>7a</b></td><td align="left">H</td><td align="left">H</td><td align="left">NO<sub>2</sub></td><td align="char" char=".">0.74 ± 0.05</td><td align="char" char=".">1.3 ± 0.01</td><td align="char" char=".">0.62 ± 0.01</td></tr><tr valign="top"><td align="left"><b>7b</b></td><td align="left">H</td><td align="left">H</td><td align="left">F</td><td align="char" char=".">0.42 ± 0.001</td><td align="char" char=".">0.63 ± 0.001</td><td align="char" char=".">0.39 ± 0.038</td></tr><tr valign="top"><td align="left"><b>7c</b></td><td align="left">H</td><td align="left">H</td><td align="left">OEt</td><td align="char" char=".">0.004 ± 0.0001</td><td align="char" char=".">0.004 ± 0.0004</td><td align="char" char=".">0.004 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7d</b></td><td align="left">H</td><td align="left">H</td><td align="left">OCHF<sub>2</sub></td><td align="char" char=".">0.009 ± 0.0002</td><td align="char" char=".">0.011 ± 0.002</td><td align="char" char=".">0.010 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7e</b></td><td align="left">H</td><td align="left">H</td><td align="left">SMe</td><td align="char" char=".">0.004 ± 0.0004</td><td align="char" char=".">0.003 ± 0.0004</td><td align="char" char=".">0.003 ± 0.0003</td></tr><tr valign="top"><td align="left"><b>7f</b></td><td align="left">H</td><td align="left">H</td><td align="left">Et</td><td align="char" char=".">0.031 ± 0.003</td><td align="char" char=".">0.026 ± 0.002</td><td align="char" char=".">0.021 ± 0.002</td></tr><tr valign="top"><td align="left"><b>7g</b></td><td align="left">H</td><td align="left">H</td><td align="left">NMe<sub>2</sub></td><td align="char" char=".">0.016 ± 0.002</td><td align="char" char=".">0.019 ± 0.004</td><td align="char" char=".">0.019 ± 0.002</td></tr><tr valign="top"><td align="left"><b>7h</b></td><td align="left">H</td><td align="left">H</td><td align="left">OH</td><td align="char" char=".">0.086 ± 0.007</td><td align="char" char=".">0.13 ± 0.007</td><td align="char" char=".">0.088 ± 0.015</td></tr><tr valign="top"><td align="left"><b>7i</b></td><td align="left">H</td><td align="left">H</td><td align="left">NH<sub>2</sub></td><td align="char" char=".">0.18 ± 0.02</td><td align="char" char=".">0.25 ± 0.01</td><td align="char" char=".">0.17 ± 0.03</td></tr><tr valign="top"><td align="left"><b>7j</b></td><td align="left">H</td><td align="left">H</td><td align="left">N<sub>3</sub></td><td align="char" char=".">0.011 ± 0.002</td><td align="char" char=".">0.012 ± 0.001</td><td align="char" char=".">0.011 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7k</b></td><td align="left">H</td><td align="left">H</td><td align="left">NHAc</td><td align="char" char=".">0.059 ± 0.003</td><td align="char" char=".">0.083 ± 0.009</td><td align="char" char=".">0.066 ± 0.006</td></tr><tr valign="top"><td align="left"><b>7l</b></td><td align="left">H</td><td align="left">F</td><td align="left">OMe</td><td align="char" char=".">0.002 ± 0.0001</td><td align="char" char=".">0.002 ± 0.0001</td><td align="char" char=".">0.002 ± 0.0001</td></tr><tr valign="top"><td align="left"><b>7m</b></td><td align="left">F</td><td align="left">H</td><td align="left">OMe</td><td align="char" char=".">0.004 ± 0.0001</td><td align="char" char=".">0.004 ± 0.0003</td><td align="char" char=".">0.004 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7n</b></td><td align="left">H</td><td align="left">OMe</td><td align="left">OMe</td><td align="char" char=".">0.010 ± 0.001</td><td align="char" char=".">0.014 ± 0.0002</td><td align="char" char=".">0.013 ± 0.001</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are the mean of three or more experiments and are reported as mean ± standard error of the mean (SEM).</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of <i>N</i>,2-Dimethyl-4-arylaminoquinazolines in the Caspase Activation Assay</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0014.gif" alt="" id="gr7" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char="±">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">entry</th><th align="center" valign="middle">A</th><th align="center" valign="middle">B</th><th align="center" valign="middle">D</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char="±">T47D</th><th align="center" valign="middle" char="±">HCT116</th><th align="center" valign="middle" char="±">SNU-398</th></tr></thead><tbody><tr valign="top"><td align="left"><b>7o</b></td><td align="left">N</td><td align="left">C</td><td align="left">C</td><td align="left">OMe</td><td align="char" char="±">0.011 ± 0.001</td><td align="char" char="±">0.015 ± 0.001</td><td align="char" char="±">0.010 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7p</b></td><td align="left">C</td><td align="left">N</td><td align="left">C</td><td align="left">OMe</td><td align="char" char="±">0.016 ± 0.001</td><td align="char" char="±">0.044 ± 0.007</td><td align="char" char="±">0.018 ± 0.001</td></tr><tr valign="top"><td align="left"><b>7q</b></td><td align="left">N</td><td align="left">C</td><td align="left">C</td><td align="left">NMe<sub>2</sub></td><td align="char" char="±">0.015 ± 0.001</td><td align="char" char="±">0.033 ± 0.006</td><td align="char" char="±">0.020 ± 0.002</td></tr><tr valign="top"><td align="left"><b>7r</b></td><td align="left">N</td><td align="left">C</td><td align="left">N</td><td align="left">OMe</td><td align="char" char="±">0.053 ± 0.003</td><td align="char" char="±">0.075 ± 0.008</td><td align="char" char="±">0.049 ± 0.002</td></tr><tr valign="top"><td align="left"><b>7s</b></td><td align="left">C</td><td align="left">N</td><td align="left">N</td><td align="left">OMe</td><td align="char" char="±">0.15 ± 0.008</td><td align="char" char="±">0.15 ± 0.008</td><td align="char" char="±">0.13 ± 0.004</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Data are the mean of three or more experiments and are reported as mean  <b>±</b> standard error of the mean (SEM).</p></div></div></div><div class="NLM_p">We have found that the methyl group on the nitrogen linker was essential for the apoptosis inducing activity, and substitution in the 6- and 7-positions of the quinazoline core structure resulted in decreased apoptosis inducing activity.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Since the Cl group in the 2-position of our lead compound <b>6b</b> could be a potential liability due to its chemical reactivity, we expanded our SAR study by replacing the 2-Cl group with other functional groups. As expected, the Cl group in <b>6b</b> was replaced by nucleophiles to produce compounds <b>6c</b>−<b>6f</b>. These analogues in general were less active than <b>6b</b> in the caspase activation assay. The 2-OMe analogue <b>6c</b> and the 2-NHMe analogue <b>6e</b>, with a small hydrophobic group at the 2-position, were the more potent ones giving EC<sub>50</sub> values of 4 and 8 nM, respectively. The more polar hydrazino analogue <b>6f</b> was the least potent one of this cluster of analogues, with an EC<sub>50</sub> value of 23 nM while the amide <b>6g</b> was more active with an EC<sub>50</sub> value of 9 nM.</div><div class="NLM_p">Since methyl is a small hydrophobic group with good chemical stability, we decided to replace the 2-chloro group in <b>6b</b> with a methyl group. Compound <b>6h</b> was found to be highly potent with an EC<sub>50</sub> value of 2 nM, a potency similar to that of <b>6b</b> in the caspase activation assay. Other alkyl and substituted alkyl groups were also introduced in the 2-position, including CH<sub>2</sub>F, CH<sub>2</sub>Cl, Et, CH<sub>2</sub>OH and CH<sub>2</sub>NMe<sub>2</sub> (<b>6i</b>−<b>6m</b>). Several of these compounds were also highly potent in our caspase activation assay. For example, the 2-CH<sub>2</sub>F analogue <b>6j</b> and 2-CH<sub>2</sub>OH analogue <b>6l</b> had potencies similar to that of <b>6h</b>. Similarly as observed above, compounds with large or polar groups in the 2-position, such as <b>6m</b>, were much less potent as inducers of apoptosis. Compound <b>9a</b>, with a hydrogen in the linker nitrogen instead of a Me group as in <b>6h</b>, was found to have an EC<sub>50</sub> value of 6400 nM, which is >3000-fold less active than <b>6h</b>, confirming our previous observation that a methyl group on the linker nitrogen was critical for the apoptosis inducing activity of <b>6h</b> and related compounds.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">We then explored the SAR of compound <b>6h</b> through altering the substitutions in the anilino ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), while keeping the 2-methyl-quinazoline ring as a “fixed” unit. The 4-nitro analogue <b>7a</b> and 4-fluoro analogue <b>7b</b> were >100-fold less potent than <b>6h</b>, indicating that an electron-withdrawing group was not preferred, in agreement with what we reported previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The 4-OEt <b>7c</b>, 4-OCHF<sub>2</sub><b>7d</b>, 4-SMe <b>7e</b> and 4-NMe<sub>2</sub><b>7g</b> analogues were all highly potent, only slightly less active than <b>6h</b>, indicating that a small hydrophobic and electron-donating group was preferred at the 4-position. The 4-OCHF<sub>2</sub> group in <b>7d</b>, a potentially more metabolically stable group, was introduced since the demethylation metabolite of <b>6h</b>, the 4-OH analogue <b>7h</b>, was significantly less active (see below). The basic 4-NMe<sub>2</sub> group in <b>7g</b> was intended to increase the aqueous solubility of the compound by using suitable salt forms. Interestingly, the 4-Et analogue <b>7f</b> was about 10-fold less potent than <b>6h</b>, indicating that a heteroatom was preferred in that position. The 4-OH analogue <b>7h</b> and 4-NH<sub>2</sub> analogue <b>7i</b> were >40-fold less potent than <b>6h</b>, indicating that a hydrophilic group was not preferred at the 4-position. The 4-azido analogue <b>7j</b> was found to have good activity with an EC<sub>50</sub> value of 16 nM, which allowed us to make a tritium labeled version <b>7v</b> that was used to identify tubulin as the primary molecular target of these apoptosis inducing 4-anilinoquinazolines.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The aromatic disubstituted analogues <b>7l</b>−<b>7n</b> were found to be highly potent with EC<sub>50</sub> values of 2−10 nM. The electron-withdrawing fluoro group in <b>7l</b> and <b>7m</b> could increase the metabolic stability of the phenyl ring.</div><div class="NLM_p">We also explored the replacement of the anilino group in <b>6h</b> by pyridylamino and other heterocyclic-amino groups (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The pyridyl analogues <b>7o</b>−<b>7q</b> were 5−8-fold less potent than <b>6h</b> but still highly active with EC<sub>50</sub> values in the 11−16 nM range. These pyridyl analogues, especially compound <b>7q</b>, were intended to be more hydrophilic and, thus, more soluble in aqueous media than <b>6h</b>. Unfortunately, the pirazinyl analogue <b>7r</b> and pyrimidyl analogue <b>7s</b> were about 25- and 75-fold less active than <b>6h</b>, respectively. Overall, these data indicated that the more hydrophobic phenyl ring was preferred over the nitrogen containing heterocycles.</div><div class="NLM_p">The activities of these compounds toward the HCT116 and SNU-398 cells were roughly parallel to their activity toward T47D cells. Compound <b>6h</b> was highly active in HCT116 and SNU-398 cells with EC<sub>50</sub> values of 3 nM and 2 nM, respectively, similar to its high activity in T47D cells. Compound <b>9a</b> was much less potent with EC<sub>50</sub> values of 6100 nM and 5300 nM in HCT116 and SNU-398 cells, respectively. This further confirmed the importance of the <i>N</i>-Me group for apoptosis inducing activity.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Selected compounds were further evaluated in the traditional growth inhibition assay to confirm that potent compounds in the ASAP assay can inhibit cancer cell growth. The growth inhibition assays in T47D, HCT116 and SNU-398 cell lines were run in a 96-well microtiter plate as described previously.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Briefly, the cancer cells in a 96-well microtiter plate were treated with serial concentrations of test compound for 48 h. The survival profiles of the cells were quantitated using the CellTiter-Glo (Promega, Madison, WI) according to the manufacturer’s protocol. The GI<sub>50</sub> values are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Compound <b>6h</b> was found to be one of the most potent inhibitors of cancer cell growth among the compounds tested, with GI<sub>50</sub> values of 3−6 nM in T47D, HCT116 and SNU-398 cells. Compounds <b>6c</b> and <b>6i</b> also were highly active with GI<sub>50</sub> values similar to that of <b>6h</b>. Compound <b>9a</b> was much less potent in the growth inhibition assay, with GI<sub>50</sub> values of 4200 to 6500 nM. This again confirmed that the <i>N</i>-Me group was important for both the apoptosis inducing and growth inhibiting activity of <b>6h</b> and related compounds.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibition of Cell Growth of 4-Arylaminoquinazolines</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">GI<sub>50</sub> (μM)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></th></tr><tr valign="top"><th align="center" valign="middle">entry</th><th align="center" valign="middle" char=".">T47D</th><th align="center" valign="middle" char=".">HCT116</th><th align="center" valign="middle" char=".">SNU-398</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6c</b></td><td align="char" char=".">0.006 ± 0.001</td><td align="char" char=".">0.006 ± 0.001</td><td align="char" char=".">0.003 ± 0.001</td></tr><tr valign="top"><td align="left"><b>6h</b></td><td align="char" char=".">0.006 ± 0.001</td><td align="char" char=".">0.006 ± 0.001</td><td align="char" char=".">0.003 ± 0.0003</td></tr><tr valign="top"><td align="left"><b>6i</b></td><td align="char" char=".">0.007 ± 0.001</td><td align="char" char=".">0.012 ± 0.002</td><td align="char" char=".">0.008 ± 0.001</td></tr><tr valign="top"><td align="left"><b>9a</b></td><td align="char" char=".">5.2 ± 0.60</td><td align="char" char=".">6.5 ± 0.79</td><td align="char" char=".">4.2 ± 0.51</td></tr><tr valign="top"><td align="left"><b>7o</b></td><td align="char" char=".">0.039 ± 0.013</td><td align="char" char=".">0.046 ± 0.010</td><td align="char" char=".">0.019 ± 0.003</td></tr><tr valign="top"><td align="left"><b>7s</b></td><td align="char" char=".">0.76 ± 0.03</td><td align="char" char=".">1.0 ± 0.04</td><td align="char" char=".">0.39 ± 0.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Data are the mean of three or more experiments and are reported as mean ± standard error of the mean (SEM).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Characterization of 6h and Related Compounds</h3><div class="NLM_p">Utilizing the tritium labeled compound <b>7v</b>, the primary molecular target of <b>6h</b> has been identified as tubulin.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Mechanistically, <b>6h</b> was found to inhibit tubulin polymerization with potency equal to that of vinblastine and to bind at or near the colchicine site.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Compound <b>6h</b> was also found to be effective in multi drug resistant cancer cell lines including P388/ADR, NCI/ADR-RES, MCF-7/MX, MCF-7/VP, with similar GI<sub>50</sub> values against cancer cell lines and drug resistant cancer cell lines,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> suggesting that it may be useful for the treatment of drug resistant cancers.</div><div class="NLM_p">The apoptosis inducing activity of <b>6h</b> was also confirmed in a flow cytometry assay. T47D cells were treated with 5 nM of <b>6h</b> for 24 or 48 h, stained with propidium iodide, and analyzed by flow cytometry. An increase in the G<sub>2</sub>/M DNA content in cells treated with compound <b>6h</b> was observed, as shown in Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B and <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C. The subdiploid DNA content (apoptotic sub-G<sub>1</sub> area) of cells increased from 1% in the control cells (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) to 15% upon compound treatment for 24 h (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B) and 34% after 48 h treatment (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C), indicating the presence of apoptotic cells which have undergone DNA degradation and nuclear fragmentation. Previously we reported that when Jurkat cells were treated with 10 nM of <b>6h</b> for 18 h, 68% of the cells were apoptotic with subdiploid DNA content as measured by flow cytometry. The apoptotic cells were decreased to 11% in the presence of a specific caspase inhibitor, confirming the apoptotic nature of the subdiploid DNA content.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug-induced apoptosis in T47D cells as measured by flow cytometric analysis. The <i>x</i>-axis is the fluorescence intensity, and the <i>y</i>-axis is the number of cells with that fluorescence intensity. A: Control cells showing most of the cells in G<sub>1</sub> phase of the cell cycle. B: Cells treated with 5 nM of compound <b>6h</b> for 24 h showing most of the cells arrested in G<sub>2</sub>/M phase. C: Cells treated with 5 nM of compound <b>6h</b> for 48 h showing a progression from G<sub>2</sub>/M to cells with subdiploid DNA content, which are apoptotic cells with fragmented nuclei.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, compound <b>6h</b> was found to be highly active in several <i>in vivo</i> anticancer models. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> shows that <b>6h</b> was highly efficacious in a MX-1 breast tumor model. No tumor growth was observed when <b>6h</b> was dosed at 7.5 and 10 mg/kg once weekly for three weeks. At 5 mg/kg <b>6h</b> also effectively inhibited the growth of MX-1 tumors. In addition, compound <b>6h</b> also significantly (<i>p</i> < 0.05) inhibited tumor growth in B16-F1 allograft and OVCAR-3, MIAPaCa-2, MCF-7, HT-29 and MDA-MB-435 xenograft models as reported previously.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>6h</b> inhibited the growth of established (∼100 mm<sup>3</sup>) MX-1 tumor xenografts in Crl:Nu/Nu-nuBR mice. Compound <b>6h</b> was dosed iv at 5, 7.5 or 10 mg/kg once weekly for three weeks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Using plasma from blood samples and homogenized whole brain samples, the brain to plasma ratio of the area under the concentration−time curves (AUC) of <b>6h</b> after a single intravenous (iv) dose of 2.5 mg/kg in mice was determined via LC−MS/MS to be about 16 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), indicating that <b>6h</b> maintained the high BBB penetration observed for <b>6b</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In comparison, many anticancer drugs have been reported to have low BBB penetrations, including erlotinib,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> lapatinib,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> imatinib (CSF penetration of 5%),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> gefitinib,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> ABT-751 (CSF penetration of 1.1%),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> oxaliplatin, cisplatin, and carboplatin (CSF penetration of 2.0%, 3.6%, and 3.8%).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Since currently there are few active treatments available for brain cancer and one of the reasons is limited BBB penetration of many anticancer drugs,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the high BBB penetration of <b>6h</b> suggests that it could potentially be developed as an effective treatment for brain cancer.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK of compound <b>6h</b> in brain and plasma after a single iv dose of 2.5 mg/kg in mice. Median brain concentrations (open circles) and median plasma concentrations (open squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The brain/plasma AUC ratios of several compounds related with <b>6h</b> also were measured using the same method at dose of 2.5 mg/kg (iv) and the results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. It has been suggested that hydrogen bond donor (HBD) of <3, ClogP of 2−5 and molecular weight (MW) of <500 are preferred for potential BBB penetration.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In addition, two simple rules have been proposed that if the number of nitrogen plus oxygen (N+O) is five or less in a molecule, then it has a high chance of entering the brain; and if log P − (N+O) > 0, then log BB (brain/blood) is positive.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Introduction of more polar groups as well as nitrogen and oxygen into the structure of <b>6h</b> therefore was expected to reduce BBB penetration and the brain/plasma AUC ratio. Compound <b>6d</b>, with the 2-Me group replaced by a more polar NMe<sub>2</sub> group and one additional nitrogen than that of <b>6h</b>, reduced the brain/plasma AUC ratio from 16 to 4.0. Similarly, introduction of 1 or 2 more nitrogens via replacing the phenyl group in <b>6h</b> with a pyridyl (<b>7o</b>) or pyrazinyl (<b>7r</b>) decreased the brain/plasma AUC ratio to 5.8 and 1.9, respectively. These data confirmed that, in this series of compounds, increasing the number of hydrogen bond acceptors (HBA) or the total number of N+O resulted in less BBB penetration. Replacing the 4-OMe group in the phenyl ring by a more polar group such as the amino group in <b>7i</b> and acetamido in <b>7k</b> also reduced the ratio to 0.90 and 0.74, respectively, indicating that introduction of HBD effectively reduced the BBB penetration. Our data are in agreement with the low BBB penetration of 4-anilinoquinazoline based kinase inhibitors due to large numbers of N+O and HBD in the structures, including gefitinib (<b>10a</b>, 7 N+O, 1 HBD), erlotinib (<b>10b</b>, 7 N+O, 1 HBD) and lapatinib (<b>10c</b>, 8 N+O, 2 HBD), as well as ABT-751 (<b>10d</b>, 7 N+O, 3 HBD), which like <b>6h</b> is a tubulin inhibitor that binds to the colchicine site<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (Chart <a class="ref internalNav" href="#cht2" aria-label=""></a>). Compound <b>6h</b> appears to be optimized for BBB penetration while other potent compounds (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) with less BBB penetration could potentially be developed for peripheral indications.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. The Brain/Plasma Ratio of AUC of 4-Arylaminoquinazolines</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="12.468827930174564%" align="left" /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.593516209476311%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.593516209476311%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="bottom">entry</th><th align="center" valign="bottom" char=".">brain/plasma ratio of AUC</th><th align="center" valign="bottom" char=".">MW</th><th align="center" valign="bottom" char=".">no. of HBA</th><th align="center" valign="bottom" char=".">no. of HBD</th><th align="center" valign="bottom" char="."># of N+O</th><th align="center" valign="bottom" char=".">ClogP<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></th><th align="center" valign="bottom" char=".">EC<sub>50</sub> (nM) T47D<a class="ref internalNav" href="#tbl5-fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>6h</b></td><td align="char" char=".">16.0</td><td align="char" char="."> 279</td><td align="char" char=".">4</td><td align="char" char=".">0</td><td align="char" char=".">4</td><td align="char" char=".">4.18</td><td align="char" char=".">2</td></tr><tr valign="top"><td align="left"><b>7o</b></td><td align="char" char=".">5.8</td><td align="char" char=".">280</td><td align="char" char=".">5</td><td align="char" char=".">0</td><td align="char" char=".">5</td><td align="char" char=".">3.61</td><td align="char" char=".">11</td></tr><tr valign="top"><td align="left"><b>6d</b></td><td align="char" char=".">4.0</td><td align="char" char=".">308</td><td align="char" char=".">5</td><td align="char" char=".">0</td><td align="char" char=".">5</td><td align="char" char=".">4.59</td><td align="char" char=".">15</td></tr><tr valign="top"><td align="left"><b>7r</b></td><td align="char" char=".">1.9</td><td align="char" char=".">281</td><td align="char" char=".">6</td><td align="char" char=".">0</td><td align="char" char=".">6</td><td align="char" char=".">2.82</td><td align="char" char=".">53</td></tr><tr valign="top"><td align="left"><b>7i</b></td><td align="char" char=".">0.90</td><td align="char" char=".">264</td><td align="char" char=".">4</td><td align="char" char=".">2</td><td align="char" char=".">4</td><td align="char" char=".">3.02</td><td align="char" char=".">59</td></tr><tr valign="top"><td align="left"><b>7k</b></td><td align="char" char=".">0.74</td><td align="char" char=".">306</td><td align="char" char=".">5</td><td align="char" char=".">1</td><td align="char" char=".">5</td><td align="char" char=".">3.27</td><td align="char" char=".">180</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">Calculated using ChemDraw.</p></div><div class="footnote" id="tbl5-fn2"><sup>b</sup><p class="last">Data from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</p></div></div></div><figure id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0002.jpeg" id="gc2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In conclusion, through SAR studies and lead optimization, compound <b>6h</b> has been identified as an anticancer development candidate. In comparison with our original lead <b>6b</b>, compound <b>6h</b> does not have the potentially reactive 2-Cl, but still maintains the desirable properties of a potent apoptosis inducing agent with good BBB penetration and high efficacy in multiple anticancer <i>in vivo</i> models. The primary molecular target of <b>6h</b> has been identified as tubulin by using a tritium labeled photoaffinity labeling reagent. From our extensive SAR and ADMET (absorption, distribution, metabolism, excretion and toxicity) lead optimizations efforts, we discovered <i>N</i>-(4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (<b>6h</b>, EP128495, MPC-6827, Azixa), as an anticancer clinical candidate with potent apoptosis inducing activity. Azixa is currently under clinical development and reports concerning its progress in the clinic will be published in due course.</div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Methods and Materials</h3><div class="NLM_p last">Commercial-grade reagents and solvents obtained from Acros, Aldrich, Apin Lancaster, TCI or VWR were used without further purification except as indicated. All reactions were stirred magnetically; moisture-sensitive reactions were performed under argon in oven-dried glassware. Thin-layer chromatography (TLC), usually using ethyl acetate/hexane as the solvent system, was used to monitor reactions. Solvents were removed by rotary evaporation under reduced pressure; where appropriate, the compound was further dried using a vacuum pump. The <sup>1</sup>H NMR spectra were recorded at 300 MHz. All samples were prepared as dilute solutions in deuteriochloroform (CDCl<sub>3</sub>) with v/v 0.05% tetramethylsilane (TMS). Chemical shifts are reported in parts per million (ppm) downfield from TMS (0.00 ppm), and <i>J</i> coupling constants are reported in hertz. Purity of tested compounds <b>6c</b>−<b>6m</b>, <b>7a</b>−<b>7s</b> and <b>9a</b> was determined by elemental analysis, HPLC or SFC to be >95% pure. Elemental analyses were performed by Numega Resonance Laboratories, Inc. (San Diego, CA). LCMS was run in the ESI mode using an Xterra MS C18 (Waters) 4.6 × 50 mm 5 μm column; HPLC purity was performed using a 4.6 × 150 mm Xterra C18 5 μm column. Both LCMS and LC were reverse phase with an acetonitile/water containing 0.01%v/v TFA gradient. SFC was run using a normal phase Luna 5u silica 4.6 × 250 mm column. Mobile phase was liquid CO<sub>2</sub> with methanol as the modifying solvent. A gradient was used in which the concentration of methanol was ramped from 5% to 50% over a course of 12 min with a 200 bar back-pressure at 40 °C. Human breast cancer cells T47D, human colorectal carcinoma cells HCT116 and hepatocellular carcinoma cancer cells SNU-398 were purchased from the American type Culture Collection (Manasas, VA).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 2-Methylquinazolin-4-ol (3a)</h3><div class="NLM_p last">To a solution of 2-aminobenzoic acid methyl ester (15.0 g, 99.3 mmol) in 500 mL of acetonitrile in a 1000 mL three necked round bottomed flask equipped with a mechanical stirrer, condenser and a dispersion tube was bubbled through HCl gas for 15 min with vigorous stirring, and the resulting mixture was refluxed overnight, then cooled to room temperature. The resulting precipitates were collected by filtration. The solid was dissolved in water (250 mL), the solution was neutralized with saturated NaHCO<sub>3</sub> (100 mL), and the precipitates were collected by filtration. The solid was washed with water (50 mL), dried at room temperature for 8 h and dried further at 70 °C under high vacuum overnight to give <b>3a</b> as white solid (14.32 g, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) 12.21 (s, broad, 1H), 8.06−8.09 (m, 1H), 7.74−7.79 (m, 1H), 7.56−7.59 (m, 1H), 7.43−7.45 (m, 1H), 2.35 (s, 3H).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-Chloro-2-methylquinazoline (4a)</h3><div class="NLM_p last">A mixture of <b>3a</b> (10.0 g, 62.6 mmol) in 190 mL of anhydrous toluene and anhydrous diisopropylethylamine (DIPEA, 17.0 mL, 97.4 mmol) in a 500 mL round bottomed flask equipped with a condenser and a drying tube was refluxed for 1 h. To this warm solution was added freshly distilled POCl<sub>3</sub> (9.0 mL, 97 mmol) and the mixture was heated at 80 °C for 2 h, and cooled to room temperature. The mixture was diluted with 500 mL of ethyl acetate, washed with 200 mL of ice cold water, 200 mL of saturated NaHCO<sub>3</sub>, 200 mL of water, citric acid (1 N, 4 × 200 mL), 200 mL of water, 200 mL of saturated NaHCO<sub>3</sub> and 200 mL of saturated NaCl. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated to obtain an off-white solid (9.69 g, 87%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.21−8.25 (m, 1H), 7.89−7.99 (m, 2H), 7.66 (ddd, <i>J</i> = 8.7, 6.6 and 1.8 Hz, 1H), 2.87 (s, 3H).</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(4-Methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine hydrochloride (6h)</h3><div class="NLM_p">To a solution of <b>4a</b> (2.31 g, 12.9 mmol) and <i>N</i>-methyl-4-methoxyaniline (<b>5a</b>, 2.00 g, 14.6 mmol) in 35 mL of anhydrous isopropanol (IPA) was added 0.6 mL of concentrated HCl, and the mixture was stirred at room temperature overnight. The yellow precipitates were collected by filtration, washed with cold isopropanol, and dried at room temperature for 3 h under house vacuum. The solid was further dried under high vacuum at 70 °C for 48 h to remove residual isopropanol, provided compound <b>6h</b> as yellow solids (2.90 g, 71%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.53 (dd, <i>J</i> = 8.1 and 0.6 Hz, 1H), 7.7 (ddd, <i>J</i> = 8.4, 7.2 and 1.2 Hz, 1H), 7.22 (m, 2H), 7.13 (ddd, <i>J</i> = 8.7, 7.2 and 1.2 Hz, 1H), 7.05 (m, 2H), 6.76 (d, <i>J</i> = 8.7 Hz, 1H), 3.91 (s, 3H), 3.78 (s, 3H), 2.96 (s, 3H). Anal. (C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O·HCl) C, H, N.</div><div class="NLM_p last">The following compounds were prepared by a procedure similar to that described for the preparation of compound <b>6h</b>.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Ethyl-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6i)</h3><div class="NLM_p last">Compound <b>6i</b> was prepared from 4-chloro-2-ethylquinazoline and <b>5a</b> and was isolated as a solid (70%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 7.55−7.49 (m, 1H), 7.13−7.09 (m, 2H), 7.03−6.89 (m, 4H), 3.83 (s, 3H), 3.60 (s, 3H), 2.97 (q, <i>J</i> = 7.5 Hz, 2H), 1.44 (t, <i>J</i> = 7.8 Hz, 3H). HRMS calcd for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 294.1608; found, 294.1597.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Fluoromethyl-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6j)</h3><div class="NLM_p last">Compound <b>6j</b> was prepared from 4-chloro-2-fluoromethylquinazoline and <b>5a</b> and was isolated as a solid (67%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.87−7.84 (m, 1H), 7.60−7.54 (m, 1H), 7.14−7.10 (m, 2H), 7.04−7.01 (m, 2H), 6.95−6.91 (m, 2H), 5.60 (s, 1H), 5.44 (s, 1H), 3.85 (s, 3H), 3.60 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 298.1357; found, 298.1343.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Chloromethyl-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6k)</h3><div class="NLM_p last">Compound <b>6k</b> was prepared from 4-chloro-2-chloromethylquinazoline and <b>5a</b> and was isolated as a solid (65%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.82 (d, <i>J</i> = 8.7 Hz, 1H), 7.59−7.53 (m, 1H), 7.15−7.12 (m, 2H), 7.03−7.00 (m, 2H), 6.95−6.91 (m, 2H), 4.73 (s, 2H), 3.85 (s, 3H), 3.62 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>17</sub>ClN<sub>3</sub>O (M + H<sup>+</sup>), 314.1062; found, 314.1042.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> <i>N</i>-(4-Methoxyphenyl)-2-methylquinazolin-4-amine (9a)</h3><div class="NLM_p last">Compound <b>9a</b> was prepared from <b>4a</b> and 4-methoxyaniline and was isolated as a solid (60%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 11.28 (brs, 1H), 8.73 (d, <i>J</i> = 8.4 Hz, 1H), 8.06 (t, <i>J</i> = 7.5 Hz, 1H), 7.85−7.78 (m, 2H), 7.66 (d, <i>J</i> = 9 Hz, 2H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 3.81 (s, 3H), 2.60 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 266.1295; found, 266.1289.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Methoxy-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6c)</h3><div class="NLM_p last">To a solution of 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (<b>6b</b>, 50 mg, 0.167 mmol) in 2 mL methanol was added sodium methoxide (500 μL, 25% by wt. in methanol). The solution was stirred at 80 °C for 1 h, and it was diluted with 50 mL ethyl acetate. The solution was washed with water, dried and concentrated. The residue was purified using small silica column (acetate and hexane, 1:9) to give <b>6c</b> as a white solid (22 mg, 54%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.89 (d, <i>J</i> = 8.4 Hz, 1H), 7.53 (ddd, <i>J</i> = 8.7, 5.4 and 2.4 Hz, 1H), 7.19- 7.14 (m, 2H), 6.99−6.93 (m, 2H), 6.90−6.85 (m, 2H), 4.14 (s, 3H), 3.86 (s, 3H), 3.64 (s, 3H). Anal. (C<sub>17</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i><sup>4</sup>-(4-Methoxyphenyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-trimethylquinazolin-2,4-diamine (6d)</h3><div class="NLM_p last">A mixture of <b>6b</b> (150 mg, 0.5 mmol) and 2.0 M dimethylamine in methanol (2.0 mL, 4 mmol) in a sealed tube was stirred at 70−80 °C overnight. The mixture was filtered, and the filtration was concentrated by vacuum. The residue was mixed with ethyl acetate (10 mL) and was washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude product was purified by chromatography on silica gel with ethyl acetate and hexane (1:9) as eluent, yielding <b>6d</b> as a solid (128 mg, 83%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.44 (d, <i>J</i> = 7.8 Hz, 1H), 7.36−7.30 (m, 1H), 7.11−7.08 (m, 2H), 6.90−6.85 (m, 3H), 6.65−6.59 (m, 1H), 3.82 (s, 3H), 3.51 (s, 3H), 3.30 (s, 6H). Anal. (C<sub>18</sub>H<sub>20</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i><sup>4</sup>-(4-Methoxyphenyl)-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylquinazolin-2,4-diamine (6e)</h3><div class="NLM_p last">Compound <b>6e</b> was prepared from reaction of <b>6b</b> with 2.0 M methylamine in THF using a procedure similar to that of <b>6d</b> and was isolated as a solid (53.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.45 (d, <i>J</i> = 7.8 Hz, 1H), 7.39−7.33 (m, 1H), 7.11−7.07 (m, 2H), 6.90−6.87 (m, 3H), 6.69−6.64 (m, 1H), 4.95 (brs, 1H), 3.82 (s, 3H), 3.50 (s, 3H), 3.11 (d, <i>J</i> = 5.1 Hz, 3H). HRMS calcd for C<sub>17</sub>H<sub>19</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 295.1560; found, 295.1542.</div></div><div id="sec2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Hydrazino-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6f)</h3><div class="NLM_p last">To a solution of <b>6b</b> (100 mg, 0.33 mmol) in 2 mL of 1,4-dioxane was added 0.4 mL of hydrazine. The reaction mixture was stirred at room temperature overnight. The solvent was removed by evaporation, and the residue was diluted with ethyl acetate (20 mL), washed with saturated NaHCO<sub>3</sub> aq, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated by vacuum, yielding <b>6f</b> as yellow solids (20 mg, 21%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.52−7.49 (m, 1H), 7.44−7.39 (m, 1H), 7.12−7.08 (m, 2H), 6.93−6.88 (m, 3H), 6.77−6.71 (m, 1H), 6.01 (brs, 1H), 4.11 (brs, 2H), 3.83 (s, 3H), 3.50 (s, 3H). Anal. (C<sub>16</sub>H<sub>17</sub>N<sub>5</sub>O) C, H, N.</div></div><div id="sec2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i><sup>4</sup>-(4-Methoxyphenyl)-<i>N</i><sup>2</sup>-acetyl-<i>N</i><sup>2</sup>,<i>N</i><sup>4</sup>-dimethylquinazolin-2,4-diamine (6g)</h3><div class="NLM_p last">To a solution of <b>6e</b> (100 mg, 0.34 mmol) in 5 mL of dichloromethane were added triethylamine (0.071 mL, 0.51 mmol) and acetyl chloride (0.036 mL, 0.51 mmol) followed by 2 mg of DMAP at 0 °C. The reaction mixture was allowed to warm to room temperature and stirred for 2 h. The solvent was removed by evaporation. The residue was dissolved in ethyl acetate (20 mL), washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated by vacuum. The crude product was purified by chromatography on silica gel with ethyl acetate, hexane and methanol (1:3 to 1:1:0.05) as eluent, yielding <b>6g</b> as a white solid (36 mg, 32%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.70−7.67 (m, 1H), 7.56−7.52 (m, 1H), 7.17−7.14 (m, 2H), 6.97−6.93 (m, 4H), 3.86 (s, 3H), 3.57 (s, 6H), 2.52 (s, 3H). Anal. (C<sub>19</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Hydroxymethyl-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6l)</h3><div class="NLM_p last">To a solution of <b>6k</b> (67 mg, 0.19 mmol) in 1,4-dioxane (3 mL) was added 2 N NaOH aqueous solution (1 mL). The mixture was heated at 80 °C for 24 h and then was cooled to room temperature. The reaction mixture was diluted with ethyl acetate (20 mL) and then was washed with water and dried with NaSO<sub>4</sub>. The solvent was evaporated, and the residue was purified by column chromatography on silica gel with ethyl acetate and hexane (1:1) as eluent, yielding <b>6l</b> as a solid (25 mg, 44%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.78−7.75 (m, 1H), 7.59−7.53 (m, 1H), 7.15−7.12 (m, 2H), 7.02−7.00 (m, 2H), 6.94−6.91 (m, 2H), 4.79 (s, 2H), 3.85 (s, 3H), 3.59 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub> (M + H<sup>+</sup>), 296.1382; found, 296.1389.</div></div><div id="sec2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(Dimethylaminomethyl)-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (6m)</h3><div class="NLM_p last">Compound <b>6m</b> was prepared from reaction of <b>6k</b> and dimethylamine by a procedure similar to that of compound <b>6l</b> and was isolated as a solid (56%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.71 (d, <i>J</i> = 8.7 Hz, 1H), 7.60 (t, <i>J</i> = 8.4 Hz, 1H), 7.20 (d, <i>J</i> = 8.4 Hz, 2H), 7.09 (t, <i>J</i> = 8.1 Hz, 1H), 7.00−6.96 (m, 3H), 3.78 (s, 3H), 3.63 (s, 2H), 3.50 (s, 3H), 2.33 (s, 6H). Anal. (C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O) C, H, N.</div></div><div id="sec2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2,<i>N</i>-Dimethyl-<i>N</i>-(4-nitrophenyl)quinazolin-4-amine (7a)</h3><div class="NLM_p last">To a solution of <b>4a</b> (1.40 g, 7.84 mmol) and <i>N</i>-methyl-4-nitroaniline (1.09 g, 7.16 mmol) in 20 mL of dimethylformamide cooled to 0 °C was added sodium hydride (0.6 g, 60 oil suspension, 15 mmol). The reaction mixture was stirred at 0 °C for 1 h and quenched by adding 200 μL of water. It was diluted with 150 mL of ethyl acetate, washed with water (100 mL × 3) and saturated NaCl, dried over anhydrous MgSO<sub>4</sub>, filtered and concentrated. The residue was purified by chromatography (30% ethyl acetate/hexanes) to give <b>7a</b> (1.41 g, 67%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.14 (m, 2H), 7.91 (m, 1H), 7.71 (ddd, <i>J</i> = 8.4, 6.6 and 1.8 Hz, 1H), 7.19−7.32 (m, 2H), 7.05 (m, 2H), 3.76 (s, 3H), 2.82 (s, 3H). Anal. (C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(4-Fluorophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7b)</h3><div class="NLM_p">A mixture of <b>4a</b> (178 mg, 1.00 mmol) and <i>N</i>-methyl-4-fluoroaniline (125 mg, 2.52 mmol) and sodium acetate (248 mg, 3.02 mmol) in 6 mL of solvent (THF:water = 1:1) was stirred at 70 °C for 1 h. The reaction mixture was diluted with 30 mL of ethyl acetate. The organics were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude product was purified by chromatography on silica gel with ethyl acetate and hexane (1:5) as eluent, yielding <b>7b</b> as a solid (125 mg, 46.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (dd, <i>J</i> = 8.3 and 0.9 Hz, 1H), 7.58−7.52 (m,1H), 7.16−7.00 (m, 6H), 3.60 (s, 3H), 2.73 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>FN<sub>3</sub> (M + H<sup>+</sup>), 268.1252; found, 268.1239.</div><div class="NLM_p last">The following intermediates were prepared by a procedure similar to that described for the preparation of compound <b>7b</b>.</div></div><div id="sec2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(4-Ethoxyphenyl)-2-methylquinazolin-4-amine (9b)</h3><div class="NLM_p last">Compound <b>9b</b> was prepared from <b>4a</b> and 4-ethoxyaniline and was isolated as a solid (93%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.83 (m, 1H), 7.81 (m, 1H), 7.42 (m, 1H), 7.65−7.71 (m, 2H), 7.46 (ddd, <i>J</i> = 8.4, 6.9 and 1.5 Hz, 1H), 7.37 (s, broad, 1H), 6.92−6.97 (m, 2H), 4.06 (q, <i>J</i> = 6.9 Hz, 2H), 2.68 (s, 3H), 1.43 (t, <i>J</i> = 6.9 Hz, 3H).</div></div><div id="sec2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(4-Difluoromethoxyphenyl)-2-methylquinazolin-4-amine (9c)</h3><div class="NLM_p last">Compound <b>9c</b> was prepared from <b>4a</b> (450 mg, 2.52 mmol) and 4-difluoromethoxyphenylamine (0.32 mL, 2.52 mmol) and was isolated as a solid (713 mg, 94%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.87−7.76 (m, 5H), 7.51 (t, <i>J</i> = 8.4 Hz, 1H), 7.40 (brs, 1H), 7.19 (d, <i>J</i> = 8.7 Hz, 2H), 6.76−6.27 (m, 1H), 2.71 (s, 3H).</div></div><div id="sec2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(4-Methylthiophenyl)-2-methylquinazolin-4-amine (9d)</h3><div class="NLM_p last">Compound <b>9d</b> was prepared from <b>4a</b> (178 mg, 1.00 mmol) and 4-methylthioaniline (139 mg, 1.00 mmol) and was isolated as a solid (273 mg, 97%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.86−7.82 (m, 2H), 7.79−7.73 (m, 3H), 7.50−7.45 (m, 2H), 7.34−7.26 (m, 2H), 2.7 (s, 3H), 2.51 (s, 3H).</div></div><div id="sec2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(4-Ethylphenyl)-2-methylquinazolin-4-amine (9e)</h3><div class="NLM_p last">Compound <b>9e</b> was prepared from <b>4a</b> (100 mg, 0.56 mmol) and 4-ethylaniline (0.07 mL, 0.56 mmol) and was isolated as a solid (134 mg, 91%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.85−7.78 (m, 2H), 7.76−7.71 (m, 3H), 7.49 (t, <i>J</i> = 7.5 Hz, 1H), 7.36 (brs, 1H), 7.24 (s, 2H), 2.70−2.69 (m, 5H), 1.26 (t, <i>J</i> = 7.5 Hz, 3H).</div></div><div id="sec2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(3-Fluoro-4-methoxyphenyl)-2-methylquinazolin-4-amine (9f)</h3><div class="NLM_p last">Compound <b>9f</b> was prepared from <b>4a</b> (150 mg, 0.84 mmol) and 3-fluoro-4-methoxyaniline (118 mg, 0.84 mmol) and was isolated as a solid (90 mg, 34%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.89−7.75 (m, 4H), 7.53−7.48 (m, 1H), 7.38−7.34 (m, 2H), 7.0 (t, <i>J</i> = 8.7 Hz, 1H), 3.92 (s, 3H), 2.71 (s, 3H).</div></div><div id="sec2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(2-Fluoro-4-methoxyphenyl)-2-methylquinazolin-4-amine (9g)</h3><div class="NLM_p last">Compound <b>9g</b> was prepared from <b>4a</b> and 2-fluoro-4-methoxyaniline and was isolated as a solid (79%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.54 (m, 1H), 7.83 (m, 2H), 7.65 (m, 1H), 7.50 (m, 1H), 7.47 (s, broad, 1H), 6.74−6.81 (m, 2H), 3.83 (s, 3H), 2.70 (s, 3H).</div></div><div id="sec2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(3,4-Dimethoxyphenyl)-2-methylquinazolin-4-amine (9h)</h3><div class="NLM_p last">Compound <b>9h</b> was prepared from <b>4a</b> (178.6 mg, 1.0 mmol) and 3,4-dimethoxyaniline (153 mg, 1.0 mmol) and was isolated as off white solids (295 mg, 100%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.85−7.70 (m, 4H), 7.51−7.46 (m, 1H), 7.38 (brs, 1H), 7.16 (dd, <i>J</i> = 8.7 and 2.1 Hz, 1H), 6.90 (d, <i>J</i> = 8.7 Hz, 1H), 3.95 (s, 3H), 3.91 (s, 3H), 2.69 (s, 3H).</div></div><div id="sec2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(6-Methoxypyridin-3-yl)-2-methylquinazolin-4-amine (9i)</h3><div class="NLM_p last">Compound <b>9i</b> was prepared from <b>4a</b> and 3-amino-6-methoxypyridine and was isolated as a solid (32%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.51 (d, <i>J</i> = 1.8 Hz, 1H), 8.12 (m, 1H), 7.72−7.89 (m, 3H), 7.49 (m, 2H), 6.81 (d, <i>J</i> = 8.7 Hz, 1H), 3.89 (s, 3H), 2.68 (s, 3H).</div></div><div id="sec2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(5-Methoxypyridin-2-yl)-2-methylquinazolin-4-amine (9j)</h3><div class="NLM_p last">Compound <b>9j</b> was prepared from <b>4a</b> and 2-amino-5-methoxypyridine and was isolated as a solid (42%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.43 (m, 1H), 7.72−7.92 (m, 2H), 7.46−7.56 (m, 2H), 7.32−7.40 (m, 2H), 3.88 (s, 3H), 2.74 (s, 3H).</div></div><div id="sec2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-(6-Dimethylaminopyridin-3-yl)-2-methylquinazolin-4-amine (9k)</h3><div class="NLM_p last">Compound <b>9k</b> was prepared from <b>4a</b> (182 mg, 1.02 mmol) and 3-amino-6-dimethylaminopyridine (140 mg, 1.02 mmol) and was isolated as a pale yellow solid (60 mg, 21%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.95 (dd, <i>J</i> = 9.3 and 2.7 Hz, 1H), 7.84−7.72 (m, 3H), 7.47 (t, <i>J</i> = 8.1 Hz, 1H), 7.16 (brs, 1H), 6.61 (d, <i>J</i> = 9.0 Hz, 1H), 3.12 (s, 6H), 2.65 (s, 3H).</div></div><div id="sec2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(5-Methoxypyrazin-2-yl)-2-methylquinazolin-4-amine (9l)</h3><div class="NLM_p last">Compound <b>9l</b> was prepared from <b>4a</b> (150 mg, 0.84 mmol) and 2-amino-5-methoxypyrazine (105 mg, 0.84 mmol) and was isolated as a solid (106 mg, 47%). The crude product was used as is in the next step.</div></div><div id="sec2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(5-Methoxypyrimidin-2-yl)-2-methylquinazolin-4-amine (9m)</h3><div class="NLM_p last">Compound <b>9m</b> was prepared from <b>4a</b> (343 mg, 1.92 mmol) and 2-amino-5-methoxypyrimidine (240 mg, 1.92 mmol) and was isolated as a solid (283 mg, 55%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.69 (dd, <i>J</i> = 8.1 and 1.5 Hz, 1H), 8.43 (s, 2H), 7.73−7.67 (m, 1H), 7.60 (d, <i>J</i> = 7.2 Hz, 1H), 7.49−7.43 (m, 1H), 3.95 (s, 3H), 2.58 (s, 3H).</div></div><div id="sec2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(4-Methylthiophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7e)</h3><div class="NLM_p">To a solution of <b>9d</b> (263 mg, 0.94 mmol) in DMF (4 mL) at 0 °C was added sodium hydride (56.4 mg, 1.40 mmol, 60% oil dispersion) and followed by methyl iodide (0.09 mL, 1.4 mmol). The mixture was stirred at 0 °C for 1 h, then allowed to warm to room temperature and stirred for an additional 2 h. The reaction mixture was diluted with ethyl acetate (15 mL), washed with saturated NaHCO<sub>3</sub> aq, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated by vacuum. The residue was purified by chromatography on silica gel with ethyl acetate and hexane (1:2 to 1:1) as eluent, yielding 120 mg of <b>7e</b> (40.7%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (d, <i>J</i> = 9.0 Hz, 1H), 7.54 (t, <i>J</i> = 7.5 Hz, 1H), 7.24−7.19 (m, 2H), 7.10−6.97 (m, 4H), 3.59 (s, 3H), 2.74 (s, 3H), 2.48 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>S (M + H<sup>+</sup>), 296.1223; found, 296.1207.</div><div class="NLM_p last">The following compounds were prepared by a procedure similar to that described for the preparation of compound <b>7e</b>.</div></div><div id="sec2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(4-Ethoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7c)</h3><div class="NLM_p last">Compound <b>7c</b> was prepared from <b>9b</b> and methyl iodide and was isolated as a solid (67%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.71−7.74 (m, 1H), 7.51 (ddd, <i>J</i> = 8.1, 6.6 and 1.5 Hz, 1H), 7.09 (m, 2H), 6.95−7.04 (m, 2H), 6.86−6.92 (m, 2H), 4.04 (q, <i>J</i> = 6.9 Hz, 2H), 3.58 (s, 3H), 2.72 (s, 3H), 1.44 (t, <i>J</i> = 6.9 Hz, 3H). HRMS calcd for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 294.1608; found, 294.1595.</div></div><div id="sec2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(4-Difluoromethoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7d)</h3><div class="NLM_p last">Compound <b>7d</b> was prepared from <b>9c</b> (710 mg, 2.36 mmol) and methyl iodide (1.03 mL, 16.5 mmol) and was isolated as a solid (301 mg, 40.8%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.77 (dd, <i>J</i> = 8.4 and 0.9 Hz, 1H), 7.59−7.53 (m, 1H), 7.17−7.10 (m, 4H), 7.06−6.99 (m, 2H), 6.78−6.29 (m, 1H), 3.62 (s, 3H), 2.75 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>16</sub>F<sub>2</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 316.1263; found, 316.1245.</div></div><div id="sec2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-(4-Ethylphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7f)</h3><div class="NLM_p last">Compound <b>7f</b> was prepared from <b>9e</b> (122 mg, 0.46 mmol) and methyl iodide (0.2 mL, 3.3 mmol) and was isolated as a solid (39 mg, 52%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.74 (d, <i>J</i> = 8.1 Hz, 1H), 7.54−7.49 (m, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 2H), 7.09−6.92 (m, 4H), 3.61 (s, 3H), 2.73−2.63 (m, 5H), 1.26 (d, <i>J</i> = 7.5 Hz, 3H). HRMS calcd for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub> (M + H<sup>+</sup>), 278.1659; found, 279.1640.</div></div><div id="sec2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(3-Fluoro-4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7l)</h3><div class="NLM_p last">Compound <b>7l</b> was prepared from <b>9f</b> (250 mg, 0.88 mmol) and methyl iodide (0.39 mL, 6.2 mmol) and was isolated as a solid (32 mg, 12%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (d, <i>J</i> = 8.4 Hz, 1H), 7.59−7.53 (m, 1H), 7.09−6.82 (m, 5H), 3.91 (s, 3H), 3.58 (s, 3H), 2.73 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 298.1357; found, 298.1343.</div></div><div id="sec2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(2-Fluoro-4-methoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7m)</h3><div class="NLM_p last">Compound <b>7m</b> was prepared from <b>9g</b> and methyl iodide and was isolated as a solid (51%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (d, <i>J</i> = 8.1 Hz, 1H), 7.55 (ddd, <i>J</i> = 8.1, 6.3 and 1.8 Hz, 1H), 6.98−7.11 (m, 3H), 6.66−6.76 (m, 2H), 3.83 (s, 3H), 3.54 (s, 3H), 2.73 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>3</sub>O (M + H<sup>+</sup>), 298.1357; found, 298.1346.</div></div><div id="sec2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(3,4-Dimethoxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7n)</h3><div class="NLM_p last">Compound <b>7n</b> was prepared from <b>9h</b> (288 mg, 0.98 mmol) and methyl iodide (0.094 mL, 1.5 mmol) and was isolated as off white solids (70 mg, 23%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.75−7.72 (m, 1H), 7.56−7.50 (m, 1H), 7.05−6.94 (m, 2H), 6.85 (d, <i>J</i> = 7.5 Hz, 1H), 6.76−6.71 (m, 2H), 3.92 (s, 3H), 3.78 (s, 3H), 3.61 (s, 3H), 2.73 (s, 3H). Anal. (C<sub>16</sub>H<sub>14</sub>N<sub>4</sub>O<sub>2</sub>) C, H, N.</div></div><div id="sec2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(6-Methoxypyridin-3-yl)-<i>N</i>,2-dimethylquinazolin-4-amine (7o)</h3><div class="NLM_p last">Compound <b>7o</b> was prepared from <b>9i</b> and methyl iodide and was isolated as a solid (28%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.03 (d, <i>J</i> = 2.7 Hz, 1H), 7.77 (m, 1H), 7.56 (ddd, <i>J</i> = 8.1, 6.3 and 1.8 Hz, 1H), 7.38 (dd, <i>J</i> = 8.7 and 3.0 Hz, 1H), 7.01 (m, 2H), 6.76 (d, <i>J</i> = 9.0 Hz, 1H), 3.96 (s, 3H), 3.59 (s, 3H), 2.73 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>17</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 281.1404; found, 281.1400.</div></div><div id="sec2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(5-Methoxypyridin-2-yl)-<i>N</i>,2-dimethylquinazolin-4-amine (7p)</h3><div class="NLM_p last">Compound <b>7p</b> was prepared from <b>9j</b> and methyl iodide and was isolated as a solid (10%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.31 (d, <i>J =</i> 3.3 Hz, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.58 (ddd, <i>J</i> = 8.4, 6.6 and 1.5 Hz, 1H), 7.13 (dd, <i>J</i> = 9.0 and 3.3 Hz, 1H), 6.99−7.10 (m, 2H), 6.82 (d, <i>J</i> = 9.0 Hz, 1H), 3.87 (s, 3H), 3.70 (s, 3H), 2.76 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>17</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 281.1404; found, 281.1384.</div></div><div id="sec2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(6-Dimethylaminopyridin-3-yl)-<i>N</i>,2-dimethylquinazolin-4-amine (7q)</h3><div class="NLM_p last">Compound <b>7q</b> was prepared from <b>9k</b> (45 mg, 0.16 mmol) and methyl iodide (0.016 mL, 0.24 mmol) and was isolated as a pale yellow solid (22 mg, 47%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.07 (d, <i>J</i> = 2.4 Hz, 1H), 7.63 (dd, <i>J</i> = 8.4 and 0.9 Hz, 1H), 7.56−7.51 (m, 1H), 7.27−7.18 (m, 2H), 7.05−7.00 (m, 1H), 6.50 (d, <i>J</i> = 9.3 Hz, 1H), 3.55 (s, 3H), 3.12 (s, 6H), 2.72 (s, 3H). HRMS calcd for C<sub>17</sub>H<sub>20</sub>N<sub>5</sub> (M + H<sup>+</sup>), 294.1720; found, 294.1693.</div></div><div id="sec2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(5-Methoxypyrazin-2-yl)-<i>N</i>,2-dimethylquinazolin-4-amine (7r)</h3><div class="NLM_p last">Compound <b>7r</b> was prepared from <b>9l</b> (106 mg, 0.40 mmol) and methyl iodide and was isolated as a solid (63 mg, 56%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.06 (d, <i>J</i> = 1.2 Hz, 1H), 7.85−7.81 (m, 1H), 7.74 (d, <i>J</i> = 1.5 Hz, 1H), 7.65−7.60 (m, 1H), 7.17−7.05 (m, 2H), 3.94 (s, 3H), 3.70 (s, 3H), 2.78 (s, 3H). HRMS calcd for C<sub>15</sub>H<sub>16</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 282.1356; found, 282.1355.</div></div><div id="sec2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(5-Methoxypyrimidin-2-yl)-<i>N</i>,2-dimethylquinazolin-4-amine (7s)</h3><div class="NLM_p last">Compound <b>7s</b> was prepared from <b>9m</b> (170 mg, 0.64 mmol) and methyl iodide and was isolated as a solid (141 mg, 50%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) 8.12 (s, 2H), 7.91 (d, <i>J</i> = 8.4 Hz, 1H), 7.74−7.69 (m, 1H), 7.38−7.34 (m, 1H), 7.30−7.24 (m, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 2.83 (s, 3H). Anal. (C<sub>15</sub>H<sub>15</sub>N<sub>5</sub>O·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-(4-Hydroxyphenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7 h)</h3><div class="NLM_p last">To a solution of <b>6h</b> (106 mg, 0.336 mmol) in dichloromethane (10 mL) at −78 °C was added slowly boron tribromide (1 M in CH<sub>2</sub>Cl<sub>2</sub>, 0.75 mL) under argon. The cold bath was removed, and the reaction mixture was allowed to warm up slowly to 10 °C in 1.5 h. The reaction mixture was quenched with water (10 mL), basified with 2 N NaOH to pH = 10, and extracted with ethyl acetate (2 × 25 mL). The ethyl acetate extracts were dried and evaporated to give a light brown residue. The crude was purified by column chromatography (SiO<sub>2</sub>, ethyl acetate:hexanes/15−50%) to give <b>7h</b> as a white solid (5 mg, 6%). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): 8.74 (s, 1H), 7.75 (m, 1H), 7.67 (m, 1H), 7.20−7.18 (m, 3H), 7.12 (m, 1H), 7.04−6.99 (m, 2H), 3.64 (s, 3H), 2.79 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>16</sub>N<sub>3</sub>O (M + H<sup>+</sup>), 266.1295; found, 266.1279.</div></div><div id="sec2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(4-Aminophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7i)</h3><div class="NLM_p last">A mixture of <b>7a</b> (200 mg, 0.68 mmol) in 25 mL of ethyl acetate was hydrogenated over palladium on carbon (70 mg) at 50 psi for 4 h, and the reaction mixture was filtered through a pad of Celite and concentrated. The resulting crude product was purified by chromatography (50% ethyl acetate/hexane) to give <b>7i</b> as a solid (140 mg, 78%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.71 (m, 1H), 7.51 (ddd, <i>J</i> = 8.4, 6.9 and 1.5 Hz, 1H), 7.09 (m, 1H), 6.93−7.05 (m, 3H), 6.68 (m, 2H), 3.74 (s, broad, 2H), 3.56 (s, 3H), 2.71 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>17</sub>N<sub>4</sub> (M + H<sup>+</sup>), 265.1455; found, 265.1436.</div></div><div id="sec2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(4-Dimethylaminophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7g)</h3><div class="NLM_p last">To a solution of <b>7i</b> (14 mg, 0.053 mmol) in methanol (1.5 mL), 37% aqueous formaldehyde (0.5 mL) and 10 μL of glacial acetic was added sodium cyanoborohydride (15 mg, 0.24 mmol), and the mixture was stirred at room temperature for 2 h. The reaction mixture was quenched by adding 50 μL of 1 N HCl. The mixture was diluted with 50 mL of ethyl acetate, washed with saturated sodium bicarbonate, and followed by saturated sodium chloride. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The residue was purified by column chromatography (25% ethyl acetate/hexanes) on silica gel to give <b>7g</b> as a solid (12 mg, 80%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.71 (m, 1H), 7.50 (ddd, <i>J</i> = 8.4, 6.9 and 1.5 Hz, 1H), 7.03−7.09 (m, 3H), 6.95 (ddd, <i>J</i> = 8.1, 6.6 and 0.9 Hz, 1H), 6.70 (m, 2H), 3.57 (s, 3H), 2.99 (s, 6H), 2.71 (s, 3H). HRMS calcd for C<sub>18</sub>H<sub>21</sub>N<sub>4</sub> (M + H<sup>+</sup>), 293.1768; found, 293.1755.</div></div><div id="sec2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(4-Azidophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7j)</h3><div class="NLM_p last">To a solution of <b>7i</b> (20 mg, 0.076 mmol) in 1.2 mL of 1 N HCl was added 100 μL of methanol and the mixture cooled to 0 °C. One drop of concentrated HCl was added, and the solution was stirred at 0 °C for 0.25 h. To the solution was added dropwise a solution of sodium nitrite (25 mg, 0.36 mmol) in 200 μL of water. The reaction mixture was stirred for 0.5 h, then was added a solution of sodium azide (25 mg, 0.38 mmol) in 300 μL of water followed by an additional batch of sodium azide (25 mg, 0.38 mmol). The reaction mixture was stirred at 0 °C for 1 h, diluted with 50 mL of ethyl acetate, and washed with saturated sodium bicarbonate followed by saturated sodium chloride. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The residue was purified by column chromatography (20−25% ethyl acetate/hexanes) on silica gel to give <b>7j</b> as a solid (20 mg, 90%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.76 (m, 1H), 7.56 (ddd, <i>J</i> = 8.1, 6.3 and 1.8 Hz, 1H), 7.13 (m, 2H), 6.98−7.13 (m, 4H), 3.61 (s, 3H), 2.74 (s, 3H). HRMS calcd for C<sub>16</sub>H<sub>15</sub>N<sub>6</sub> (M + H<sup>+</sup>), 291.1360; found, 291.1347.</div></div><div id="sec2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(4-Acetamidophenyl)-<i>N</i>,2-dimethylquinazolin-4-amine (7k)</h3><div class="NLM_p last">To a solution of <b>7i</b> (28 mg, 0.11 mmol) in 2 mL of dichloromethane with triethylamine (50 μL, 0.36 mmol) cooled at 0 °C was added acetic anhydride (50 μL, 0.53 mmol), followed by a few crystals of 4-dimethylaminopyridine, and the mixture was allowed to warm to room temperature. The reaction mixture was stirred for 0.5 h and 25 mL of ethyl acetate was added. The solution was washed with saturated NaHCO<sub>3</sub>, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated. The crude was purified by column chromatography (80% ethyl acetate/hexane) to give <b>7k</b> (32.5 mg, 100%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.75 (d, <i>J</i> = 8.1 Hz, 1H), 7.5−7.57 (m, 3H), 6.94−7.12 (m, 4H), 3.60 (s, 3H), 2.72 (s, 3H), 2.42 (s, 3H). HRMS calcd for C<sub>18</sub>H<sub>19</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 307.1560; found, 307.1553.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm801315b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analysis and HPLC data for the targeted compounds <b>6c</b>−<b>6m</b>, <b>7a</b>−<b>7s</b> and <b>9a</b>. Caspase activation assays, growth inhibition assays, tubulin inhibition assay, cell cycle analysis, MX-1 tumor model studies of <b>6h</b>, and determination of brain/plasma AUC ratio of <b>6h</b> and related analogues. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801315b/suppl_file/jm801315b_si_001.pdf">jm801315b_si_001.pdf (61.17 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm801315b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56811" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56811" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Adam Willardsen</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#becddddfd7fedbced7dddbceca90ddd1d39edfdadfd390c9d7d2d2dfccdacddbd0fed3c7ccd7dfdaced6dfccd3df90ddd1d3"><span class="__cf_email__" data-cfemail="2b58484a426b4e5b42484e5b5f05484446">[email protected]</span> <span class="__cf_email__" data-cfemail="137277727e3d647a7f7f72617760767d537e6a617a7277637b72617e723d707c7e">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sui Xiong Cai</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#720111131b3217021b111702065c111d1f521316131f5c051b1e1e13001601171c321f0b001b1316021a13001f135c111d1f"><span class="__cf_email__" data-cfemail="136070727a5376637a707663673d707c7e">[email protected]</span> <span class="__cf_email__" data-cfemail="9bfafffaf6b5ecf2f7f7fae9ffe8fef5dbf6e2e9f2faffebf3fae9f6fab5f8f4f6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nilantha Sirisoma</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Azra Pervin</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhang</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Songchun Jiang</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark B. Anderson</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Mather</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher M. Pleiman</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shailaja Kasibhatla</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ben Tseng</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Drewe</span> - <span class="hlFld-Affiliation affiliation">EpiCept Corporation, 6650 Nancy Ridge Drive, San Diego, California 92121, and Myriad Pharmaceuticals Inc., 320 Wakara Way, Salt Lake City, Utah 84108</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 38 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">The new era in cancer research</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1162-1165&author=H.+Varmus&title=The+new+era+in+cancer+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DThe%2520new%2520era%2520in%2520cancer%2520research%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1162%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Kingston, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, D. J.</span><span> </span><span class="NLM_article-title">Taxoids: cancer-fighting compounds from nature</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=130-144&author=D.+G.+Kingstonauthor=D.+J.+Newman&title=Taxoids%3A+cancer-fighting+compounds+from+nature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKingston%26aufirst%3DD.%2BG.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DTaxoids%253A%2520cancer-fighting%2520compounds%2520from%2520nature%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D130%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Cross, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyseng-Williamson, K. A.</span><span> </span><span class="NLM_article-title">Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2645</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2645-2654&author=S.+A.+Crossauthor=K.+A.+Lyseng-Williamson&title=Imatinib%3A+in+relapsed+or+refractory+Philadelphia+chromosome-positive+acute+lymphoblastic+leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DS.%2BA.%26aulast%3DLyseng-Williamson%26aufirst%3DK.%2BA.%26atitle%3DImatinib%253A%2520in%2520relapsed%2520or%2520refractory%2520Philadelphia%2520chromosome-positive%2520acute%2520lymphoblastic%2520leukaemia%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D2645%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">Targeting tyrosine kinases in cancer: the second wave</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1175-1158&author=J.+Baselga&title=Targeting+tyrosine+kinases+in+cancer%3A+the+second+wave"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DTargeting%2520tyrosine%2520kinases%2520in%2520cancer%253A%2520the%2520second%2520wave%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1175%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Wood, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchen, B.</span><span> </span><span class="NLM_article-title">Sorafenib: a promising new targeted therapy for renal cell carcinoma</span> <span class="citation_source-journal">Clin. J. Oncol. Nurs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1188%2F07.CJON.649-656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17962173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A280%3ADC%252BD2snjslahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=649-656&author=L.+S.+Woodauthor=B.+Manchen&title=Sorafenib%3A+a+promising+new+targeted+therapy+for+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib: a promising new targeted therapy for renal cell carcinoma</span></div><div class="casAuthors">Wood Laura S; Manchen Beth</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of oncology nursing</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-56</span>
        ISSN:<span class="NLM_cas:issn">1092-1095</span>.
    </div><div class="casAbstract">Diagnosis of renal cell carcinoma (RCC) frequently occurs at advanced stages, severely limiting the success of treatment, and median survival is barely more than a year.  Previously, treatment of renal cancer was limited to nephrectomy or immunotherapy (interleukin or interferon-alpha), which was effective in a small subset of patients but often was accompanied by severe side effects.  New orally administered targeted therapies have become available, offering broader benefits to patients with advanced RCC.  Sorafenib is an oral, multikinase inhibitor recently approved by the U.S.  Food and Drug Administration as treatment for advanced RCC based on its extension of median progression-free survival from 12-24 weeks.  Oncology nurses must ensure patient adherence and manage side effects of emerging treatments.  This article reviews the management of skin rash, hand-foot skin reaction, hypertension, diarrhea, and fatigue in patients receiving sorafenib.  In addition, a case study of a patient receiving sorafenib is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhi6aRvGRCIhLSh9fo81bfW6udTcc2eaj-JXuGi9Zlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snjslahsw%253D%253D&md5=fed9756b7502ec6c86c594f7e63e7d5f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1188%2F07.CJON.649-656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F07.CJON.649-656%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%2BS.%26aulast%3DManchen%26aufirst%3DB.%26atitle%3DSorafenib%253A%2520a%2520promising%2520new%2520targeted%2520therapy%2520for%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2007%26volume%3D11%26spage%3D649%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0liJORbPTPCIrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Sunitinib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1517%2F14656566.8.14.2359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17927489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFeqt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=2359-2369&author=B.+I.+Rini&title=Sunitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sunitinib</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2359-2369</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Sunitinib is a small-mol. inhibitor of several receptor tyrosine kinases relevant to tumor angiogenesis, including the vascular endothelial growth factor (VEGF) receptor.  Potent inhibition of this related family of receptors and consequent antiangiogenic effects have been demonstrated in vitro and in murine models.  Human studies have established 50 mg daily dosing given on an intermittent schedule as a tolerable dose.  Significant antitumor effects have been obsd., most notably in advanced renal cell carcinoma (RCC) and imatinib refractory/intolerant gastrointestinal stromal tumor (GIST).  Sunitinib has received regulatory approval in these two indications, and is at present being investigated across a broad array of solid tumors.  Despite these initial results, several questions remain to optimize the utility of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmLEQXPQvMCLVg90H21EOLACvtfcHk0liJORbPTPCIrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFeqt77N&md5=7ccb4c3860b4612b2e81fab02d15907a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14656566.8.14.2359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.8.14.2359%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DSunitinib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2007%26volume%3D8%26spage%3D2359%26epage%3D2369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Roccaro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribatti, D.</span><span> </span><span class="NLM_article-title">Bortezomib in the treatment of cancer</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=397-403&author=A.+M.+Roccaroauthor=A.+Vaccaauthor=D.+Ribatti&title=Bortezomib+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoccaro%26aufirst%3DA.%2BM.%26aulast%3DVacca%26aufirst%3DA.%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DBortezomib%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D397%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Temsirolimus, an inhibitor of mammalian target of rapamycin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-07-4719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18316545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1286-1290&author=B.+I.+Rini&title=Temsirolimus%2C+an+inhibitor+of+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1286-1290</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Temsirolimus, an inhibitor of mammalian target of rapamycin, a mol. implicated in multiple tumor-promoting intracellular signaling pathways is discussed.  A brief description of temsirolimus and mTOR as well as the different studies regarding the field of interest are presented.  Results from these studies validated mTOR as a relevant therapeutic target in renal cell carcinoma (RCC), at least in the subset of patients with multiple adverse risk features.  The temsirolimus-related adverse events and the other rapamycin analog inhibitors of mTOR currently clin. testing are also given.  Still, more potent mTOR inhibition, simultaneous inhibition of multiple signaling pathways, and/or more precise mol. phenotyping of tumors to define mTOR pathway reliance are needed to build on the obsd. clin. benefits of temsirolimus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgD87VNVhdWLVg90H21EOLACvtfcHk0liJORbPTPCIrw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSku7Y%253D&md5=b2abad3901820fc28b06254e12b7666c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4719%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DTemsirolimus%252C%2520an%2520inhibitor%2520of%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1286%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The blood-brain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood-brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0lgDjapy4_vzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood-brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Broniscer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-06-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17332296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1511-1515&author=A.+Broniscerauthor=J.+C.+Panettaauthor=M.+O%E2%80%99Shaughnessyauthor=C.+Fragaauthor=F.+Baiauthor=M.+J.+Krasinauthor=A.+Gajjarauthor=C.+F.+Stewart&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+erlotinib+and+its+active+metabolite+OSI-420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span></div><div class="casAuthors">Broniscer, Alberto; Panetta, John C.; O'Shaughnessy, Melinda; Fraga, Charles; Bai, Feng; Krasin, Matthew J.; Gajjar, Amar; Stewart, Clinton F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1515</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To report cerebrospinal fluid (CSF) penetration of erlotinib and its metabolite OSI-420.  Pharmacokinetic measurements were done in plasma (days 1, 2, 3, and 8 of therapy) and, concurrently, in plasma and CSF (before and at 1, 2, 4, 8, and 24 h after dose on day 34 of therapy) in an 8-yr-old patient diagnosed with glioblastoma who received local irradn. and oral erlotinib in a phase I protocol.  CSF samples were collected from a ventriculoperitoneal shunt, which was externalized because of infection.  Erlotinib concns. were detd. by liq. chromatog./mass spectrometry.  CSF penetration of erlotinib and OSI-420 were estd. by a compartmental model and by calcg. the ratio of CSF to plasma 24-h area under concn.-time curve (AUC0-24).  This patient was assigned to receive erlotinib at a dose level of 70 mg/m2, but the actual daily dose was 75 mg (78 mg/m2).  Erlotinib and OSI-420 plasma pharmacokinetic variables on days 8 and 34 overlapped to suggest that steady state had been reached.  Whereas erlotinib and OSI-420 AUC0-24 in plasma on day 34 were 30,365 and 2,527 ng h/mL, resp., the correspondent AUC0-24 in the CSF were 2,129 and 240 ng h/mL, resp.  Erlotinib and OSI-420 CSF penetration were 7% and ∼9%, resp., using both est. methods.  The max. steady-state CSF concn. of erlotinib was ∼130 ng/mL (325 nmol/L).  The plasma pharmacokinetics of erlotinib in this child overlapped with results described in adults.  Oral administration of erlotinib achieves CSF concns. comparable with those active against several cancer cell lines in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoldU23ij5mgLVg90H21EOLACvtfcHk0lgDjapy4_vzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D&md5=9b1e3b0a3d448075085ee7fd38ca635e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2372%26sid%3Dliteratum%253Aachs%26aulast%3DBroniscer%26aufirst%3DA.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DKrasin%26aufirst%3DM.%2BJ.%26aulast%3DGajjar%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520erlotinib%2520and%2520its%2520active%2520metabolite%2520OSI-420%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Franceschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosso, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scopece, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crinò, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span> </span><span class="NLM_article-title">Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1038%2Fsj.bjc.6603669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17353924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsleksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1047-1051&author=E.+Franceschiauthor=G.+Cavalloauthor=S.+Lonardiauthor=E.+Magriniauthor=A.+Tosoniauthor=D.+Grossoauthor=L.+Scopeceauthor=V.+Blattauthor=B.+Urbiniauthor=A.+Pessionauthor=G.+Talliniauthor=L.+Crin%C3%B2author=A.+A.+Brandes&title=Gefitinib+in+patients+with+progressive+high-grade+gliomas%3A+a+multicentre+phase+II+study+by+Gruppo+Italiano+Cooperativo+di+Neuro-Oncologia+%28GICNO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)</span></div><div class="casAuthors">Franceschi, E.; Cavallo, G.; Lonardi, S.; Magrini, E.; Tosoni, A.; Grosso, D.; Scopece, L.; Blatt, V.; Urbini, B.; Pession, A.; Tallini, G.; Crino, L.; Brandes, A. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1047-1051</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To investigate the role of gefitinib in patients with high-grade gliomas (HGGs), a phase II trial (1839IL/0116) was conducted in patients with disease recurrence following surgery plus radiotherapy and first-line chemotherapy.  Adult patients with histol. confirmed recurrent HGGs following surgery, radiotherapy and first-line chemotherapy, were considered eligible.  Patients were treated with gefitinib (250 mg day-1) continuously until disease progression.  The primary end point was progression-free survival at 6 mo progression-free survival at 6 mo (PFS-6).  Tissue biomarkers (epidermal growth factor receptor (EGFR) gene status and expression, phosphorylated Akt (p-Akt) expression) were assessed.  Twenty-eight patients (median age, 55 years; median ECOG performance status, 1) were enrolled; all were evaluable for drug activity and safety.  Sixteen patients had glioblastoma, three patients had anaplastic oligodendrogliomas and nine patients had anaplastic astrocytoma.  Five patients (17.9%, 95% CI 6.1-36.9%) showed disease stabilization.  The overall median time to progression was 8.4 (range 2-104+) weeks and PFS-6 was 14.3% (95% CI 4.0-32.7%).  The median overall survival was 24.6 wk (range 4-104+).  No grade 3-4 gefitinib-related toxicity was found.  Gefitinib showed limited activity in patients affected by HGGs.  Epidermal growth factor receptor expression or gene status, and p-Akt expression do not seem to predict activity of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYiU3YpISpS7Vg90H21EOLACvtfcHk0lgDjapy4_vzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsleksLw%253D&md5=bb2c9941b1869d9cc98bb04d339e6f77</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603669%26sid%3Dliteratum%253Aachs%26aulast%3DFranceschi%26aufirst%3DE.%26aulast%3DCavallo%26aufirst%3DG.%26aulast%3DLonardi%26aufirst%3DS.%26aulast%3DMagrini%26aufirst%3DE.%26aulast%3DTosoni%26aufirst%3DA.%26aulast%3DGrosso%26aufirst%3DD.%26aulast%3DScopece%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DV.%26aulast%3DUrbini%26aufirst%3DB.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DTallini%26aufirst%3DG.%26aulast%3DCrin%25C3%25B2%26aufirst%3DL.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26atitle%3DGefitinib%2520in%2520patients%2520with%2520progressive%2520high-grade%2520gliomas%253A%2520a%2520multicentre%2520phase%2520II%2520study%2520by%2520Gruppo%2520Italiano%2520Cooperativo%2520di%2520Neuro-Oncologia%2520%2528GICNO%2529%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1047%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penne, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrand, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duyn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenzel, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed Rasheed, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourt-Uhlig, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vredenburgh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">Phase II trial of gefitinib in recurrent glioblastoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1200%2FJCO.2004.08.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=14638850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=133-142&author=J.+N.+Richauthor=D.+A.+Reardonauthor=T.+Peeryauthor=J.+M.+Dowellauthor=J.+A.+Quinnauthor=K.+L.+Penneauthor=C.+J.+Wikstrandauthor=L.+B.+Van+Duynauthor=J.+E.+Danceyauthor=R.+E.+McLendonauthor=J.+C.+Kaoauthor=T.+T.+Stenzelauthor=B.+K.+Ahmed+Rasheedauthor=S.+E.+Tourt-Uhligauthor=J.+E.+Herndonauthor=J.+J.+Vredenburghauthor=J.+H.+Sampsonauthor=A.+H.+Friedmanauthor=D.+D.+Bignerauthor=H.+S.+Friedman&title=Phase+II+trial+of+gefitinib+in+recurrent+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of gefitinib in recurrent glioblastoma</span></div><div class="casAuthors">Rich, Jeremy N.; Reardon, David A.; Peery, Terry; Dowell, Jeannette M.; Quinn, Jennifer A.; Penne, Kara L.; Wikstrand, Carol J.; van Duyn, Lauren B.; Dancey, Janet E.; McLendon, Roger E.; Kao, James C.; Stenzel, Timothy T.; Rasheed, B. K. Ahmed; Tourt-Uhlig, Sandra E.; Herndon, James E., II; Vredenburgh, James J.; Sampson, John H.; Friedman, Allan H.; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-142</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to evaluate the efficacy and tolerability of gefitinib (ZD1839, Iressa; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.  This was an open-label, single-center phase II trial.  Fifty-seven patients with first recurrence of a glioblastoma who were previously treated with surgical resection, radiation, and usually chemotherapy underwent an open biopsy or resection at evaluation for confirmation of tumor recurrence.  Each patient initially received 500 mg of gefitinib orally once daily; dose escalation to 750 mg then 1,000 mg, if a patient received enzyme-inducing antiepileptic drugs or dexamethasone, was allowed within each patient.  Although no objective tumor responses were seen among the 53 assessable patients, only 21% of patients (11 of 53 patients) had measurable disease at treatment initiation.  Seventeen percent of patients (nine of 53 patients) underwent at least six 4-wk cycles, and the 6-mo event-free survival (EFS) was 13% (seven of 53 patients).  The median EFS time was 8.1 wk, and the median overall survival (OS) time from treatment initiation was 39.4 wk.  Adverse events were generally mild (grade 1 or 2) and consisted mainly of skin reactions and diarrhea.  Drug-related toxicities were more frequent at higher doses.  Withdrawal caused by drug-related adverse events occurred in 6% of patients (three of 53 patients).  Although the presence of diarrhea pos. predicted favorable OS from treatment initiation, epidermal growth factor receptor expression did not correlate with either EFS or OS.  Gefitinib is well tolerated and has activity in patients with recurrent glioblastoma.  Further study of this agent at higher doses is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVwxzaQ62e7Vg90H21EOLACvtfcHk0liqmESWelCVpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKhsr8%253D&md5=4477591e92c2ce1272a21b1bbf8e451a</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.08.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.08.110%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DPeery%26aufirst%3DT.%26aulast%3DDowell%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DPenne%26aufirst%3DK.%2BL.%26aulast%3DWikstrand%26aufirst%3DC.%2BJ.%26aulast%3DVan%2BDuyn%26aufirst%3DL.%2BB.%26aulast%3DDancey%26aufirst%3DJ.%2BE.%26aulast%3DMcLendon%26aufirst%3DR.%2BE.%26aulast%3DKao%26aufirst%3DJ.%2BC.%26aulast%3DStenzel%26aufirst%3DT.%2BT.%26aulast%3DAhmed%2BRasheed%26aufirst%3DB.%2BK.%26aulast%3DTourt-Uhlig%26aufirst%3DS.%2BE.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DVredenburgh%26aufirst%3DJ.%2BJ.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DPhase%2520II%2520trial%2520of%2520gefitinib%2520in%2520recurrent%2520glioblastoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupp, R.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-07-1810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18281526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2ntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=957-960&author=A.+A.+Brandesauthor=E.+Franceschiauthor=A.+Tosoniauthor=M.+E.+Hegiauthor=R.+Stupp&title=Epidermal+growth+factor+receptor+inhibitors+in+neuro-oncology%3A+hopes+and+disappointments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments</span></div><div class="casAuthors">Brandes, Alba A.; Franceschi, Enrico; Tosoni, Alicia; Hegi, Monika E.; Stupp, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">957-960</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite advances in diagnosis and treatment made over the past two decades, high-grade gliomas are still incurable neoplasms.  Moreover, after failing adjuvant therapy, few active treatments are available.  In this setting, novel agents, such as new chemotherapy compds. and anticancer agents against specific mol. targets, have therefore been investigated.  Epidermal growth factor receptor (EGFR) is an intriguing target in high-grade gliomas because it is frequently overexpressed due to amplification of the EGFR gene.  Gefitinib and erlotinib act as ATP mimetic agents, binding to the cytoplasmic ATP pocket domain and blocking receptor phosphorylations and, thereby, EGFR-mediated activation of downstream pathways.  These drugs have been evaluated in several clin. trials treating recurrent high-grade gliomas with contrasting results.  Retrospective correlative analyses generated a plethora of putative predictive factors of activity of EGFR tyrosine kinase inhibitors.  The first generations of studies on EGFR inhibitors have not found significant activity of these agents in high-grade gliomas.  Furthermore, no clear mol. or clin. predictors have been identified.  As with other targeted agents, prospective trials using specific criteria and standardized methods to evaluate tissue biomarkers are required to find predictors of EGFR inhibitors activity in high-grade glioma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPxtOeDUc1zLVg90H21EOLACvtfcHk0liqmESWelCVpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2ntL0%253D&md5=20ae26e0f0b80bcfe55be0fcd52bc66b</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1810%26sid%3Dliteratum%253Aachs%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DFranceschi%26aufirst%3DE.%26aulast%3DTosoni%26aufirst%3DA.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DStupp%26aufirst%3DR.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520in%2520neuro-oncology%253A%2520hopes%2520and%2520disappointments%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D957%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mara, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John-Williams, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span> </span><span class="NLM_article-title">The role of efflux and uptake transporters in N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=695-701&author=J.+W.+Polliauthor=J.+E.+Humphreysauthor=K.+A.+Harmonauthor=S.+Castellinoauthor=M.+J.+O%E2%80%99Maraauthor=K.+L.+Olsonauthor=L.+S.+John-Williamsauthor=K.+M.+Kochauthor=C.+J.+Serabjit-Singh&title=The+role+of+efflux+and+uptake+transporters+in+N-%7B3-chloro-4-%5B%283-fluorobenzyl%29oxy%5Dphenyl%7D-6-%5B5-%28%7B%5B2-%28methylsulfonyl%29ethyl%5Damino%7Dmethyl%29-2-furyl%5D-4-quinazolinamine+%28GW572016%2C+lapatinib%29+disposition+and+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DHarmon%26aufirst%3DK.%2BA.%26aulast%3DCastellino%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Mara%26aufirst%3DM.%2BJ.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJohn-Williams%26aufirst%3DL.%2BS.%26aulast%3DKoch%26aufirst%3DK.%2BM.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520role%2520of%2520efflux%2520and%2520uptake%2520transporters%2520in%2520N-%257B3-chloro-4-%255B%25283-fluorobenzyl%2529oxy%255Dphenyl%257D-6-%255B5-%2528%257B%255B2-%2528methylsulfonyl%2529ethyl%255Damino%257Dmethyl%2529-2-furyl%255D-4-quinazolinamine%2520%2528GW572016%252C%2520lapatinib%2529%2520disposition%2520and%2520drug%2520interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lukas, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, M. K.</span><span> </span><span class="NLM_article-title">Emerging therapies for malignant glioma</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">S29−36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&author=R.+V.+Lukasauthor=A.+Boireauthor=M.+K.+Nicholas&title=Emerging+therapies+for+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BV.%26aulast%3DBoire%26aufirst%3DA.%26aulast%3DNicholas%26aufirst%3DM.%2BK.%26atitle%3DEmerging%2520therapies%2520for%2520malignant%2520glioma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fischer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Osthoff, K.</span><span> </span><span class="NLM_article-title">New approaches and therapeutics targeting apoptosis in disease</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=187-215&author=U.+Fischerauthor=K.+Schulze-Osthoff&title=New+approaches+and+therapeutics+targeting+apoptosis+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DNew%2520approaches%2520and%2520therapeutics%2520targeting%2520apoptosis%2520in%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D187%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">O’Driscoll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, M.</span><span> </span><span class="NLM_article-title">Survivin: role in normal cells and in pathological conditions</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F1568009033482038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=12678716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=131-152&author=L.+O%E2%80%99Driscollauthor=R.+Linehanauthor=M.+Clynes&title=Survivin%3A+role+in+normal+cells+and+in+pathological+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin: Role in normal cells and in pathological conditions</span></div><div class="casAuthors">O'Driscoll, L.; Linehan, R.; Clynes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-152</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Survivin, an inhibitor of apoptosis (IAP) contg. one baculovirus IAP repeat (BIR) domain, has been reported to be capable of regulating both cellular proliferation and apoptotic cell death.  Survivin splice variants, survivin-ΔEx3 and survivin-2B, have apparently retained and lost anti-apoptotic potential, resp.  As survivin was first discovered due to its high homol. with effector cell protease receptor (EPR-1), a protein involved in blood coagulation, it has been suggested (but not proven) that EPR-1 may act as a natural anti-sense to survivin in cells.  Survivin homologs have been found in non-human species.  Survivin expression has been described during embryonic development and in adult cancerous tissues, with greatly reduced expression in adult normal differentiated tissues, particularly if their proliferation index is low.  Survivin has been defined as a universal tumor antigen and as the fourth most significant transcriptosome expressed in human tumors.  Although survivin is usually located in the cell cytoplasmic region and assocd. with poor prognosis in cancer, nuclear localization, indicative of favorable prognosis, has also been reported.  Survivin expression has also been reported in a no. of proliferating normal adult tissues.  Extensive research has been conducted, aimed at increasing our understanding of survivin, by detg. its sub-cellular structure and location, mechanism(s) of action and control of expression.  While much important information on this mol. has been accumulated, there are still many areas of controversy or limited information.  Further research may enable exploitation of survivin overexpression in cancer compared to normal tissues, making survivin a potentially attractive target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTyDh2jQIlKLVg90H21EOLACvtfcHk0liCZbvGblMcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D&md5=444e29c17b6ad4954f8a1a8e182850af</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568009033482038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033482038%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DL.%26aulast%3DLinehan%26aufirst%3DR.%26aulast%3DClynes%26aufirst%3DM.%26atitle%3DSurvivin%253A%2520role%2520in%2520normal%2520cells%2520and%2520in%2520pathological%2520conditions%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D131%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Grivicich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Rocha, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartsmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J. A.</span><span> </span><span class="NLM_article-title">Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines</span> <span class="citation_source-journal">Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16491956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=385-392&author=I.+Grivicichauthor=A.+Regnerauthor=A.+B.+da+Rochaauthor=L.+B.+Grassauthor=P.+A.+Alvesauthor=G.+B.+Kayserauthor=G.+Schwartsmannauthor=J.+A.+Henriques&title=Irinotecan%2F5-fluorouracil+combination+induces+alterations+in+mitochondrial+membrane+potential+and+caspases+on+colon+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines</span></div><div class="casAuthors">Grivicich, Ivana; Regner, Andrea; da Rocha, Adriana B.; Grass, Luciano B.; Alves, Pedro A. G.; Kayser, Guilherme B.; Schwartsmann, Gilberto; Henriques, Joao A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7/8</span>),
    <span class="NLM_cas:pages">385-392</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">The combination of irinotecan (CPT-11) and 5-fluorouracil (5-FU) is currently used in the treatment of advanced colorectal carcinoma.  When compared to both agents alone, CPT-11 followed by 5-FU treatment demonstrated a synergistic effect.  This observation can be related to increased in apoptosis induction after caspase activation.  Several studies have demonstrated that changes in mitochondrial membrane potential occur earlier in apoptosis.  In this study, we verified whether the collapse in mitochondrial membrane and the activation of caspases is responsible for increased apoptosis obsd. with CPT-11/5-FU treatment.  Thus, HT-29 and SNU-C4 human colon carcinoma cell lines were exposed for 24 h to each drug alone, and to various combinations and treatment sequences, and assessed for colony formation, changes in the mitochondrial membrane potential, and the activities of caspase-3, -8, and -9.  The CPT-11/5-FU treatment induced apoptosis in both cell lines; however, the most pronounced effect was obsd. in HT-29 cells.  In these cells, both caspase-3 and -9 were involved in the activation of apoptosis after CPT-11/5-FU treatment.  Moreover, in these cells, a redn. of 50% in mitochondrial membrane potential was obsd. with this treatment.  On the other hand, in the SNU-C4 cell line in addn. to caspase-3 and -9, caspase-8 seems to be important to apoptosis after CPT-11/5-FU treatment.  Furthermore, in this cell line we did not observe alterations in mitochondrial membrane potential.  In spite of the differences among the cell lines, these results indicated that the increase in apoptosis in HT-29 cells obsd. with CPT-11 followed by 5-FU treatment could be explained by a disruption in mitochondria membrane potential that induced caspases activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHbrkcrRK3ubVg90H21EOLACvtfcHk0liCZbvGblMcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOjsL4%253D&md5=191ee04e5ee6876e035f2947746ba2f4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrivicich%26aufirst%3DI.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3Dda%2BRocha%26aufirst%3DA.%2BB.%26aulast%3DGrass%26aufirst%3DL.%2BB.%26aulast%3DAlves%26aufirst%3DP.%2BA.%26aulast%3DKayser%26aufirst%3DG.%2BB.%26aulast%3DSchwartsmann%26aufirst%3DG.%26aulast%3DHenriques%26aufirst%3DJ.%2BA.%26atitle%3DIrinotecan%252F5-fluorouracil%2520combination%2520induces%2520alterations%2520in%2520mitochondrial%2520membrane%2520potential%2520and%2520caspases%2520on%2520colon%2520cancer%2520cell%2520lines%26jtitle%3DOncol.%2520Res.%26date%3D2005%26volume%3D15%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kolomeichuk, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upreti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajasekaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. C.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=128-136&author=S.+N.+Kolomeichukauthor=A.+Beneauthor=M.+Upretiauthor=R.+A.+Dennisauthor=C.+S.+Lyleauthor=M.+Rajasekaranauthor=T.+C.+Chambers&title=Induction+of+apoptosis+by+vinblastine+via+c-Jun+autoamplification+and+p53-independent+down-regulation+of+p21WAF1%2FCIP1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolomeichuk%26aufirst%3DS.%2BN.%26aulast%3DBene%26aufirst%3DA.%26aulast%3DUpreti%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DR.%2BA.%26aulast%3DLyle%26aufirst%3DC.%2BS.%26aulast%3DRajasekaran%26aufirst%3DM.%26aulast%3DChambers%26aufirst%3DT.%2BC.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520vinblastine%2520via%2520c-Jun%2520autoamplification%2520and%2520p53-independent%2520down-regulation%2520of%2520p21WAF1%252FCIP1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kolenko, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzzo, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, J. H.</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kolenko%2C+V.+M.%3B+Uzzo%2C+R.+G.%3B+Bukowski%2C+R.%3B+Finke%2C+J.+H.Apoptosis+2000%2C+5%2C+17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolenko%26aufirst%3DV.%2BM.%26aulast%3DUzzo%26aufirst%3DR.%2BG.%26aulast%3DBukowski%26aufirst%3DR.%26aulast%3DFinke%26aufirst%3DJ.%2BH.%26jtitle%3DApoptosis%26date%3D2000%26volume%3D5%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Promoting apoptosis as a strategy for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1038%2Fnrc1736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16239906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=876-885&author=S.+W.+Fesik&title=Promoting+apoptosis+as+a+strategy+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Promoting apoptosis as a strategy for cancer drug discovery</span></div><div class="casAuthors">Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-885</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptosis is deregulated in many cancers, making it difficult to kill tumors.  Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive.  Apoptosis targets that are currently being explored for cancer drug discovery include the tumor-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOkjz2FXKfBbVg90H21EOLACvtfcHk0liCZbvGblMcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J&md5=0976f3fb83374260702a71fd856a4834</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1736%26sid%3Dliteratum%253Aachs%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPromoting%2520apoptosis%2520as%2520a%2520strategy%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0lhAkqPb2df-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb600276q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=525-533&author=K.+Zobelauthor=L.+Wangauthor=E.+Varfolomeevauthor=M.+C.+Franklinauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=D.+C.+Okawaauthor=J.+A.+Flygareauthor=D.+Vucicauthor=W.+J.+Fairbrotherauthor=K.+Deshayes&title=Design%2C+synthesis%2C+and+biological+activity+of+a+potent+Smac+mimetic+that+sensitizes+cancer+cells+to+apoptosis+by+antagonizing+IAPs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fcb600276q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600276q%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DOkawa%26aufirst%3DD.%2BC.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520potent%2520Smac%2520mimetic%2520that%2520sensitizes%2520cancer%2520cells%2520to%2520apoptosis%2520by%2520antagonizing%2520IAPs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1073%2Fpnas.0708917105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18316739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3933-3938&author=S.+Shangaryauthor=D.+Qinauthor=D.+McEachernauthor=M.+Liuauthor=R.+S.+Millerauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=K.+Dingauthor=G.+Wangauthor=J.+Chenauthor=D.+Bernardauthor=J.+Zhangauthor=Y.+Luauthor=Q.+Guauthor=R.+B.+Shahauthor=K.+J.+Pientaauthor=X.+Lingauthor=S.+Kangauthor=M.+Guoauthor=Y.+Sunauthor=D.+Yangauthor=S.+Wang&title=Temporal+activation+of+p53+by+a+specific+MDM2+inhibitor+is+selectively+toxic+to+tumors+and+leads+to+complete+tumor+growth+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition</span></div><div class="casAuthors">Shangary, Sanjeev; Qin, Dongguang; McEachern, Donna; Liu, Meilan; Miller, Rebecca S.; Qiu, Su; Nikolovska-Coleska, Zaneta; Ding, Ke; Wang, Guoping; Chen, Jianyong; Bernard, Denzil; Zhang, Jian; Lu, Yipin; Gu, Qingyang; Shah, Rajal B.; Pienta, Kenneth J.; Ling, Xiaolan; Kang, Sanmao; Guo, Ming; Sun, Yi; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3933-3938</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have designed MI-219 as a potent, highly selective and orally active small-mol. inhibitor of the MDM2-p53 interaction.  MI-219 binds to human MDM2 with a Ki value of 5 nM and is 10,000-fold selective for MDM2 over MDMX.  It disrupts the MDM2-p53 interaction and activates the p53 pathway in cells with wild-type p53, which leads to induction of cell cycle arrest in all cells and selective apoptosis in tumor cells.  MI-219 stimulates rapid but transient p53 activation in established tumor xenograft tissues, resulting in inhibition of cell proliferation, induction of apoptosis, and complete tumor growth inhibition.  MI-219 activates p53 in normal tissues with minimal p53 accumulation and is not toxic to animals.  MI-219 warrants clin. investigation as a new agent for cancer treatment.+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQBsJgWWIJ-LVg90H21EOLACvtfcHk0lhAkqPb2df-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Ohtb4%253D&md5=cf97e00f9748744da7617491da96f37e</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0708917105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0708917105%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DR.%2BS.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DR.%2BB.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTemporal%2520activation%2520of%2520p53%2520by%2520a%2520specific%2520MDM2%2520inhibitor%2520is%2520selectively%2520toxic%2520to%2520tumors%2520and%2520leads%2520to%2520complete%2520tumor%2520growth%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3933%26epage%3D3938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, E.</span><span> </span><span class="NLM_article-title">Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=39-42&author=S.+X.+Caiauthor=H.-Z.+Zhangauthor=J.+Guastellaauthor=J.+Dreweauthor=W.+Yangauthor=E.+Weber&title=Design+and+synthesis+of+rhodamine+110+derivative+and+caspase-3+substrate+for+enzyme+and+cell-based+fluorescent+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520rhodamine%2520110%2520derivative%2520and%2520caspase-3%2520substrate%2520for%2520enzyme%2520and%2520cell-based%2520fluorescent%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F092986706778201521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17017915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2627-2644&author=S.+X.+Caiauthor=J.+Dreweauthor=S.+Kasibhatla&title=A+chemical+genetics+approach+for+the+discovery+of+apoptosis+inducers%3A+from+phenotypic+cell+based+HTS+assay+and+structure-activity+relationship+studies%2C+to+identification+of+potential+anticancer+agents+and+molecular+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span></div><div class="casAuthors">Cai, Sui Xiong; Drewe, John; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2627-2644</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The approach of chem. genetics has been widely used to study biol. systems and to discover new drugs, signaling pathways and targets.  The current review focuses on the development and utilization of a cell- and caspase-based apoptosis induction assay for the discovery of apoptosis inducers.  We began with the development of a cell based phenotypic assay, which was used for the identification of small mols. that exhibit apoptosis inducing activities, including N-Ph nicotinamides, gambogic acid, indole-2-carboxylic acid benzylidene-hydrazides, 4-aryl-4H-chromenes and 3-aryl-5-aryl-1,2,4-oxadiazoles.  Through medicinal chem. and biol. studies, in vivo active compds. were identified, such as MX116407 as a tumor vascular disrupting agent with potent in vivo anticancer activity.  The mol. targets of in vivo active compds. were identified using reagents designed and synthesized based on the SAR, including the identification of tail-interacting protein 47 (TIP47), an insulin-like growth factor II (IGF II) receptor binding protein, as the mol. target of 3-aryl-5-aryl-1,2,4-oxadiazoles; and Transferrin receptor I (TfR), a transmembrane protein that interacts with transferrin (Tf) for the transport of iron into cells, as the mol. target of gambogic acid.  We demonstrated that chem. genetics is a very useful approach for anticancer drug research, from the discovery of potential drugs, to the understanding of signaling pathways and identification of druggable targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bmsD_VBUGLVg90H21EOLACvtfcHk0lgRLm3Xu1a-PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D&md5=d4ca29e8367b8dd6a882df747760c9a2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F092986706778201521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778201521%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DA%2520chemical%2520genetics%2520approach%2520for%2520the%2520discovery%2520of%2520apoptosis%2520inducers%253A%2520from%2520phenotypic%2520cell%2520based%2520HTS%2520assay%2520and%2520structure-activity%2520relationship%2520studies%252C%2520to%2520identification%2520of%2520potential%2520anticancer%2520agents%2520and%2520molecular%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2627%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Discovery of substituted <i>N</i>-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2481</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2474-2481&author=S.+X.+Caiauthor=B.+Nguyenauthor=S.+Jiaauthor=J.+Herichauthor=J.+Guastellaauthor=S.+Reddyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+Kasibhatla&title=Discovery+of+substituted+N-phenyl+nicotinamides+as+potent+inducers+of+apoptosis+using+a+cell-+and+caspase-based+high+throughput+screening+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205200%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520substituted%2520N-phenyl%2520nicotinamides%2520as%2520potent%2520inducers%2520of%2520apoptosis%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2474%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=309-317&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=Y.+Wangauthor=J.+Herichauthor=J.+Guastellaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery%2C+characterization+and+SAR+of+gambogic+acid+as+a+potent+apoptosis+inducer+by+a+HTS+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%252C%2520characterization%2520and%2520SAR%2520of%2520gambogic%2520acid%2520as%2520a%2520potent%2520apoptosis%2520inducer%2520by%2520a%2520HTS%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rej, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6299</span><span class="NLM_x">–</span> <span class="NLM_lpage">6310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049640t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6299-6310&author=W.+Kemnitzerauthor=S.+Kasibhatlaauthor=S.+Jiangauthor=H.+Zhangauthor=Y.+Wangauthor=J.+Zhaoauthor=S.+Jiaauthor=J.+Herichauthor=D.+Labrequeauthor=R.+Storerauthor=K.+Meerovitchauthor=D.+Bouffardauthor=R.+Rejauthor=R.+Denisauthor=C.+Blaisauthor=S.+Lamotheauthor=G.+Attardoauthor=H.+Gourdeauauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+1.+Structure-activity+relationships+of+the+4-aryl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm049640t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049640t%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DRej%26aufirst%3DR.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DBlais%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25201.%2520Structure-activity%2520relationships%2520of%2520the%25204-aryl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6299%26epage%3D6310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2858</span><span class="NLM_x">–</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070216c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2858-2864&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=J.+Zhaoauthor=C.+Crogan-Grundyauthor=L.+Xuauthor=S.+Lamotheauthor=H.+Gourdeauauthor=R.+Denisauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+3.+Structure-activity+relationships+of+fused+rings+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm070216c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070216c%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25203.%2520Structure-activity%2520relationships%2520of%2520fused%2520rings%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2858%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubenick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of <i>N</i>-alkyl substituted pyrrole fused at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=417-423&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=C.+Crogan-Grundyauthor=D.+Labrequeauthor=M.+Bubenickauthor=G.+Attardoauthor=R.+Denisauthor=S.+Lamotheauthor=H.+Gourdeauauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+4.+Structure-activity+relationships+of+N-alkyl+substituted+pyrrole+fused+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Fjm7010657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010657%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DBubenick%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25204.%2520Structure-activity%2520relationships%2520of%2520N-alkyl%2520substituted%2520pyrrole%2520fused%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliis-Mason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogran-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5215</span><span class="NLM_x">–</span> <span class="NLM_lpage">5223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050292k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5215-5223&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=J.+Kuemmerleauthor=W.+Kemnitzerauthor=K.+Oliis-Masonauthor=L.+Quiauthor=C.+Crogran-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+3-aryl-5-aryl-1%2C2%2C4-oxadiazoles+as+a+new+series+of+apoptosis+inducers+and+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm050292k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050292k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DOliis-Mason%26aufirst%3DK.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DCrogran-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%25203-aryl-5-aryl-1%252C2%252C4-oxadiazoles%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5215%26epage%3D5223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claassen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 1. Structure-activity relationships of the 4-anilino group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7761</span><span class="NLM_x">–</span> <span class="NLM_lpage">7773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7761-7773&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=B.+Nguyenauthor=A.+Pervinauthor=Y.+Wangauthor=G.+Claassenauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+substituted+4-anilino-2-%282-pyridyl%29pyrimidines+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+1.+Structure-activity+relationships+of+the+4-anilino+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DClaassen%26aufirst%3DG.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520substituted%25204-anilino-2-%25282-pyridyl%2529pyrimidines%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25201.%2520Structure-activity%2520relationships%2520of%2520the%25204-anilino%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7761%26epage%3D7773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claassen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of <i>N</i>-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinolin-4-amines as a new series of potent apoptosis inducers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=222-231&author=H.-Z.+Zhangauthor=G.+Claassenauthor=C.+Crogan-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+N-phenyl-1H-pyrazolo%5B3%2C4-b%5Dquinolin-4-amines+as+a+new+series+of+potent+apoptosis+inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DClaassen%26aufirst%3DG.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%2520N-phenyl-1H-pyrazolo%255B3%252C4-b%255Dquinolin-4-amines%2520as%2520a%2520new%2520series%2520of%2520potent%2520apoptosis%2520inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D18%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4771-4779&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=V.+Baichwalauthor=G.+G.+Matherauthor=K.+Jessingauthor=R.+Hussainauthor=K.+Hoangauthor=C.+M.+Pleimanauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+2-chloro-N-%284-methoxyphenyl%29-N-methylquinazolin-4-amine+%28EP128265%2C+MPI-0441138%29+as+a+potent+inducer+of+apoptosis+with+high+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003653%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DJessing%26aufirst%3DK.%26aulast%3DHussain%26aufirst%3DR.%26aulast%3DHoang%26aufirst%3DK.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25202-chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2520%2528EP128265%252C%2520MPI-0441138%2529%2520as%2520a%2520potent%2520inducer%2520of%2520apoptosis%2520with%2520high%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4771%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Connolly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiry, P. J.</span><span> </span><span class="NLM_article-title">Preparation and resolution of a modular class of axially chiral quinazoline-containing ligands and their application in asymmetric rhodium-catalyzed olefin hydroboration</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6589</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049195%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=6572-6589&author=D.+J.+Connollyauthor=P.+M.+Laceyauthor=M.+McCarthyauthor=C.+P.+Saundersauthor=A.-M.+Carrollauthor=R.+Goddardauthor=P.+J.+Guiry&title=Preparation+and+resolution+of+a+modular+class+of+axially+chiral+quinazoline-containing+ligands+and+their+application+in+asymmetric+rhodium-catalyzed+olefin+hydroboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo049195%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049195%252B%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DD.%2BJ.%26aulast%3DLacey%26aufirst%3DP.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DC.%2BP.%26aulast%3DCarroll%26aufirst%3DA.-M.%26aulast%3DGoddard%26aufirst%3DR.%26aulast%3DGuiry%26aufirst%3DP.%2BJ.%26atitle%3DPreparation%2520and%2520resolution%2520of%2520a%2520modular%2520class%2520of%2520axially%2520chiral%2520quinazoline-containing%2520ligands%2520and%2520their%2520application%2520in%2520asymmetric%2520rhodium-catalyzed%2520olefin%2520hydroboration%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D6572%26epage%3D6589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: a small molecule inhibitor of microtubule formation that is not a substrate for multi-drug resistance pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+a+small+molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multi-drug+resistance+pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520a%2520small%2520molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multi-drug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Neville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parise, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleksic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuffey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-03-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=15073132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=2525-2529&author=K.+Nevilleauthor=R.+A.+Pariseauthor=P.+Thompsonauthor=A.+Aleksicauthor=M.+J.+Egorinauthor=F.+M.+Balisauthor=L.+McGuffeyauthor=C.+McCullyauthor=S.+L.+Bergauthor=S.+M.+Blaney&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+imatinib+after+administration+to+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates</span></div><div class="casAuthors">Neville, Kathleen; Parise, Robert A.; Thompson, Patrick; Aleksic, Alexander; Egorin, Merrill J.; Balis, Frank M.; McGuffey, Leticia; McCully, Cynthia; Berg, Stacey L.; Blaney, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2525-2529</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Imatinib mesylate (Gleevec, Glivec, STI571, imatinib) is a potent tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors.  The role of imatinib in the treatment of malignant gliomas and other solid tumors is being evaluated.  We used a nonhuman primate model that is highly predictive of the cerebrospinal fluid penetration of drugs in humans to study the pharmacokinetics of imatinib in plasma and cerebrospinal fluid (CSF) after i.v. and p.o. administration.  Imatinib, 15 mg/kg i.v. over 30 min (n = 3) or 30 mg/kg p.o. (n = 3), was administered to nonhuman primates.  Imatinib was measured in serial samples of plasma and CSF using high-pressure liq. chromatog. with UV absorbance or mass spectroscopic detection.  Pharmacokinetic parameters were estd. using model-independent methods.  Peak plasma imatinib concns. ranged from 6.4 to 9.5 μM after i.v. dosing and 0.8 to 2.8 μM after p.o. dosing.  The mean ±SD area under the plasma concn. vs. time curve was 2480 ±1340 μM·min and 1191 ±146 μM·min after i.v. and p.o. dosing, resp.  The terminal half-life was 529 ±167 min after i.v. dosing and 266 ±88 min after p.o. dosing.  After i.v. dosing the steady state vol. of distribution was 5.9 ±2.8 L/kg, and the total body clearance was 12 ±5 mL/min/kg.  The mean peak CSF concn. was 0.25 ±0.07 μM after i.v. dosing and 0.07 ±0.04 μM after p.o. dosing.  The mean CSF:plasma area under the plasma concn. vs. time curve ratio for all of the animals was 5% ±2%.  There is limited penetration of imatinib into the CSF of nonhuman primates after i.v. and p.o. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMPjbJK4TVxrVg90H21EOLACvtfcHk0liZzhYnbrtQfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSqsbo%253D&md5=1849626bb417a9aaa5b6b6e13c45bc5c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0155%26sid%3Dliteratum%253Aachs%26aulast%3DNeville%26aufirst%3DK.%26aulast%3DParise%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DAleksic%26aufirst%3DA.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DMcGuffey%26aufirst%3DL.%26aulast%3DMcCully%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520imatinib%2520after%2520administration%2520to%2520nonhuman%2520primates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D2525%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Heimberger, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chewning, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuck, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pracyk, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span> </span><span class="NLM_article-title">Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3496</span><span class="NLM_x">–</span> <span class="NLM_lpage">3502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=12429640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVCgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=3496-3502&author=A.+B.+Heimbergerauthor=C.+A.+Learnauthor=G.+E.+Archerauthor=R.+E.+McLendonauthor=T.+A.+Chewningauthor=F.+L.+Tuckauthor=J.+B.+Pracykauthor=A.+H.+Friedmanauthor=H.+S.+Friedmanauthor=D.+D.+Bignerauthor=J.+H.+Sampson&title=Brain+tumors+in+mice+are+susceptible+to+blockade+of+epidermal+growth+factor+receptor+%28EGFR%29+with+the+oral%2C+specific%2C+EGFR-tyrosine+kinase+inhibitor+ZD1839+%28iressa%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (Iressa)</span></div><div class="casAuthors">Heimberger, Amy B.; Learn, Chris A.; Archer, Gary E.; McLendon, Roger E.; Chewning, Tracy A.; Tuck, Frank L.; Pracyk, John B.; Friedman, Allan H.; Friedman, Henry S.; Bigner, Darell D.; Sampson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3496-3502</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Iressa (ZD 1839) is a p.o.-active, selective, epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that blocks signal transduction pathways implicated in cancer cell proliferation, survival, and host-dependent processes promoting cancer growth.  EGFR is up-regulated in primary malignant tumors of the central nervous system (CNS) and in many systemic tumors that metastasize to the CNS.  The purpose of our study was to evaluate the efficacy and toxicity of p.o.-administered ZD 1839 for the treatment of established intracerebral (i.c.) tumors expressing EGFR or the tumorigenic mutated variant EGFRvIII, which is constitutively phosphorylated.  Oral administration of ZD 1839 at 50 or 100 mg/kg/day for 3 wk in athymic mice with established i.c. A431 human epidermoid carcinoma expressing EGFR increased median survival by 88% and 105%, resp.  Addnl., there was no evidence of systemic or CNS toxicity.  However, ZD 1839 failed to inhibit either s.c. or i.c. in vivo tumor growth when tumorigenicity was conferred by EGFRvIII.  Western blotting revealed that treatment with ZD 1839 virtually ablated phosphorylation of EGFR Tyr-1173 in A431 tumors.  However, treatment of NR6M tumors with ZD 1839 only partially decreased phosphorylation of EGFRvIII Tyr-1173 while up-regulating overall expression, suggesting that EGFRvIII may not be susceptible to the same mol. mechanisms of tyrosine kinase inhibition as EGFR.  In conclusion, ZD 1839 is active in a brain tumor model expressing EGFR, but not EGFRvIII, as EGFR mutations may lead to relative therapeutic resistance.  On the basis of these observations, we believe that clin. trials of ZD 1839 against brain tumors expressing EGFR are warranted, but that special consideration should be given to tumors that coexpress EGFRvIII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodn9-INoJ17Vg90H21EOLACvtfcHk0lgXLnHfTZvr7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVCgtLs%253D&md5=fffc5229788f76544cc97e65708914ce</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeimberger%26aufirst%3DA.%2BB.%26aulast%3DLearn%26aufirst%3DC.%2BA.%26aulast%3DArcher%26aufirst%3DG.%2BE.%26aulast%3DMcLendon%26aufirst%3DR.%2BE.%26aulast%3DChewning%26aufirst%3DT.%2BA.%26aulast%3DTuck%26aufirst%3DF.%2BL.%26aulast%3DPracyk%26aufirst%3DJ.%2BB.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26atitle%3DBrain%2520tumors%2520in%2520mice%2520are%2520susceptible%2520to%2520blockade%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520with%2520the%2520oral%252C%2520specific%252C%2520EGFR-tyrosine%2520kinase%2520inhibitor%2520ZD1839%2520%2528iressa%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D3496%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1007%2Fs00280-006-0402-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17187251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=563-567&author=S.+Y.+Choauthor=E.+Foxauthor=C.+McCullyauthor=J.+Bauchauthor=K.+Marshauthor=F.+M.+Balis&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+intravenously+administered+ABT-751+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates</span></div><div class="casAuthors">Cho, Steve Y.; Fox, Elizabeth; McCully, Cynthia; Bauch, Joy; Marsh, Kennan; Balis, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-567</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: ABT-751 is an orally bioavailable sulfonamide that binds to the colchicine binding site on β-tubulin and inhibits microtubule polymn.  The plasma and cerebrospinal fluid (CSF) pharmacokinetics of ABT-751, after a short i.v. infusion, were evaluated in a non-human primate (Macaca mulatta) model that is highly predictive of the CSF penetration of drugs in humans.  Materials and methods: Plasma and CSF samples were collected over 24 h after 7.5 mg/kg (150 mg/m2) ABT-751 infused over 0.25-0.70 h, and ABT-751 concns. in plasma and CSF were quantified using a validated HPLC-MS/MS assay.  Pharmacokinetic parameters in plasma and CSF were derived using non-compartmental methods.  Results and conclusion: Plasma disappearance was bi-exponential with a terminal half-life of 13 h.  The mean ± SD clearance was 100 ± 18 mL/min m2, the mean ± SD vol. of distribution at steady state was 1.3 ± 0.5 l/kg, and the mean ± SD mean residence time was 4.6 ± 1.8 h.  The mean ± SD peak ABT-751 concn. in CSF was 0.26 ± 0.08 μM, and the mean ± SD CSF half-life of 1.3 ± 0.3 h.  CSF penetration was limited (mean ± SD AUCCSF:AUCplasma, 1.1 ± 0.3%) relative to total (protein-bound + free) plasma drug concns., but the CSF concns. approximated the estd. free drug concns. in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdC0MjbKyHbVg90H21EOLACvtfcHk0lgXLnHfTZvr7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFKntr0%253D&md5=50e5747b8835e1b986f4e742522f6b74</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0402-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0402-7%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DFox%26aufirst%3DE.%26aulast%3DMcCully%26aufirst%3DC.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520intravenously%2520administered%2520ABT-751%2520in%2520non-human%2520primates%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D563%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jacobs, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-04-1807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=15746072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1669-1674&author=S.+S.+Jacobsauthor=E.+Foxauthor=C.+Dennieauthor=L.+B.+Morganauthor=C.+L.+McCullyauthor=F.+M.+Balis&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+intravenous+oxaliplatin%2C+cisplatin%2C+and+carboplatin+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates</span></div><div class="casAuthors">Jacobs, Shana S.; Fox, Elizabeth; Dennie, Christopher; Morgan, Lindsey B.; McCully, Cynthia L.; Balis, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1669-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Describe and compare the central nervous system pharmacol. of the platinum analogs, cisplatin, carboplatin, and oxaliplatin and develop a pharmacokinetic model to distinguish the disposition of active drug from inert platinum species.  Oxaliplatin (7 or 5 mg/kg), cisplatin (2 mg/kg), or carboplatin (10 mg/kg) was given i.v.  Serial plasma and cerebrospinal fluid (CSF) samples were collected over 24 h.  Plasma ultrafiltrates were prepd. immediately.  Platinum concns. were measured using at. absorption spectrometry.  Areas under the concn. x time curve were derived using the linear trapezoidal method.  CSF penetration was defined as the CSF AUC0-24/plasma ultrafiltrate AUC0-24 ratio.  A four-compartment model with first-order rate consts. was fit to the data to distinguish active drug from inactive metabolites.  The mean ± SD AUCs in plasma ultrafiltrate for oxaliplatin, cisplatin, and carboplatin were 61 ± 22, 18 ± 6, and 211 ± 64 μmol/L hour, resp.  The AUCs in CSF were 1.2 ± 0.4 μmol/L hour for oxaliplatin, 0.56 ± 0.08 μmol/L hour for cisplatin, and 8 ± 2.2 μmol/L hour for carboplatin, and CSF penetration was 2.0%, 3.6%, and 3.8%, resp.  For oxaliplatin, cisplatin, and carboplatin, the pharmacokinetic model estd. that active drug accounted for 29%, 79%, and 81% of platinum in plasma ultrafiltrate, resp., and 25%, 89%, and 56% of platinum in CSF, resp.  The CSF penetration of active drug was 1.6% for oxaliplatin, 3.7% for cisplatin, and 2.6% for carboplatin.  The CSF penetration of the platinum analogs is limited.  The pharmacokinetic model distinguished between active drug and their inactive (inert) metabolites in plasma and CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_OFcn4uU-KLVg90H21EOLACvtfcHk0lgXLnHfTZvr7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSrt7s%253D&md5=1aafc40d922a2ccc7104e9e995f1a0b4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1807%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DS.%2BS.%26aulast%3DFox%26aufirst%3DE.%26aulast%3DDennie%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DL.%2BB.%26aulast%3DMcCully%26aufirst%3DC.%2BL.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520intravenous%2520oxaliplatin%252C%2520cisplatin%252C%2520and%2520carboplatin%2520in%2520nonhuman%2520primates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1669%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0liooWAhWSRing"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood-brain distribution</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1016%2FS0169-409X%2802%2900005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=11922949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood-brain+distribution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Computational approaches to the prediction of the blood-brain distribution</span></div><div class="casAuthors">Norinder, Ulf; Haeberlein, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-313</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  This review attempts to summarize present knowledge related to the theor. modeling of drug transport across the blood-brain barrier.  Several computational protocols are described ranging from quantum mechanics-based approaches through mol. mechanics-related techniques to simple and fast procedures based on only the 2-D graph of the investigated structures.  Amazingly, few descriptors have been shown to influence the derived relationships in a significant manner and a cornerstone in most of the described models are terms describing hydrogen bonding.  A very quick quant. assessment of the brain partitioning of a compd. has also been devised using the following two rules: If N+O (the no. of nitrogen and oxygen atoms) in a mol. is less than or equal to five, it has a high chance of entering the brain.  The second rule predicts that if log P-(N+O) is pos. then log BB is pos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9Yd_Pc0M07Vg90H21EOLACvtfcHk0liooWAhWSRing"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D&md5=cc689594714a0afb9f67917c77530d8c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900005-4%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood-brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 81 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yumiko Suzuki, Ayana Otake, Satoshi Ueno, Kensuke Hayashi, Hirosuke Ishii, Nao Miyoshi, Kenta Kuroiwa, Masashi Tachikawa, Yuki Fujimaki, Kotaro Nishiyama, Kei Manabe, Ryuta Yamazaki, <span class="NLM_string-name hlFld-ContribAuthor">Akira Asai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Anticancer Agent PVHD303 with in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 1287-1291. <a href="https://doi.org/10.1021/acsmedchemlett.0c00119" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00119%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAnticancer%252BAgent%252BPVHD303%252Bwith%252Bin%252BVivo%252BActivity%26aulast%3DSuzuki%26aufirst%3DYumiko%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D09032020%26date%3D08052020%26date%3D11052020%26date%3D08052020%26volume%3D11%26issue%3D6%26spage%3D1287%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenlong Li, Feijie Xu, Wen Shuai, Honghao Sun, Hong Yao, Cong Ma, Shengtao Xu, Hequan Yao, Zheying Zhu, Dong-Hua Yang, Zhe-Sheng Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jinyi Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Quinoline–Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 993-1013. <a href="https://doi.org/10.1021/acs.jmedchem.8b01755" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01755%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BQuinoline%2525E2%252580%252593Chalcone%252BDerivatives%252Bas%252BPotent%252BAntitumor%252BAgents%252Bwith%252BMicrotubule%252BPolymerization%252BInhibitory%252BActivity%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11112018%26date%3D24122018%26date%3D11122018%26volume%3D62%26issue%3D2%26spage%3D993%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaowei Zhang, Sheng Wang, Yu Liu, <span class="NLM_string-name hlFld-ContribAuthor">Chanjuan Xi</span>. </span><span class="cited-content_cbyCitation_article-title">Triflates-Triggered Intermolecular Cyclization of Carbodiimides Leading to 2-Aminoquinazolinone and 2,4-Diaminoquinazoline Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 2148-2151. <a href="https://doi.org/10.1021/acs.orglett.8b00314" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00314%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DTriflates-Triggered%252BIntermolecular%252BCyclization%252Bof%252BCarbodiimides%252BLeading%252Bto%252B2-Aminoquinazolinone%252Band%252B2%25252C4-Diaminoquinazoline%252BDerivatives%26aulast%3DZhang%26aufirst%3DXiaowei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29012018%26date%3D05042018%26volume%3D20%26issue%3D8%26spage%3D2148%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">J. S. Dileep Kumar, Kiran Kumar Solingapuram Sai, Jaya Prabhakaran, Hakeem R. Oufkir, Gayathri Ramanathan, Christopher T. Whitlow, Hima Dileep, Akiva Mintz, <span class="NLM_string-name hlFld-ContribAuthor">J. John Mann</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and in Vivo Evaluation of [11C]MPC-6827, the First Brain Penetrant Microtubule PET Ligand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 2118-2123. <a href="https://doi.org/10.1021/acs.jmedchem.8b00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRadiosynthesis%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B%25255B11C%25255DMPC-6827%25252C%252Bthe%252BFirst%252BBrain%252BPenetrant%252BMicrotubule%252BPET%252BLigand%26aulast%3DKumar%26aufirst%3DJ.%2BS.%2BDileep%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08012018%26date%3D23022018%26date%3D19022018%26volume%3D61%26issue%3D5%26spage%3D2118%26epage%3D2123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María-Jesús  Pérez-Pérez</span>, <span class="hlFld-ContribAuthor ">Eva-María  Priego</span>, <span class="hlFld-ContribAuthor ">Oskía  Bueno</span>, <span class="hlFld-ContribAuthor ">Maria Solange  Martins</span>, <span class="hlFld-ContribAuthor ">María-Dolores  Canela</span>, and <span class="hlFld-ContribAuthor ">Sandra  Liekens</span>  . </span><span class="cited-content_cbyCitation_article-title">Blocking Blood Flow to Solid Tumors by Destabilizing Tubulin: An Approach to Targeting Tumor Growth. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8685-8711. <a href="https://doi.org/10.1021/acs.jmedchem.6b00463" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00463%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBlocking%252BBlood%252BFlow%252Bto%252BSolid%252BTumors%252Bby%252BDestabilizing%252BTubulin%25253A%252BAn%252BApproach%252Bto%252BTargeting%252BTumor%252BGrowth%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DMar%25C3%25ADa-Jes%25C3%25BAs%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29032016%26date%3D27062016%26date%3D13102016%26volume%3D59%26issue%3D19%26spage%3D8685%26epage%3D8711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenta  Kuroiwa</span>, <span class="hlFld-ContribAuthor ">Hirosuke  Ishii</span>, <span class="hlFld-ContribAuthor ">Kenji  Matsuno</span>, <span class="hlFld-ContribAuthor ">Akira  Asai</span>, and <span class="hlFld-ContribAuthor ">Yumiko  Suzuki</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Structure–Activity Relationship Study of 1-Phenyl-1-(quinazolin-4-yl)ethanols as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 287-291. <a href="https://doi.org/10.1021/ml5004684" title="DOI URL">https://doi.org/10.1021/ml5004684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5004684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5004684%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%252Bof%252B1-Phenyl-1-%252528quinazolin-4-yl%252529ethanols%252Bas%252BAnticancer%252BAgents%26aulast%3DKuroiwa%26aufirst%3DKenta%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D11112014%26date%3D10012015%26date%3D21012015%26date%3D12032015%26date%3D10012015%26volume%3D6%26issue%3D3%26spage%3D287%26epage%3D291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Fang  Guan</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Wanjun  Guo</span>, <span class="hlFld-ContribAuthor ">Lili  Wang</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Zhu</span>, <span class="hlFld-ContribAuthor ">Sheng-Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Li-Ting  Wang</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Dexuan  Yang</span>, <span class="hlFld-ContribAuthor ">Linna  Li</span>, <span class="hlFld-ContribAuthor ">Keduo  Qian</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Shoujun  Yuan</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, and <span class="hlFld-ContribAuthor ">Lan  Xie</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of 4-(N-Cycloamino)phenylquinazolines as a Novel Class of Tubulin-Polymerization Inhibitors Targeting the Colchicine Site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1390-1402. <a href="https://doi.org/10.1021/jm4016526" title="DOI URL">https://doi.org/10.1021/jm4016526</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4016526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4016526%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252B4-%252528N-Cycloamino%252529phenylquinazolines%252Bas%252Ba%252BNovel%252BClass%252Bof%252BTubulin-Polymerization%252BInhibitors%252BTargeting%252Bthe%252BColchicine%252BSite%26aulast%3DWang%26aufirst%3DXiao-Feng%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25102013%26date%3D06022014%26date%3D27022014%26volume%3D57%26issue%3D4%26spage%3D1390%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyamaheshwar  Peddibhotla</span>, <span class="hlFld-ContribAuthor ">Michael P.  Hedrick</span>, <span class="hlFld-ContribAuthor ">Paul  Hershberger</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Maloney</span>, <span class="hlFld-ContribAuthor ">Yujie  Li</span>, <span class="hlFld-ContribAuthor ">Monika  Milewski</span>, <span class="hlFld-ContribAuthor ">Palak  Gosalia</span>, <span class="hlFld-ContribAuthor ">Wilson  Gray</span>, <span class="hlFld-ContribAuthor ">Alka  Mehta</span>, <span class="hlFld-ContribAuthor ">Eliot  Sugarman</span>, <span class="hlFld-ContribAuthor ">Becky  Hood</span>, <span class="hlFld-ContribAuthor ">Eigo  Suyama</span>, <span class="hlFld-ContribAuthor ">Kevin  Nguyen</span>, <span class="hlFld-ContribAuthor ">Susanne  Heynen-Genel</span>, <span class="hlFld-ContribAuthor ">Stefan  Vasile</span>, <span class="hlFld-ContribAuthor ">Sumeet  Salaniwal</span>, <span class="hlFld-ContribAuthor ">Derek  Stonich</span>, <span class="hlFld-ContribAuthor ">Ying  Su</span>, <span class="hlFld-ContribAuthor ">Arianna  Mangravita-Novo</span>, <span class="hlFld-ContribAuthor ">Michael  Vicchiarelli</span>, <span class="hlFld-ContribAuthor ">Gregory P.  Roth</span>, <span class="hlFld-ContribAuthor ">Layton H.  Smith</span>, <span class="hlFld-ContribAuthor ">Thomas D. Y.  Chung</span>, <span class="hlFld-ContribAuthor ">Glen R.  Hanson</span>, <span class="hlFld-ContribAuthor ">James B.  Thomas</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>, <span class="hlFld-ContribAuthor ">Lawrence S.  Barak</span>, and <span class="hlFld-ContribAuthor ">Anthony B.  Pinkerton</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (9)
                                     , 846-851. <a href="https://doi.org/10.1021/ml400176n" title="DOI URL">https://doi.org/10.1021/ml400176n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml400176n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml400176n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BML314%25252C%252Ba%252BBrain%252BPenetrant%252BNonpeptidic%252B%2525CE%2525B2-Arrestin%252BBiased%252BAgonist%252Bof%252Bthe%252BNeurotensin%252BNTR1%252BReceptor%26aulast%3DPeddibhotla%26aufirst%3DSatyamaheshwar%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D13052013%26date%3D22072013%26date%3D30072013%26date%3D12092013%26date%3D22072013%26volume%3D4%26issue%3D9%26spage%3D846%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trapti  Aggarwal</span>, <span class="hlFld-ContribAuthor ">Maryam  Imam</span>, <span class="hlFld-ContribAuthor ">Naveen K.  Kaushik</span>, <span class="hlFld-ContribAuthor ">Virander S.  Chauhan</span>, and <span class="hlFld-ContribAuthor ">Akhilesh K.  Verma</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrano[4,3-b]quinolines Library Generation via Iodocyclization and Palladium-Catalyzed Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2011,</strong> <em>13 </em>
                                    (5)
                                     , 530-536. <a href="https://doi.org/10.1021/co200100z" title="DOI URL">https://doi.org/10.1021/co200100z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co200100z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco200100z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DPyrano%25255B4%25252C3-b%25255Dquinolines%252BLibrary%252BGeneration%252Bvia%252BIodocyclization%252Band%252BPalladium-Catalyzed%252BCoupling%252BReactions%26aulast%3DAggarwal%26aufirst%3DTrapti%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02062011%26date%3D19072011%26date%3D02082011%26date%3D12092011%26date%3D27072011%26volume%3D13%26issue%3D5%26spage%3D530%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Honggen  Wang</span>, <span class="hlFld-ContribAuthor ">Jiangling  Peng</span>, and <span class="hlFld-ContribAuthor ">Qiang  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Intramolecular C(sp2)–H Amidination by Isonitrile Insertion Provides Direct Access to 4-Aminoquinazolines from N-Arylamidines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (17)
                                     , 4604-4607. <a href="https://doi.org/10.1021/ol201807n" title="DOI URL">https://doi.org/10.1021/ol201807n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol201807n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol201807n%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BIntramolecular%252BC%252528sp2%252529%2525E2%252580%252593H%252BAmidination%252Bby%252BIsonitrile%252BInsertion%252BProvides%252BDirect%252BAccess%252Bto%252B4-Aminoquinazolines%252Bfrom%252BN-Arylamidines%26aulast%3DWang%26aufirst%3DYong%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D06072011%26date%3D05082011%26date%3D02092011%26volume%3D13%26issue%3D17%26spage%3D4604%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rupa S.  Shetty</span>, <span class="hlFld-ContribAuthor ">Younghee  Lee</span>, <span class="hlFld-ContribAuthor ">Bin  Liu</span>, <span class="hlFld-ContribAuthor ">Arifa  Husain</span>, <span class="hlFld-ContribAuthor ">Rhoda W.  Joseph</span>, <span class="hlFld-ContribAuthor ">Yixin  Lu</span>, <span class="hlFld-ContribAuthor ">David  Nelson</span>, <span class="hlFld-ContribAuthor ">John  Mihelcic</span>, <span class="hlFld-ContribAuthor ">Wenchun  Chao</span>, <span class="hlFld-ContribAuthor ">Kristofer K.  Moffett</span>, <span class="hlFld-ContribAuthor ">Andreas  Schumacher</span>, <span class="hlFld-ContribAuthor ">Dietmar  Flubacher</span>, <span class="hlFld-ContribAuthor ">Aleksandar  Stojanovic</span>, <span class="hlFld-ContribAuthor ">Marina  Bukhtiyarova</span>, <span class="hlFld-ContribAuthor ">Ken  Williams</span>, <span class="hlFld-ContribAuthor ">Kyoung-Jin  Lee</span>, <span class="hlFld-ContribAuthor ">Alexander R.  Ochman</span>, <span class="hlFld-ContribAuthor ">Michael S.  Saporito</span>, <span class="hlFld-ContribAuthor ">William R.  Moore</span>, <span class="hlFld-ContribAuthor ">Gary A.  Flynn</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>, <span class="hlFld-ContribAuthor ">Eric B.  Springman</span>, <span class="hlFld-ContribAuthor ">Ted  Fujimoto</span>, and <span class="hlFld-ContribAuthor ">Martha J.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of N-(3-(1H-Indol-4-yl)-5-(2-methoxyisonicotinoyl)phenyl)methanesulfonamide (LP-261), a Potent Antimitotic Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (1)
                                     , 179-200. <a href="https://doi.org/10.1021/jm100659v" title="DOI URL">https://doi.org/10.1021/jm100659v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100659v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100659v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BN-%2525283-%2525281H-Indol-4-yl%252529-5-%2525282-methoxyisonicotinoyl%252529phenyl%252529methanesulfonamide%252B%252528LP-261%252529%25252C%252Ba%252BPotent%252BAntimitotic%252BAgent%26aulast%3DShetty%26aufirst%3DRupa%2BS.%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D01062010%26date%3D02122010%26date%3D13012011%26volume%3D54%26issue%3D1%26spage%3D179%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>, <span class="hlFld-ContribAuthor ">Ying  Zhao</span>, <span class="hlFld-ContribAuthor ">Lu  Lin</span>, <span class="hlFld-ContribAuthor ">Sudhir  Raghavan</span>, <span class="hlFld-ContribAuthor ">Elizabeth G.  Roberts</span>, <span class="hlFld-ContribAuthor ">April L.  Risinger</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, and <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 8116-8128. <a href="https://doi.org/10.1021/jm101010n" title="DOI URL">https://doi.org/10.1021/jm101010n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101010n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101010n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BDiscovery%252Bof%252BWater-Soluble%252BMicrotubule%252BTargeting%252BAgents%252Bthat%252BBind%252Bto%252Bthe%252BColchicine%252BSite%252Bon%252BTubulin%252Band%252BCircumvent%252BPgp%252BMediated%252BResistance%26aulast%3DGangjee%26aufirst%3DAleem%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D04082010%26date%3D25102010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D8116%26epage%3D8128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Velma Ganga  Reddy</span>, <span class="hlFld-ContribAuthor ">T.  Srinivasa Reddy</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Rahul  Kumar</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bhargava</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104765. <a href="https://doi.org/10.1016/j.bioorg.2021.104765" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104765%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCinnamide%252Bderived%252Bpyrimidine-benzimidazole%252Bhybrids%252Bas%252Btubulin%252Binhibitors%25253A%252BSynthesis%25252C%252Bin%252Bsilico%252Band%252Bcell%252Bgrowth%252Binhibition%252Bstudies%26aulast%3DSana%26aufirst%3DSravani%26date%3D2021%26volume%3D110%26spage%3D104765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna V.  Evdokimova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Alexeev</span>, <span class="hlFld-ContribAuthor ">Evgeniya V.  Nurieva</span>, <span class="hlFld-ContribAuthor ">Elena R.  Milaeva</span>, <span class="hlFld-ContribAuthor ">Sergei A.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Olga N.  Zefirova</span>. </span><span class="cited-content_cbyCitation_article-title">N-(4-Methoxyphenyl)-substituted bicyclic isothioureas: effect on morphology of cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2021,</strong> <em>31 </em>
                                    (3)
                                     , 288-290. <a href="https://doi.org/10.1016/j.mencom.2021.04.003" title="DOI URL">https://doi.org/10.1016/j.mencom.2021.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2021.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2021.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DN-%2525284-Methoxyphenyl%252529-substituted%252Bbicyclic%252Bisothioureas%25253A%252Beffect%252Bon%252Bmorphology%252Bof%252Bcancer%252Bcells%26aulast%3DEvdokimova%26aufirst%3DAnna%2BV.%26date%3D2021%26volume%3D31%26issue%3D3%26spage%3D288%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna V.  Evdokimova</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Alexeev</span>, <span class="hlFld-ContribAuthor ">Evgeniya V.  Nurieva</span>, <span class="hlFld-ContribAuthor ">Elena R.  Milaeva</span>, <span class="hlFld-ContribAuthor ">Sergei A.  Kuznetsov</span>, <span class="hlFld-ContribAuthor ">Olga N.  Zefirova</span>. </span><span class="cited-content_cbyCitation_article-title">N-(4-Methoxyphenyl)-substituted bicyclic isothioureas: effect on morphology of cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2021,</strong> <em>31 </em>
                                    (3)
                                     , 288-290. <a href="https://doi.org/10.1016/j.mencom.2021.05.003" title="DOI URL">https://doi.org/10.1016/j.mencom.2021.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2021.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2021.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DN-%2525284-Methoxyphenyl%252529-substituted%252Bbicyclic%252Bisothioureas%25253A%252Beffect%252Bon%252Bmorphology%252Bof%252Bcancer%252Bcells%26aulast%3DEvdokimova%26aufirst%3DAnna%2BV.%26date%3D2021%26volume%3D31%26issue%3D3%26spage%3D288%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shruti  Choudhary</span>, <span class="hlFld-ContribAuthor ">Arpit  Doshi</span>, <span class="hlFld-ContribAuthor ">Lerin  Luckett-Chastain</span>, <span class="hlFld-ContribAuthor ">Michael  Ihnat</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Susan L.  Mooberry</span>, <span class="hlFld-ContribAuthor ">Aleem  Gangjee</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>35 </em>, 116061. <a href="https://doi.org/10.1016/j.bmc.2021.116061" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPotential%252Bof%252Bsubstituted%252Bquinazolines%252Bto%252Binteract%252Bwith%252Bmultiple%252Btargets%252Bin%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DChoudhary%26aufirst%3DShruti%26date%3D2021%26volume%3D35%26spage%3D116061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huajian  Zhu</span>, <span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Limei  Yang</span>, <span class="hlFld-ContribAuthor ">Yuchen  Tan</span>, <span class="hlFld-ContribAuthor ">Tiandong  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Dong-Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Zhe-Sheng  Chen</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113316. <a href="https://doi.org/10.1016/j.ejmech.2021.113316" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113316%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BN-benzylbenzamide%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Bpotent%252Bantitumor%252Bactivities%26aulast%3DZhu%26aufirst%3DHuajian%26date%3D2021%26volume%3D216%26spage%3D113316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vakhid А.  Mamedov</span>, <span class="hlFld-ContribAuthor ">Nataliya А.  Zhukova</span>, <span class="hlFld-ContribAuthor ">Milyausha S.  Kadyrova</span>. </span><span class="cited-content_cbyCitation_article-title">The Dimroth Rearrangement in the Synthesis of Condensed Pyrimidines – Structural Analogs of Antiviral Compounds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (4)
                                     , 342-368. <a href="https://doi.org/10.1007/s10593-021-02913-7" title="DOI URL">https://doi.org/10.1007/s10593-021-02913-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02913-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02913-7%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DThe%252BDimroth%252BRearrangement%252Bin%252Bthe%252BSynthesis%252Bof%252BCondensed%252BPyrimidines%252B%2525E2%252580%252593%252BStructural%252BAnalogs%252Bof%252BAntiviral%252BCompounds%26aulast%3DMamedov%26aufirst%3DVakhid%2B%25D0%2590.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D4%26spage%3D342%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Álvarez</span>, <span class="hlFld-ContribAuthor ">Laura  Aramburu</span>, <span class="hlFld-ContribAuthor ">Consuelo  Gajate</span>, <span class="hlFld-ContribAuthor ">Alba  Vicente-Blázquez</span>, <span class="hlFld-ContribAuthor ">Faustino  Mollinedo</span>, <span class="hlFld-ContribAuthor ">Manuel  Medarde</span>, <span class="hlFld-ContribAuthor ">Rafael  Peláez</span>. </span><span class="cited-content_cbyCitation_article-title">Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112933. <a href="https://doi.org/10.1016/j.ejmech.2020.112933" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112933%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMethylsulfanylpyridine%252Bbased%252Bdiheteroaryl%252Bisocombretastatin%252Banalogs%252Bas%252Bpotent%252Banti-proliferative%252Bagents%26aulast%3D%25C3%2581lvarez%26aufirst%3DRaquel%26date%3D2021%26volume%3D209%26spage%3D112933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.K.  Vyas</span>, <span class="hlFld-ContribAuthor ">G.  Qureshi</span>, <span class="hlFld-ContribAuthor ">H.  Dayani</span>, <span class="hlFld-ContribAuthor ">A.  Jha</span>, <span class="hlFld-ContribAuthor ">M.  Ghate</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore-based identification and in vitro validation of apoptosis inducers as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2020,</strong> <em>31 </em>
                                    (11)
                                     , 869-881. <a href="https://doi.org/10.1080/1062936X.2020.1827030" title="DOI URL">https://doi.org/10.1080/1062936X.2020.1827030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2020.1827030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2020.1827030%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DPharmacophore-based%252Bidentification%252Band%252Bin%252Bvitro%252Bvalidation%252Bof%252Bapoptosis%252Binducers%252Bas%252Banticancer%252Bagents%26aulast%3DVyas%26aufirst%3DV.K.%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D11%26spage%3D869%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Lei</span>, <span class="hlFld-ContribAuthor ">Liang  Ma</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel Substituted 4‐Anilinoquinazolines as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>96 </em>
                                    (4)
                                     , 1084-1094. <a href="https://doi.org/10.1111/cbdd.12706" title="DOI URL">https://doi.org/10.1111/cbdd.12706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BSubstituted%252B4%2525E2%252580%252590Anilinoquinazolines%252Bas%252BAntitumor%252BAgents%26aulast%3DCao%26aufirst%3DDong%26date%3D2020%26date%3D2020%26volume%3D96%26issue%3D4%26spage%3D1084%26epage%3D1094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yvonnick  Loidreau</span>, <span class="hlFld-ContribAuthor ">Marie-Renée  Nourrisson</span>, <span class="hlFld-ContribAuthor ">Corinne  Fruit</span>, <span class="hlFld-ContribAuthor ">Cécile  Corbière</span>, <span class="hlFld-ContribAuthor ">Pascal  Marchand</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-Assisted Synthesis of Potential Bioactive Benzo-, Pyrido- or Pyrazino-thieno[3,2-d]pyrimidin-4-amine Analogs of MPC-6827. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (9)
                                     , 202. <a href="https://doi.org/10.3390/ph13090202" title="DOI URL">https://doi.org/10.3390/ph13090202</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13090202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13090202%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DMicrowave-Assisted%252BSynthesis%252Bof%252BPotential%252BBioactive%252BBenzo-%25252C%252BPyrido-%252Bor%252BPyrazino-thieno%25255B3%25252C2-d%25255Dpyrimidin-4-amine%252BAnalogs%252Bof%252BMPC-6827%26aulast%3DLoidreau%26aufirst%3DYvonnick%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D9%26spage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satyendra  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazolinone and Quinazoline Derivatives: Synthesis and Biological Application. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.5772/intechopen.89203" title="DOI URL">https://doi.org/10.5772/intechopen.89203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.89203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.89203%26sid%3Dliteratum%253Aachs%26atitle%3DQuinazolinone%252Band%252BQuinazoline%252BDerivatives%25253A%252BSynthesis%252Band%252BBiological%252BApplication%26aulast%3DMishra%26aufirst%3DSatyendra%26date%3D2020%26date%3D2020%26pub%3DIntechOpen%26atitle%3DQuinazolinone%252Band%252BQuinazoline%252BDerivatives%26aulast%3DGamal%2BAl-kaf%26aufirst%3DAli%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Álvarez</span>, <span class="hlFld-ContribAuthor ">Laura  Aramburu</span>, <span class="hlFld-ContribAuthor ">Consuelo  Gajate</span>, <span class="hlFld-ContribAuthor ">Alba  Vicente-Blázquez</span>, <span class="hlFld-ContribAuthor ">Faustino  Mollinedo</span>, <span class="hlFld-ContribAuthor ">Manuel  Medarde</span>, <span class="hlFld-ContribAuthor ">Rafael  Peláez</span>. </span><span class="cited-content_cbyCitation_article-title">Potent colchicine-site ligands with improved intrinsic solubility by replacement of the 3,4,5-trimethoxyphenyl ring with a 2-methylsulfanyl-6-methoxypyridine ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>98 </em>, 103755. <a href="https://doi.org/10.1016/j.bioorg.2020.103755" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103755%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPotent%252Bcolchicine-site%252Bligands%252Bwith%252Bimproved%252Bintrinsic%252Bsolubility%252Bby%252Breplacement%252Bof%252Bthe%252B3%25252C4%25252C5-trimethoxyphenyl%252Bring%252Bwith%252Ba%252B2-methylsulfanyl-6-methoxypyridine%252Bring%26aulast%3D%25C3%2581lvarez%26aufirst%3DRaquel%26date%3D2020%26volume%3D98%26spage%3D103755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdallah  Hamze</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>, <span class="hlFld-ContribAuthor ">Olivier  Provot</span>. </span><span class="cited-content_cbyCitation_article-title">Developments of isoCombretastatin A-4 derivatives as highly cytotoxic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112110. <a href="https://doi.org/10.1016/j.ejmech.2020.112110" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112110%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopments%252Bof%252BisoCombretastatin%252BA-4%252Bderivatives%252Bas%252Bhighly%252Bcytotoxic%252Bagents%26aulast%3DHamze%26aufirst%3DAbdallah%26date%3D2020%26volume%3D190%26spage%3D112110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.S.  Dileep Kumar</span>, <span class="hlFld-ContribAuthor ">Jaya  Prabhakaran</span>, <span class="hlFld-ContribAuthor ">Naresh  Damuka</span>, <span class="hlFld-ContribAuthor ">Justin Wayne  Hines</span>, <span class="hlFld-ContribAuthor ">Skylar  Norman</span>, <span class="hlFld-ContribAuthor ">Meghana  Dodda</span>, <span class="hlFld-ContribAuthor ">J.  John Mann</span>, <span class="hlFld-ContribAuthor ">Akiva  Mintz</span>, <span class="hlFld-ContribAuthor ">Kiran Kumar Solingapuram  Sai</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo comparison of N-11CH3 vs O-11CH3 radiolabeled microtubule targeted PET ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126785. <a href="https://doi.org/10.1016/j.bmcl.2019.126785" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126785%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIn%252Bvivo%252Bcomparison%252Bof%252BN-11CH3%252Bvs%252BO-11CH3%252Bradiolabeled%252Bmicrotubule%252Btargeted%252BPET%252Bligands%26aulast%3DDileep%2BKumar%26aufirst%3DJ.S.%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chengkun  Ye</span>, <span class="hlFld-ContribAuthor ">Bomin  Pan</span>, <span class="hlFld-ContribAuthor ">Haoyue  Xu</span>, <span class="hlFld-ContribAuthor ">Zongren  Zhao</span>, <span class="hlFld-ContribAuthor ">Jiawei  Shen</span>, <span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Rutong  Yu</span>, <span class="hlFld-ContribAuthor ">Hongmei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Medicine</span><span> <strong>2019,</strong> <em>97 </em>
                                    (11)
                                     , 1575-1588. <a href="https://doi.org/10.1007/s00109-019-01843-4" title="DOI URL">https://doi.org/10.1007/s00109-019-01843-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00109-019-01843-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00109-019-01843-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Medicine%26atitle%3DCo-delivery%252Bof%252BGOLPH3%252BsiRNA%252Band%252Bgefitinib%252Bby%252Bcationic%252Blipid-PLGA%252Bnanoparticles%252Bimproves%252BEGFR-targeted%252Btherapy%252Bfor%252Bglioma%26aulast%3DYe%26aufirst%3DChengkun%26date%3D2019%26date%3D2019%26volume%3D97%26issue%3D11%26spage%3D1575%26epage%3D1588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Yin</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Feijie  Xu</span>, <span class="hlFld-ContribAuthor ">Hong  Yao</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Keguang  Cheng</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 380-390. <a href="https://doi.org/10.1016/j.bioorg.2018.10.027" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.10.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.10.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.10.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bquinazolines%252Bas%252Bpotential%252Banti-tubulin%252Bagents%252Boccupying%252Bthree%252Bzones%252Bof%252Bcolchicine%252Bdomain%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2019%26volume%3D83%26spage%3D380%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Wen  Shuai</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Feijie  Xu</span>, <span class="hlFld-ContribAuthor ">Yi  Bi</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>, <span class="hlFld-ContribAuthor ">Cong  Ma</span>, <span class="hlFld-ContribAuthor ">Hequan  Yao</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of quinoline-indole derivatives as anti-tubulin agents targeting the colchicine binding site. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 428-442. <a href="https://doi.org/10.1016/j.ejmech.2018.11.070" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.070%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bquinoline-indole%252Bderivatives%252Bas%252Banti-tubulin%252Bagents%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2019%26volume%3D163%26spage%3D428%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacek  Mularski</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Malarz</span>, <span class="hlFld-ContribAuthor ">Marcin  Pacholczyk</span>, <span class="hlFld-ContribAuthor ">Robert  Musiol</span>. </span><span class="cited-content_cbyCitation_article-title">The p53 stabilizing agent CP-31398 and multi-kinase inhibitors. Designing, synthesizing and screening of styrylquinazoline series. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 610-625. <a href="https://doi.org/10.1016/j.ejmech.2018.12.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bp53%252Bstabilizing%252Bagent%252BCP-31398%252Band%252Bmulti-kinase%252Binhibitors.%252BDesigning%25252C%252Bsynthesizing%252Band%252Bscreening%252Bof%252Bstyrylquinazoline%252Bseries%26aulast%3DMularski%26aufirst%3DJacek%26date%3D2019%26volume%3D163%26spage%3D610%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malose  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Mmakwena  Mmonwa</span>, <span class="hlFld-ContribAuthor ">Abimbola  Aro</span>, <span class="hlFld-ContribAuthor ">Lyndy  McGaw</span>, <span class="hlFld-ContribAuthor ">Yee  Choong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Biological Evaluation and Molecular Docking of Novel Indole-Aminoquinazoline Hybrids for Anticancer Properties. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2018,</strong> <em>19 </em>
                                    (8)
                                     , 2232. <a href="https://doi.org/10.3390/ijms19082232" title="DOI URL">https://doi.org/10.3390/ijms19082232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms19082232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms19082232%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSynthesis%25252C%252BBiological%252BEvaluation%252Band%252BMolecular%252BDocking%252Bof%252BNovel%252BIndole-Aminoquinazoline%252BHybrids%252Bfor%252BAnticancer%252BProperties%26aulast%3DMphahlele%26aufirst%3DMalose%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D8%26spage%3D2232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chandan  Bodhak</span>, <span class="hlFld-ContribAuthor ">Subhenjit  Hazra</span>, <span class="hlFld-ContribAuthor ">Animesh  Pramanik</span>. </span><span class="cited-content_cbyCitation_article-title">Graphene Oxide: An Efficient Carbocatalyst for the Facile Synthesis of Isoindolo[2, 1‐
              a
              ]quinazoline‐5,11‐diones via Domino Condensation under Solvent‐Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (27)
                                     , 7707-7712. <a href="https://doi.org/10.1002/slct.201801322" title="DOI URL">https://doi.org/10.1002/slct.201801322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201801322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201801322%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DGraphene%252BOxide%25253A%252BAn%252BEfficient%252BCarbocatalyst%252Bfor%252Bthe%252BFacile%252BSynthesis%252Bof%252BIsoindolo%25255B2%25252C%2525E2%252580%2525891%2525E2%252580%252590%252Ba%252B%25255Dquinazoline%2525E2%252580%2525905%25252C11%2525E2%252580%252590diones%252Bvia%252BDomino%252BCondensation%252Bunder%252BSolvent%2525E2%252580%252590Free%252BConditions%26aulast%3DBodhak%26aufirst%3DChandan%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D27%26spage%3D7707%26epage%3D7712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malose J.  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Marole M.  Maluleka</span>, <span class="hlFld-ContribAuthor ">Abimbola  Aro</span>, <span class="hlFld-ContribAuthor ">Lyndy J.  McGaw</span>, <span class="hlFld-ContribAuthor ">Yee Siew  Choong</span>. </span><span class="cited-content_cbyCitation_article-title">Benzofuran–appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1516-1528. <a href="https://doi.org/10.1080/14756366.2018.1510919" title="DOI URL">https://doi.org/10.1080/14756366.2018.1510919</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1510919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1510919%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DBenzofuran%2525E2%252580%252593appended%252B4-aminoquinazoline%252Bhybrids%252Bas%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%252Btyrosine%252Bkinase%252Binhibitors%25253A%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DMphahlele%26aufirst%3DMalose%2BJ.%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1516%26epage%3D1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Honghao  Sun</span>, <span class="hlFld-ContribAuthor ">Shengtao  Xu</span>, <span class="hlFld-ContribAuthor ">Zheying  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinyi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (15)
                                     , 1765-1794. <a href="https://doi.org/10.4155/fmc-2017-0100" title="DOI URL">https://doi.org/10.4155/fmc-2017-0100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0100%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTubulin%252Binhibitors%252Btargeting%252Bthe%252Bcolchicine%252Bbinding%252Bsite%25253A%252Ba%252Bperspective%252Bof%252Bprivileged%252Bstructures%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2017%26volume%3D9%26issue%3D15%26spage%3D1765%26epage%3D1794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bo  Chao</span>, <span class="hlFld-ContribAuthor ">Bingbing X.  Li</span>, <span class="hlFld-ContribAuthor ">Xiangshu  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of antitumor acylated monoaminopyrroloquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (14)
                                     , 3107-3110. <a href="https://doi.org/10.1016/j.bmcl.2017.05.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bantitumor%252Bacylated%252Bmonoaminopyrroloquinazolines%26aulast%3DChao%26aufirst%3DBo%26date%3D2017%26volume%3D27%26issue%3D14%26spage%3D3107%26epage%3D3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paola  Acosta</span>, <span class="hlFld-ContribAuthor ">Alejandro  Ortiz</span>, <span class="hlFld-ContribAuthor ">Braulio  Insuasty</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Abonia</span>, <span class="hlFld-ContribAuthor ">Jairo  Quiroga</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and study of the electronic properties of pyrazolo[1,5-c]pyrrolo[1,2-a]quinazoline and pyrazolo[1,5-c]pyrido[1,2-a]quinazoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2017,</strong> <em>148 </em>
                                    (2)
                                     , 237-244. <a href="https://doi.org/10.1007/s00706-016-1783-x" title="DOI URL">https://doi.org/10.1007/s00706-016-1783-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-016-1783-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-016-1783-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DSynthesis%252Band%252Bstudy%252Bof%252Bthe%252Belectronic%252Bproperties%252Bof%252Bpyrazolo%25255B1%25252C5-c%25255Dpyrrolo%25255B1%25252C2-a%25255Dquinazoline%252Band%252Bpyrazolo%25255B1%25252C5-c%25255Dpyrido%25255B1%25252C2-a%25255Dquinazoline%252Bderivatives%26aulast%3DAcosta%26aufirst%3DPaola%26date%3D2017%26date%3D2016%26volume%3D148%26issue%3D2%26spage%3D237%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilhem  Khelifi</span>, <span class="hlFld-ContribAuthor ">Timothée  Naret</span>, <span class="hlFld-ContribAuthor ">Dolor  Renko</span>, <span class="hlFld-ContribAuthor ">Abdallah  Hamze</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bernadat</span>, <span class="hlFld-ContribAuthor ">Jérome  Bignon</span>, <span class="hlFld-ContribAuthor ">Christine  Lenoir</span>, <span class="hlFld-ContribAuthor ">Joëlle  Dubois</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Olivier  Provot</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and anticancer properties of Iso CombretaQuinolines as potent tubulin assembly inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 1025-1034. <a href="https://doi.org/10.1016/j.ejmech.2016.11.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Banticancer%252Bproperties%252Bof%252BIso%252BCombretaQuinolines%252Bas%252Bpotent%252Btubulin%252Bassembly%252Binhibitors%26aulast%3DKhelifi%26aufirst%3DIlhem%26date%3D2017%26volume%3D127%26spage%3D1025%26epage%3D1034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamidreza  Akrami</span>, <span class="hlFld-ContribAuthor ">Maliheh  Safavi</span>, <span class="hlFld-ContribAuthor ">Bibi Fatemeh  Mirjalili</span>, <span class="hlFld-ContribAuthor ">Mahmood  Dehghani Ashkezari</span>, <span class="hlFld-ContribAuthor ">Farhang  Dadfar</span>, <span class="hlFld-ContribAuthor ">Najme  Mohaghegh</span>, <span class="hlFld-ContribAuthor ">Saeed  Emami</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Salehi</span>, <span class="hlFld-ContribAuthor ">Hamid  Nadri</span>, <span class="hlFld-ContribAuthor ">Sussan K.  Ardestani</span>, <span class="hlFld-ContribAuthor ">Loghman  Firoozpour</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoobi</span>, <span class="hlFld-ContribAuthor ">Alireza  Foroumadi</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis and antiproliferative activity of 7H-benzo[7,8]chromeno[2,3-d]pyrimidin-8-amines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>127 </em>, 128-136. <a href="https://doi.org/10.1016/j.ejmech.2016.12.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.12.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.12.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.12.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFacile%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252B7H-benzo%25255B7%25252C8%25255Dchromeno%25255B2%25252C3-d%25255Dpyrimidin-8-amines%26aulast%3DAkrami%26aufirst%3DHamidreza%26date%3D2017%26volume%3D127%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malose J.  Mphahlele</span>, <span class="hlFld-ContribAuthor ">Tshepiso J.  Makhafola</span>, <span class="hlFld-ContribAuthor ">Mmakwena M.  Mmonwa</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro cytotoxicity of novel 2,5,7-tricarbo-substituted indoles derived from 2-amino-5-bromo-3-iodoacetophenone. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (19)
                                     , 4576-4586. <a href="https://doi.org/10.1016/j.bmc.2016.07.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.07.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.07.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.07.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DIn%252Bvitro%252Bcytotoxicity%252Bof%252Bnovel%252B2%25252C5%25252C7-tricarbo-substituted%252Bindoles%252Bderived%252Bfrom%252B2-amino-5-bromo-3-iodoacetophenone%26aulast%3DMphahlele%26aufirst%3DMalose%2BJ.%26date%3D2016%26volume%3D24%26issue%3D19%26spage%3D4576%26epage%3D4586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hugues  Paumo</span>, <span class="hlFld-ContribAuthor ">Tshepiso  Makhafola</span>, <span class="hlFld-ContribAuthor ">Malose  Mphahlele</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vitro Cytotoxic Properties of Polycarbo-Substituted 4-(Arylamino)quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (10)
                                     , 1366. <a href="https://doi.org/10.3390/molecules21101366" title="DOI URL">https://doi.org/10.3390/molecules21101366</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21101366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21101366%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BCytotoxic%252BProperties%252Bof%252BPolycarbo-Substituted%252B4-%252528Arylamino%252529quinazolines%26aulast%3DPaumo%26aufirst%3DHugues%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D10%26spage%3D1366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumathi  Vodnala</span>, <span class="hlFld-ContribAuthor ">A.K.D.  Bhavani</span>, <span class="hlFld-ContribAuthor ">Ramakrishna  Kamutam</span>, <span class="hlFld-ContribAuthor ">V.G.M.  Naidu</span>, <span class="hlFld-ContribAuthor ">Promila</span>, <span class="hlFld-ContribAuthor ">Ch.  Prabhakar</span>. </span><span class="cited-content_cbyCitation_article-title">DABCO-catalyzed one-pot three component synthesis of dihydropyrano[3,2-c]chromene substituted quinazolines and their evaluation towards anticancer activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (16)
                                     , 3973-3977. <a href="https://doi.org/10.1016/j.bmcl.2016.07.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.07.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.07.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDABCO-catalyzed%252Bone-pot%252Bthree%252Bcomponent%252Bsynthesis%252Bof%252Bdihydropyrano%25255B3%25252C2-c%25255Dchromene%252Bsubstituted%252Bquinazolines%252Band%252Btheir%252Bevaluation%252Btowards%252Banticancer%252Bactivity%26aulast%3DVodnala%26aufirst%3DSumathi%26date%3D2016%26volume%3D26%26issue%3D16%26spage%3D3973%26epage%3D3977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rong-Zhang  Jin</span>, <span class="hlFld-ContribAuthor ">Wen-Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu-Jing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiang-Shan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-catalyzed synthesis of 5H-phthalazino[1,2-b]quinazoline and isoindolo[2,1-a]quinazoline derivatives via a chemoselective reaction of 2-aminobenzohydrazide and 2-formylbenzoic acid in ionic liquids. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2016,</strong> <em>57 </em>
                                    (23)
                                     , 2515-2519. <a href="https://doi.org/10.1016/j.tetlet.2016.04.101" title="DOI URL">https://doi.org/10.1016/j.tetlet.2016.04.101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2016.04.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2016.04.101%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DIodine-catalyzed%252Bsynthesis%252Bof%252B5H-phthalazino%25255B1%25252C2-b%25255Dquinazoline%252Band%252Bisoindolo%25255B2%25252C1-a%25255Dquinazoline%252Bderivatives%252Bvia%252Ba%252Bchemoselective%252Breaction%252Bof%252B2-aminobenzohydrazide%252Band%252B2-formylbenzoic%252Bacid%252Bin%252Bionic%252Bliquids%26aulast%3DJin%26aufirst%3DRong-Zhang%26date%3D2016%26volume%3D57%26issue%3D23%26spage%3D2515%26epage%3D2519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Lei</span>, <span class="hlFld-ContribAuthor ">Liang  Ma</span>, <span class="hlFld-ContribAuthor ">Fang  Wang</span>, <span class="hlFld-ContribAuthor ">Chunyu  Wang</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Wei  Xiang</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Hongyang  Li</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, in vitro and in vivo evaluation of novel substituted N-(4-(2-(4-benzylpiperazin-1-yl)ethoxy)phenyl)-N-methyl-quinazolin-4-amines as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (8)
                                     , 1931-1935. <a href="https://doi.org/10.1016/j.bmcl.2016.03.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252Bnovel%252Bsubstituted%252BN-%2525284-%2525282-%2525284-benzylpiperazin-1-yl%252529ethoxy%252529phenyl%252529-N-methyl-quinazolin-4-amines%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DCao%26aufirst%3DDong%26date%3D2016%26volume%3D26%26issue%3D8%26spage%3D1931%26epage%3D1935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soňa  Jantová</span>, <span class="hlFld-ContribAuthor ">Martina  Melušová</span>, <span class="hlFld-ContribAuthor ">Miroslav  Pánik</span>, <span class="hlFld-ContribAuthor ">Vlasta  Brezová</span>, <span class="hlFld-ContribAuthor ">Zuzana  Barbieriková</span>. </span><span class="cited-content_cbyCitation_article-title">UVA-induced effects of 2,6-disubstituted 4-anilinoquinazolines on cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Photochemistry and Photobiology B: Biology</span><span> <strong>2016,</strong> <em>154 </em>, 77-88. <a href="https://doi.org/10.1016/j.jphotobiol.2015.11.014" title="DOI URL">https://doi.org/10.1016/j.jphotobiol.2015.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphotobiol.2015.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphotobiol.2015.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Photochemistry%2520and%2520Photobiology%2520B%253A%2520Biology%26atitle%3DUVA-induced%252Beffects%252Bof%252B2%25252C6-disubstituted%252B4-anilinoquinazolines%252Bon%252Bcancer%252Bcell%252Blines%26aulast%3DJantov%25C3%25A1%26aufirst%3DSo%25C5%2588a%26date%3D2016%26volume%3D154%26spage%3D77%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Biao  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Bingjie  Qin</span>, <span class="hlFld-ContribAuthor ">Emika  Ohkoshi</span>, <span class="hlFld-ContribAuthor ">Kan-Yen  Hsieh</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Mu-Tian  Cui</span>, <span class="hlFld-ContribAuthor ">Dong-Qing  Zhu</span>, <span class="hlFld-ContribAuthor ">Masuo  Goto</span>, <span class="hlFld-ContribAuthor ">Susan L.  Morris-Natschke</span>, <span class="hlFld-ContribAuthor ">Kuo-Hsiung  Lee</span>, <span class="hlFld-ContribAuthor ">Lan  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of N -aryl-6-methoxy-1,2,3,4-tetrahydroquinolines as tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5740-5747. <a href="https://doi.org/10.1016/j.bmc.2015.07.016" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BN%252B-aryl-6-methoxy-1%25252C2%25252C3%25252C4-tetrahydroquinolines%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DWang%26aufirst%3DSheng-Biao%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5740%26epage%3D5747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed Ali  Soussi</span>, <span class="hlFld-ContribAuthor ">Olivier  Provot</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bernadat</span>, <span class="hlFld-ContribAuthor ">Jérome  Bignon</span>, <span class="hlFld-ContribAuthor ">Déborah  Desravines</span>, <span class="hlFld-ContribAuthor ">Joëlle  Dubois</span>, <span class="hlFld-ContribAuthor ">Jean-Daniel  Brion</span>, <span class="hlFld-ContribAuthor ">Samir  Messaoudi</span>, <span class="hlFld-ContribAuthor ">Mouad  Alami</span>. </span><span class="cited-content_cbyCitation_article-title">Iso
              CombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (8)
                                     , 1392-1402. <a href="https://doi.org/10.1002/cmdc.201500069" title="DOI URL">https://doi.org/10.1002/cmdc.201500069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500069%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DIso%252BCombretaQuinazolines%25253A%252BPotent%252BCytotoxic%252BAgents%252Bwith%252BAntitubulin%252BActivity%26aulast%3DSoussi%26aufirst%3DMohamed%2BAli%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D8%26spage%3D1392%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V.  Kannappan</span>, <span class="hlFld-ContribAuthor ">P.  Vidhya</span>, <span class="hlFld-ContribAuthor ">V.  Sathyanarayanamoorthi</span>. </span><span class="cited-content_cbyCitation_article-title">Quantum mechanical study of solvation analysis on some nitrogen containing heterocyclic compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Liquids</span><span> <strong>2015,</strong> <em>207 </em>, 7-13. <a href="https://doi.org/10.1016/j.molliq.2015.03.012" title="DOI URL">https://doi.org/10.1016/j.molliq.2015.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molliq.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molliq.2015.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Liquids%26atitle%3DQuantum%252Bmechanical%252Bstudy%252Bof%252Bsolvation%252Banalysis%252Bon%252Bsome%252Bnitrogen%252Bcontaining%252Bheterocyclic%252Bcompounds%26aulast%3DKannappan%26aufirst%3DV.%26date%3D2015%26volume%3D207%26spage%3D7%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ibrahim M.  Abdou</span>, <span class="hlFld-ContribAuthor ">Shaikha S.  Al-Neyadi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of quinazolines and quinazolinones via palladium-mediated approach. </span><span class="cited-content_cbyCitation_journal-name">Heterocyclic Communications</span><span> <strong>2015,</strong> <em>21 </em>
                                    (3)
                                     , 115-132. <a href="https://doi.org/10.1515/hc-2014-0181" title="DOI URL">https://doi.org/10.1515/hc-2014-0181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/hc-2014-0181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fhc-2014-0181%26sid%3Dliteratum%253Aachs%26jtitle%3DHeterocyclic%2520Communications%26atitle%3DSynthesis%252Bof%252Bquinazolines%252Band%252Bquinazolinones%252Bvia%252Bpalladium-mediated%252Bapproach%26aulast%3DAbdou%26aufirst%3DIbrahim%2BM.%26date%3D2015%26volume%3D21%26issue%3D3%26spage%3D115%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María-Dolores  Canela</span>, <span class="hlFld-ContribAuthor ">Sandra  Liekens</span>, <span class="hlFld-ContribAuthor ">María-José  Camarasa</span>, <span class="hlFld-ContribAuthor ">Eva María  Priego</span>, <span class="hlFld-ContribAuthor ">María-Jesús  Pérez-Pérez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiproliferative activity of 6-phenylaminopurines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>87 </em>, 421-428. <a href="https://doi.org/10.1016/j.ejmech.2014.09.093" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252B6-phenylaminopurines%26aulast%3DCanela%26aufirst%3DMar%25C3%25ADa-Dolores%26date%3D2014%26volume%3D87%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saurabh  Prabhu</span>, <span class="hlFld-ContribAuthor ">Frederick  Harris</span>, <span class="hlFld-ContribAuthor ">Robert  Lea</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Snape</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule clinical trial candidates for the treatment of glioma. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2014,</strong> <em>19 </em>
                                    (9)
                                     , 1298-1308. <a href="https://doi.org/10.1016/j.drudis.2014.02.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2014.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2014.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2014.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DSmall-molecule%252Bclinical%252Btrial%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252Bglioma%26aulast%3DPrabhu%26aufirst%3DSaurabh%26date%3D2014%26volume%3D19%26issue%3D9%26spage%3D1298%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Omar</span>, <span class="hlFld-ContribAuthor ">Jürgen  Conrad</span>, <span class="hlFld-ContribAuthor ">Uwe  Beifuss</span>. </span><span class="cited-content_cbyCitation_article-title">Assembly of 4H-chromenes, imidazobenzothiazines and quinazolines via copper-catalyzed domino reactions using 2-halobenzyl tosylates as substrates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (35)
                                     , 5682-5695. <a href="https://doi.org/10.1016/j.tet.2014.06.071" title="DOI URL">https://doi.org/10.1016/j.tet.2014.06.071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.06.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.06.071%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAssembly%252Bof%252B4H-chromenes%25252C%252Bimidazobenzothiazines%252Band%252Bquinazolines%252Bvia%252Bcopper-catalyzed%252Bdomino%252Breactions%252Busing%252B2-halobenzyl%252Btosylates%252Bas%252Bsubstrates%26aulast%3DOmar%26aufirst%3DMohamed%2BA.%26date%3D2014%26volume%3D70%26issue%3D35%26spage%3D5682%26epage%3D5695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavin  Marvania</span>, <span class="hlFld-ContribAuthor ">Rajesh  Kakadiya</span>, <span class="hlFld-ContribAuthor ">Wilson  Christian</span>, <span class="hlFld-ContribAuthor ">Tai-Lin  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-Hsi  Wu</span>, <span class="hlFld-ContribAuthor ">Sharda  Suman</span>, <span class="hlFld-ContribAuthor ">Kiran  Tala</span>, <span class="hlFld-ContribAuthor ">Te-Chang  Lee</span>, <span class="hlFld-ContribAuthor ">Anamik  Shah</span>, <span class="hlFld-ContribAuthor ">Tsann-Long  Su</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis and biological evaluation of new DNA-directed alkylating agents, phenyl N-mustard-4-anilinoquinoline conjugates containing a urea linker. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>83 </em>, 695-708. <a href="https://doi.org/10.1016/j.ejmech.2014.06.066" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.06.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.06.066%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252BDNA-directed%252Balkylating%252Bagents%25252C%252Bphenyl%252BN-mustard-4-anilinoquinoline%252Bconjugates%252Bcontaining%252Ba%252Burea%252Blinker%26aulast%3DMarvania%26aufirst%3DBhavin%26date%3D2014%26volume%3D83%26spage%3D695%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, <span class="hlFld-ContribAuthor ">Marc C.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Sean  Grimm</span>, <span class="hlFld-ContribAuthor ">Surasak  Phuphanich</span>, <span class="hlFld-ContribAuthor ">Larry  Recht</span>, <span class="hlFld-ContribAuthor ">Jay Z.  Zhu</span>, <span class="hlFld-ContribAuthor ">Lyndon  Kim</span>, <span class="hlFld-ContribAuthor ">Steve  Rosenfeld</span>, <span class="hlFld-ContribAuthor ">Camilo E.  Fadul</span>. </span><span class="cited-content_cbyCitation_article-title">A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC). </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuro-Oncology</span><span> <strong>2014,</strong> <em>118 </em>
                                    (2)
                                     , 335-343. <a href="https://doi.org/10.1007/s11060-014-1437-y" title="DOI URL">https://doi.org/10.1007/s11060-014-1437-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11060-014-1437-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11060-014-1437-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuro-Oncology%26atitle%3DA%252Bphase%252B2%252Btrial%252Bof%252Bverubulin%252Bfor%252Brecurrent%252Bglioblastoma%25253A%252Ba%252Bprospective%252Bstudy%252Bby%252Bthe%252Bbrain%252Btumor%252Binvestigational%252Bconsortium%252B%252528BTIC%252529%26aulast%3DChamberlain%26aufirst%3DMarc%2BC.%26date%3D2014%26date%3D2014%26volume%3D118%26issue%3D2%26spage%3D335%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Omar</span>, <span class="hlFld-ContribAuthor ">Jürgen  Conrad</span>, <span class="hlFld-ContribAuthor ">Uwe  Beifuss</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed domino reaction between 1-(2-halophenyl)methanamines and amidines or imidates for the synthesis of 2-substituted quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2014,</strong> <em>70 </em>
                                    (18)
                                     , 3061-3072. <a href="https://doi.org/10.1016/j.tet.2014.02.066" title="DOI URL">https://doi.org/10.1016/j.tet.2014.02.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2014.02.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2014.02.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCopper-catalyzed%252Bdomino%252Breaction%252Bbetween%252B1-%2525282-halophenyl%252529methanamines%252Band%252Bamidines%252Bor%252Bimidates%252Bfor%252Bthe%252Bsynthesis%252Bof%2525C2%2525A02-substituted%252Bquinazolines%26aulast%3DOmar%26aufirst%3DMohamed%2BA.%26date%3D2014%26volume%3D70%26issue%3D18%26spage%3D3061%26epage%3D3072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katharina  Mahal</span>, <span class="hlFld-ContribAuthor ">Marcus  Resch</span>, <span class="hlFld-ContribAuthor ">Ralf  Ficner</span>, <span class="hlFld-ContribAuthor ">Rainer  Schobert</span>, <span class="hlFld-ContribAuthor ">Bernhard  Biersack</span>, <span class="hlFld-ContribAuthor ">Thomas  Mueller</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of the Tumor-Vasculature-Disrupting Agent Verubulin and Two Heteroaryl Analogues on Cancer Cells, Endothelial Cells, and Blood Vessels. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (4)
                                     , 847-854. <a href="https://doi.org/10.1002/cmdc.201300531" title="DOI URL">https://doi.org/10.1002/cmdc.201300531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300531%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DEffects%252Bof%252Bthe%252BTumor-Vasculature-Disrupting%252BAgent%252BVerubulin%252Band%252BTwo%252BHeteroaryl%252BAnalogues%252Bon%252BCancer%252BCells%25252C%252BEndothelial%252BCells%25252C%252Band%252BBlood%252BVessels%26aulast%3DMahal%26aufirst%3DKatharina%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D4%26spage%3D847%26epage%3D854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiyuan  Peng</span>, <span class="hlFld-ContribAuthor ">Ping  Huang</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Yirong  Zhou</span>, <span class="hlFld-ContribAuthor ">Jianjun  Yuan</span>, <span class="hlFld-ContribAuthor ">Qin  Yang</span>, <span class="hlFld-ContribAuthor ">Xin  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhihong  Deng</span>, <span class="hlFld-ContribAuthor ">Jingshi  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-alkynylquinazolines: Pd–Cu-cocatalyzed coupling of quinazoline-4-tosylates with terminal alkynes using N-heterocyclic carbenes as ligands. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2014,</strong> <em>12 </em>
                                    (31)
                                     , 5922. <a href="https://doi.org/10.1039/C4OB00700J" title="DOI URL">https://doi.org/10.1039/C4OB00700J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB00700J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB00700J%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252B4-alkynylquinazolines%25253A%252BPd%2525E2%252580%252593Cu-cocatalyzed%252Bcoupling%252Bof%252Bquinazoline-4-tosylates%252Bwith%252Bterminal%252Balkynes%252Busing%252BN-heterocyclic%252Bcarbenes%252Bas%252Bligands%26aulast%3DPeng%26aufirst%3DYiyuan%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D31%26spage%3D5922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">B.  Srinivasa Reddy</span>, <span class="hlFld-ContribAuthor ">A.  Naidu</span>, <span class="hlFld-ContribAuthor ">P. K.  Dubey</span>. </span><span class="cited-content_cbyCitation_article-title">PEG-600-mediated, green and efficient, tandem syntheses of N-subtituted-2-styrylquinazolin-4- ones. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry Letters and Reviews</span><span> <strong>2013,</strong> <em>6 </em>
                                    (3)
                                     , 254-261. <a href="https://doi.org/10.1080/17518253.2012.742142" title="DOI URL">https://doi.org/10.1080/17518253.2012.742142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17518253.2012.742142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17518253.2012.742142%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%2520Letters%2520and%2520Reviews%26atitle%3DPEG-600-mediated%25252C%252Bgreen%252Band%252Befficient%25252C%252Btandem%252Bsyntheses%252Bof%252BN-subtituted-2-styrylquinazolin-4-%252Bones%26aulast%3DSrinivasa%2BReddy%26aufirst%3DB.%26date%3D2013%26volume%3D6%26issue%3D3%26spage%3D254%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bini  Mathew</span>, <span class="hlFld-ContribAuthor ">Larry  Ross</span>, <span class="hlFld-ContribAuthor ">Robert C.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">A novel quinoline derivative that inhibits mycobacterial FtsZ. </span><span class="cited-content_cbyCitation_journal-name">Tuberculosis</span><span> <strong>2013,</strong> <em>93 </em>
                                    (4)
                                     , 398-400. <a href="https://doi.org/10.1016/j.tube.2013.04.002" title="DOI URL">https://doi.org/10.1016/j.tube.2013.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tube.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tube.2013.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTuberculosis%26atitle%3DA%252Bnovel%252Bquinoline%252Bderivative%252Bthat%252Binhibits%252Bmycobacterial%252BFtsZ%26aulast%3DMathew%26aufirst%3DBini%26date%3D2013%26volume%3D93%26issue%3D4%26spage%3D398%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alka  Sharma</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, single crystal and antitumor activities of benzimidazole–quinazoline hybrids. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3288-3294. <a href="https://doi.org/10.1016/j.bmcl.2013.03.107" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.107%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%25252C%252Bsingle%252Bcrystal%252Band%252Bantitumor%252Bactivities%252Bof%252Bbenzimidazole%2525E2%252580%252593quinazoline%252Bhybrids%26aulast%3DSharma%26aufirst%3DAlka%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3288%26epage%3D3294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baoxiang  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaochu  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Sheng</span>, <span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Zhenlu  Shen</span>, <span class="hlFld-ContribAuthor ">Xinquan  Hu</span>, <span class="hlFld-ContribAuthor ">Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Weimin  Mo</span>. </span><span class="cited-content_cbyCitation_article-title">Hexachlorocyclotriphosphazene (HCCP)-Mediated Direct Formation of Thioethers and Ethers from Quinazolin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (5)
                                     , 5580-5593. <a href="https://doi.org/10.3390/molecules18055580" title="DOI URL">https://doi.org/10.3390/molecules18055580</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18055580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18055580%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DHexachlorocyclotriphosphazene%252B%252528HCCP%252529-Mediated%252BDirect%252BFormation%252Bof%252BThioethers%252Band%252BEthers%252Bfrom%252BQuinazolin-4%2525283H%252529-ones%26aulast%3DHu%26aufirst%3DBaoxiang%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D5%26spage%3D5580%26epage%3D5593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivaputra A  Patil</span>, <span class="hlFld-ContribAuthor ">Renukadevi  Patil</span>, <span class="hlFld-ContribAuthor ">Duane D  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (16)
                                     , 2085-2115. <a href="https://doi.org/10.4155/fmc.12.141" title="DOI URL">https://doi.org/10.4155/fmc.12.141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.141%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DIndole%252Bmolecules%252Bas%252Binhibitors%252Bof%252Btubulin%252Bpolymerization%25253A%252Bpotential%252Bnew%252Banticancer%252Bagents%26aulast%3DPatil%26aufirst%3DShivaputra%2BA%26date%3D2012%26volume%3D4%26issue%3D16%26spage%3D2085%26epage%3D2115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Yanfang  Zhao</span>, <span class="hlFld-ContribAuthor ">Yajing  Liu</span>, <span class="hlFld-ContribAuthor ">Baohui  Qi</span>, <span class="hlFld-ContribAuthor ">Haiyan  Tao</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>54 </em>, 534-541. <a href="https://doi.org/10.1016/j.ejmech.2012.05.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.05.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.05.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B2-%2525282-arylmethylene%252529hydrazinyl-4-aminoquinazoline%252Bderivatives%252Bas%252Bpotent%252Bantitumor%252Bagents%26aulast%3DJiang%26aufirst%3DNan%26date%3D2012%26volume%3D54%26spage%3D534%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Alafeefy</span>, <span class="hlFld-ContribAuthor ">Abdelkader E.  Ashour</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2012,</strong> <em>27 </em>
                                    (4)
                                     , 541-545. <a href="https://doi.org/10.3109/14756366.2011.601302" title="DOI URL">https://doi.org/10.3109/14756366.2011.601302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2011.601302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2011.601302%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bquinazoline%252Bderivatives%252Bas%252Bpotential%252Banti-cancer%252Bagents%26aulast%3DAlafeefy%26aufirst%3DAhmed%2BM.%26date%3D2012%26date%3D2011%26volume%3D27%26issue%3D4%26spage%3D541%26epage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esther  Moreno</span>, <span class="hlFld-ContribAuthor ">Daniel  Plano</span>, <span class="hlFld-ContribAuthor ">Iranzu  Lamberto</span>, <span class="hlFld-ContribAuthor ">María  Font</span>, <span class="hlFld-ContribAuthor ">Ignacio  Encío</span>, <span class="hlFld-ContribAuthor ">Juan Antonio  Palop</span>, <span class="hlFld-ContribAuthor ">Carmen  Sanmartín</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur and selenium derivatives of quinazoline and pyrido[2,3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>47 </em>, 283-298. <a href="https://doi.org/10.1016/j.ejmech.2011.10.056" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.10.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.10.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.10.056%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfur%252Band%252Bselenium%252Bderivatives%252Bof%252Bquinazoline%252Band%252Bpyrido%25255B2%25252C3-d%25255Dpyrimidine%25253A%252BSynthesis%252Band%252Bstudy%252Bof%252Btheir%252Bpotential%252Bcytotoxic%252Bactivity%252Bin%2525C2%2525A0vitro%26aulast%3DMoreno%26aufirst%3DEsther%26date%3D2012%26volume%3D47%26spage%3D283%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenlu  Shen</span>, <span class="hlFld-ContribAuthor ">Xiaofei  He</span>, <span class="hlFld-ContribAuthor ">Jialiang  Dai</span>, <span class="hlFld-ContribAuthor ">Weimin  Mo</span>, <span class="hlFld-ContribAuthor ">Baoxiang  Hu</span>, <span class="hlFld-ContribAuthor ">Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Xinquan  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient HCCP-mediated direct amination of quinazolin-4(3H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2011,</strong> <em>67 </em>
                                    (9)
                                     , 1665-1672. <a href="https://doi.org/10.1016/j.tet.2010.12.067" title="DOI URL">https://doi.org/10.1016/j.tet.2010.12.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.12.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.12.067%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DAn%252Befficient%252BHCCP-mediated%252Bdirect%252Bamination%252Bof%252Bquinazolin-4%2525283H%252529-ones%26aulast%3DShen%26aufirst%3DZhenlu%26date%3D2011%26volume%3D67%26issue%3D9%26spage%3D1665%26epage%3D1672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J.  Edwards</span>, <span class="hlFld-ContribAuthor ">John A.  Hadfield</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Wallace</span>, <span class="hlFld-ContribAuthor ">Sylvie  Ducki</span>. </span><span class="cited-content_cbyCitation_article-title">Tubulin-binding dibenz[c,e]oxepines as colchinol analogues for targeting tumour vasculature. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2011,</strong> <em>9 </em>
                                    (1)
                                     , 219-231. <a href="https://doi.org/10.1039/C0OB00500B" title="DOI URL">https://doi.org/10.1039/C0OB00500B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0OB00500B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0OB00500B%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DTubulin-binding%252Bdibenz%25255Bc%25252Ce%25255Doxepines%252Bas%252Bcolchinol%252Banalogues%252Bfor%252Btargeting%252Btumour%252Bvasculature%26aulast%3DEdwards%26aufirst%3DDavid%2BJ.%26date%3D2011%26date%3D2011%26volume%3D9%26issue%3D1%26spage%3D219%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Vyas</span>, <span class="hlFld-ContribAuthor ">Manjunath  Ghate</span>, <span class="hlFld-ContribAuthor ">Hitesh  Katariya</span>. </span><span class="cited-content_cbyCitation_article-title">2D and 3D-QSAR study on 4-anilinoquinozaline derivatives as potent apoptosis inducer and efficacious anticancer agent. </span><span class="cited-content_cbyCitation_journal-name">Organic and Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>1 </em>
                                    (1)
                                     , 13. <a href="https://doi.org/10.1186/2191-2858-1-13" title="DOI URL">https://doi.org/10.1186/2191-2858-1-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/2191-2858-1-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F2191-2858-1-13%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520and%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2D%252Band%252B3D-QSAR%252Bstudy%252Bon%252B4-anilinoquinozaline%252Bderivatives%252Bas%252Bpotent%252Bapoptosis%252Binducer%252Band%252Befficacious%252Banticancer%252Bagent%26aulast%3DVyas%26aufirst%3DVivek%26date%3D2011%26volume%3D1%26issue%3D1%26spage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong-Ze  Li</span>, <span class="hlFld-ContribAuthor ">Hai-Yun  He</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Han</span>, <span class="hlFld-ContribAuthor ">Xin  Gu</span>, <span class="hlFld-ContribAuthor ">Lin  He</span>, <span class="hlFld-ContribAuthor ">Qing-Rong  Qi</span>, <span class="hlFld-ContribAuthor ">Ying-Lan  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">A General Synthetic Procedure for 2-chloromethyl-4(3H)-quinazolinone Derivatives and Their Utilization in the Preparation of Novel Anticancer Agents with 4-Anilinoquinazoline Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2010,</strong> <em>15 </em>
                                    (12)
                                     , 9473-9485. <a href="https://doi.org/10.3390/molecules15129473" title="DOI URL">https://doi.org/10.3390/molecules15129473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules15129473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules15129473%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DA%252BGeneral%252BSynthetic%252BProcedure%252Bfor%252B2-chloromethyl-4%2525283H%252529-quinazolinone%252BDerivatives%252Band%252BTheir%252BUtilization%252Bin%252Bthe%252BPreparation%252Bof%252BNovel%252BAnticancer%252BAgents%252Bwith%252B4-Anilinoquinazoline%252BScaffolds%26aulast%3DLi%26aufirst%3DHong-Ze%26date%3D2010%26date%3D2010%26volume%3D15%26issue%3D12%26spage%3D9473%26epage%3D9485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Idit  Sagiv-Barfi</span>, <span class="hlFld-ContribAuthor ">Ester  Weiss</span>, <span class="hlFld-ContribAuthor ">Alexander  Levitzki</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of quinazoline T cell proliferation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2010,</strong> <em>18 </em>
                                    (17)
                                     , 6404-6413. <a href="https://doi.org/10.1016/j.bmc.2010.07.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2010.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2010.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2010.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bquinazoline%252BT%252Bcell%252Bproliferation%252Binhibitors%26aulast%3DSagiv-Barfi%26aufirst%3DIdit%26date%3D2010%26volume%3D18%26issue%3D17%26spage%3D6404%26epage%3D6413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Cell-based apoptosis assays in oncology drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2010,</strong> <em>5 </em>
                                    (6)
                                     , 583-596. <a href="https://doi.org/10.1517/17460441.2010.486829" title="DOI URL">https://doi.org/10.1517/17460441.2010.486829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2010.486829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2010.486829%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DCell-based%252Bapoptosis%252Bassays%252Bin%252Boncology%252Bdrug%252Bdiscovery%26aulast%3DDrewe%26aufirst%3DJohn%26date%3D2010%26date%3D2010%26volume%3D5%26issue%3D6%26spage%3D583%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Foucourt</span>, <span class="hlFld-ContribAuthor ">Carole  Dubouilh-Benard</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Chosson</span>, <span class="hlFld-ContribAuthor ">Cécile  Corbière</span>, <span class="hlFld-ContribAuthor ">Catherine  Buquet</span>, <span class="hlFld-ContribAuthor ">Mauro  Iannelli</span>, <span class="hlFld-ContribAuthor ">Bertrand  Leblond</span>, <span class="hlFld-ContribAuthor ">Francis  Marsais</span>, <span class="hlFld-ContribAuthor ">Thierry  Besson</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-accelerated Dimroth rearrangement for the synthesis of 4-anilino-6-nitroquinazolines. Application to an efficient synthesis of a microtubule destabilizing agent. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2010,</strong> <em>66 </em>
                                    (25)
                                     , 4495-4502. <a href="https://doi.org/10.1016/j.tet.2010.04.066" title="DOI URL">https://doi.org/10.1016/j.tet.2010.04.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.04.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.04.066%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DMicrowave-accelerated%252BDimroth%252Brearrangement%252Bfor%252Bthe%252Bsynthesis%252Bof%252B4-anilino-6-nitroquinazolines.%252BApplication%252Bto%252Ban%252Befficient%252Bsynthesis%252Bof%252Ba%252Bmicrotubule%252Bdestabilizing%252Bagent%26aulast%3DFoucourt%26aufirst%3DAlicia%26date%3D2010%26volume%3D66%26issue%3D25%26spage%3D4495%26epage%3D4502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sung Hwan  Kim</span>, <span class="hlFld-ContribAuthor ">Se Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Taek Hyeon  Kim</span>, <span class="hlFld-ContribAuthor ">Jae Nyoung  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 4-allylquinazolines from N-(2-cyanoaryl)amides via the In-mediated allylation of nitrile and dehydrative cyclization cascade. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (20)
                                     , 2774-2777. <a href="https://doi.org/10.1016/j.tetlet.2010.03.076" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.03.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.03.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.03.076%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B4-allylquinazolines%252Bfrom%252BN-%2525282-cyanoaryl%252529amides%252Bvia%252Bthe%252BIn-mediated%252Ballylation%252Bof%252Bnitrile%252Band%252Bdehydrative%252Bcyclization%252Bcascade%26aulast%3DKim%26aufirst%3DSung%2BHwan%26date%3D2010%26volume%3D51%26issue%3D20%26spage%3D2774%26epage%3D2777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Azra  Pervin</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">J.  Adam Willardsen</span>, <span class="hlFld-ContribAuthor ">Mark B.  Anderson</span>, <span class="hlFld-ContribAuthor ">Gary  Mather</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Pleiman</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-methyl-4-(4-methoxyanilino)quinazolines as potent apoptosis inducers. Structure–activity relationship of the quinazoline ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2330-2334. <a href="https://doi.org/10.1016/j.bmcl.2010.01.155" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.155%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-methyl-4-%2525284-methoxyanilino%252529quinazolines%252Bas%252Bpotent%252Bapoptosis%252Binducers.%252BStructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bthe%252Bquinazoline%252Bring%26aulast%3DSirisoma%26aufirst%3DNilantha%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2330%26epage%3D2334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simonas  Rudys</span>, <span class="hlFld-ContribAuthor ">Carla  Ríos-Luci</span>, <span class="hlFld-ContribAuthor ">Eduardo  Pérez-Roth</span>, <span class="hlFld-ContribAuthor ">Inga  Cikotiene</span>, <span class="hlFld-ContribAuthor ">José M.  Padrón</span>. </span><span class="cited-content_cbyCitation_article-title">Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (5)
                                     , 1504-1506. <a href="https://doi.org/10.1016/j.bmcl.2010.01.112" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.112%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAntiproliferative%252Bactivity%252Bof%252Bnovel%252Bbenzo%25255Bb%25255D%25255B1%25252C6%25255Dnaphthyridines%252Bin%252Bhuman%252Bsolid%252Btumor%252Bcell%252Blines%26aulast%3DRudys%26aufirst%3DSimonas%26date%3D2010%26volume%3D20%26issue%3D5%26spage%3D1504%26epage%3D1506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure–activity relationships of the 9-oxo-9H-fluorene ring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (3)
                                     , 1288-1292. <a href="https://doi.org/10.1016/j.bmcl.2009.11.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-aryl-9-oxo-9H-fluorene-1-carboxamides%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B2.%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B9-oxo-9H-fluorene%252Bring%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1288%26epage%3D1292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vouy Linh  Truong</span>, <span class="hlFld-ContribAuthor ">Michelle  Morrow</span>. </span><span class="cited-content_cbyCitation_article-title">Mild and efficient ligand-free copper-catalyzed condensation for the synthesis of quinazolines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (4)
                                     , 758-760. <a href="https://doi.org/10.1016/j.tetlet.2009.11.133" title="DOI URL">https://doi.org/10.1016/j.tetlet.2009.11.133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2009.11.133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2009.11.133%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DMild%252Band%252Befficient%252Bligand-free%252Bcopper-catalyzed%252Bcondensation%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bquinazolines%26aulast%3DTruong%26aufirst%3DVouy%2BLinh%26date%3D2010%26volume%3D51%26issue%3D4%26spage%3D758%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin  Peese</span>. </span><span class="cited-content_cbyCitation_article-title">Orally bioavailable proteasome inhibitors: preclinical development of PR-047. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2009,</strong> <em>14 </em>
                                    (17-18)
                                     , 905-906. <a href="https://doi.org/10.1016/j.drudis.2009.06.005" title="DOI URL">https://doi.org/10.1016/j.drudis.2009.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2009.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2009.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DOrally%252Bbioavailable%252Bproteasome%252Binhibitors%25253A%252Bpreclinical%252Bdevelopment%252Bof%252BPR-047%26aulast%3DPeese%26aufirst%3DKevin%26date%3D2009%26volume%3D14%26issue%3D17-18%26spage%3D905%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Jared  Kuemmerle</span>, <span class="hlFld-ContribAuthor ">Han-Zhong  Zhang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers. 2. Identification of more aqueous soluble analogs as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (15)
                                     , 4410-4415. <a href="https://doi.org/10.1016/j.bmcl.2009.05.052" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3-aryl-5-aryl-1%25252C2%25252C4-oxadiazoles%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers.%252B2.%252BIdentification%252Bof%252Bmore%252Baqueous%252Bsoluble%252Banalogs%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D15%26spage%3D4410%26epage%3D4415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Chris  May</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (13)
                                     , 3536-3540. <a href="https://doi.org/10.1016/j.bmcl.2009.04.145" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.04.145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.04.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.04.145%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-anilino-N-methylthieno%25255B3%25252C2-d%25255Dpyrimidines%252Band%252B4-anilino-N-methylthieno%25255B2%25252C3-d%25255Dpyrimidines%252Bas%252Bpotent%252Bapoptosis%252Binducers%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3536%26epage%3D3540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Jared  Kuemmerle</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure–activity relationships of the 4-, 5-, 6-, 7- and 8-positions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (13)
                                     , 3481-3484. <a href="https://doi.org/10.1016/j.bmcl.2009.05.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B1-benzoyl-3-cyanopyrrolo%25255B1%25252C2-a%25255Dquinolines%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B2%25253A%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252B4-%25252C%252B5-%25252C%252B6-%25252C%252B7-%252Band%252B8-positions%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D13%26spage%3D3481%26epage%3D3484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William  Kemnitzer</span>, <span class="hlFld-ContribAuthor ">Nilantha  Sirisoma</span>, <span class="hlFld-ContribAuthor ">Bao  Nguyen</span>, <span class="hlFld-ContribAuthor ">Songchun  Jiang</span>, <span class="hlFld-ContribAuthor ">Shailaja  Kasibhatla</span>, <span class="hlFld-ContribAuthor ">Candace  Crogan-Grundy</span>, <span class="hlFld-ContribAuthor ">Ben  Tseng</span>, <span class="hlFld-ContribAuthor ">John  Drewe</span>, <span class="hlFld-ContribAuthor ">Sui Xiong  Cai</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-aryl-9-oxo-9H-fluorene-1-carboxamides as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure–activity relationships of the carboxamide group. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (11)
                                     , 3045-3049. <a href="https://doi.org/10.1016/j.bmcl.2009.04.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-aryl-9-oxo-9H-fluorene-1-carboxamides%252Bas%252Ba%252Bnew%252Bseries%252Bof%252Bapoptosis%252Binducers%252Busing%252Ba%252Bcell-%252Band%252Bcaspase-based%252Bhigh-throughput%252Bscreening%252Bassay.%252B1.%252BStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bthe%252Bcarboxamide%252Bgroup%26aulast%3DKemnitzer%26aufirst%3DWilliam%26date%3D2009%26volume%3D19%26issue%3D11%26spage%3D3045%26epage%3D3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0015.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0001.jpeg" id="rightTab-gc1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0006.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) RCN (<b>2</b>), HCl(g); (b) POCl<sub>3</sub>, DIPEA, toluene; (c) 4-MeO-PhNHMe (<b>5a</b>), IPA, HCl; (d) NaOH; (e) NHMe<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0007.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>6c</b>, NaOMe; <b>6d</b>, NHMe<sub>2</sub>; <b>6e</b>, NH<sub>2</sub>Me; <b>6f</b>, NH<sub>2</sub>NH<sub>2</sub>; (b) AcCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0008.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) <b>7a</b>, 4-NO<sub>2</sub>−PhNHMe, NaH, DMF; <b>7b</b>, 4-F-PhNHMe, NaAc, THF/H<sub>2</sub>O; <b>9a</b>, 4-MeO-PhNH<sub>2</sub>, IPA, HCl.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0009.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) ArNH<sub>2</sub> (<b>8</b>), NaAc, THF/H<sub>2</sub>O; (b) MeI, NaH, DMF.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0010.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Conditions: (a) H<sub>2</sub>, Pd/C, EtOH; (b) HCHO, sodium cyanoborohydride; (c) Br<sub>2</sub>, AcOH; (d) T<sub>2</sub>, Pd/C, EtOH; (e) NaNO<sub>2</sub>, HCl, then NaN<sub>3</sub>.</p></p></figure><figure data-id="fig1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Drug-induced apoptosis in T47D cells as measured by flow cytometric analysis. The <i>x</i>-axis is the fluorescence intensity, and the <i>y</i>-axis is the number of cells with that fluorescence intensity. A: Control cells showing most of the cells in G<sub>1</sub> phase of the cell cycle. B: Cells treated with 5 nM of compound <b>6h</b> for 24 h showing most of the cells arrested in G<sub>2</sub>/M phase. C: Cells treated with 5 nM of compound <b>6h</b> for 48 h showing a progression from G<sub>2</sub>/M to cells with subdiploid DNA content, which are apoptotic cells with fragmented nuclei.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>6h</b> inhibited the growth of established (∼100 mm<sup>3</sup>) MX-1 tumor xenografts in Crl:Nu/Nu-nuBR mice. Compound <b>6h</b> was dosed iv at 5, 7.5 or 10 mg/kg once weekly for three weeks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. PK of compound <b>6h</b> in brain and plasma after a single iv dose of 2.5 mg/kg in mice. Median brain concentrations (open circles) and median plasma concentrations (open squares).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/medium/jm-2008-01315b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0002.jpeg" id="rightTab-gc2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-8/jm801315b/production/images/large/jm-2008-01315b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm801315b&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 38 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Varmus, H.</span><span> </span><span class="NLM_article-title">The new era in cancer research</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1165</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1162-1165&author=H.+Varmus&title=The+new+era+in+cancer+research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVarmus%26aufirst%3DH.%26atitle%3DThe%2520new%2520era%2520in%2520cancer%2520research%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1162%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Kingston, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newman, D. J.</span><span> </span><span class="NLM_article-title">Taxoids: cancer-fighting compounds from nature</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=130-144&author=D.+G.+Kingstonauthor=D.+J.+Newman&title=Taxoids%3A+cancer-fighting+compounds+from+nature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKingston%26aufirst%3DD.%2BG.%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26atitle%3DTaxoids%253A%2520cancer-fighting%2520compounds%2520from%2520nature%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D130%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Cross, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyseng-Williamson, K. A.</span><span> </span><span class="NLM_article-title">Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">2645</span><span class="NLM_x">–</span> <span class="NLM_lpage">2654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=2645-2654&author=S.+A.+Crossauthor=K.+A.+Lyseng-Williamson&title=Imatinib%3A+in+relapsed+or+refractory+Philadelphia+chromosome-positive+acute+lymphoblastic+leukaemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DS.%2BA.%26aulast%3DLyseng-Williamson%26aufirst%3DK.%2BA.%26atitle%3DImatinib%253A%2520in%2520relapsed%2520or%2520refractory%2520Philadelphia%2520chromosome-positive%2520acute%2520lymphoblastic%2520leukaemia%26jtitle%3DDrugs%26date%3D2007%26volume%3D67%26spage%3D2645%26epage%3D2654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Baselga, J.</span><span> </span><span class="NLM_article-title">Targeting tyrosine kinases in cancer: the second wave</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1175-1158&author=J.+Baselga&title=Targeting+tyrosine+kinases+in+cancer%3A+the+second+wave"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaselga%26aufirst%3DJ.%26atitle%3DTargeting%2520tyrosine%2520kinases%2520in%2520cancer%253A%2520the%2520second%2520wave%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1175%26epage%3D1158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Wood, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manchen, B.</span><span> </span><span class="NLM_article-title">Sorafenib: a promising new targeted therapy for renal cell carcinoma</span> <span class="citation_source-journal">Clin. J. Oncol. Nurs.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1188%2F07.CJON.649-656" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17962173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A280%3ADC%252BD2snjslahsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2007&pages=649-656&author=L.+S.+Woodauthor=B.+Manchen&title=Sorafenib%3A+a+promising+new+targeted+therapy+for+renal+cell+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Sorafenib: a promising new targeted therapy for renal cell carcinoma</span></div><div class="casAuthors">Wood Laura S; Manchen Beth</div><div class="citationInfo"><span class="NLM_cas:title">Clinical journal of oncology nursing</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">649-56</span>
        ISSN:<span class="NLM_cas:issn">1092-1095</span>.
    </div><div class="casAbstract">Diagnosis of renal cell carcinoma (RCC) frequently occurs at advanced stages, severely limiting the success of treatment, and median survival is barely more than a year.  Previously, treatment of renal cancer was limited to nephrectomy or immunotherapy (interleukin or interferon-alpha), which was effective in a small subset of patients but often was accompanied by severe side effects.  New orally administered targeted therapies have become available, offering broader benefits to patients with advanced RCC.  Sorafenib is an oral, multikinase inhibitor recently approved by the U.S.  Food and Drug Administration as treatment for advanced RCC based on its extension of median progression-free survival from 12-24 weeks.  Oncology nurses must ensure patient adherence and manage side effects of emerging treatments.  This article reviews the management of skin rash, hand-foot skin reaction, hypertension, diarrhea, and fatigue in patients receiving sorafenib.  In addition, a case study of a patient receiving sorafenib is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVhi6aRvGRCIhLSh9fo81bfW6udTcc2ebhekScMyQfWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2snjslahsw%253D%253D&md5=fed9756b7502ec6c86c594f7e63e7d5f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1188%2F07.CJON.649-656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1188%252F07.CJON.649-656%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DL.%2BS.%26aulast%3DManchen%26aufirst%3DB.%26atitle%3DSorafenib%253A%2520a%2520promising%2520new%2520targeted%2520therapy%2520for%2520renal%2520cell%2520carcinoma%26jtitle%3DClin.%2520J.%2520Oncol.%2520Nurs.%26date%3D2007%26volume%3D11%26spage%3D649%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0lipU1yTEIyy-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Sunitinib</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1517%2F14656566.8.14.2359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17927489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFeqt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=2359-2369&author=B.+I.+Rini&title=Sunitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Sunitinib</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2359-2369</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Sunitinib is a small-mol. inhibitor of several receptor tyrosine kinases relevant to tumor angiogenesis, including the vascular endothelial growth factor (VEGF) receptor.  Potent inhibition of this related family of receptors and consequent antiangiogenic effects have been demonstrated in vitro and in murine models.  Human studies have established 50 mg daily dosing given on an intermittent schedule as a tolerable dose.  Significant antitumor effects have been obsd., most notably in advanced renal cell carcinoma (RCC) and imatinib refractory/intolerant gastrointestinal stromal tumor (GIST).  Sunitinib has received regulatory approval in these two indications, and is at present being investigated across a broad array of solid tumors.  Despite these initial results, several questions remain to optimize the utility of this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmLEQXPQvMCLVg90H21EOLACvtfcHk0lipU1yTEIyy-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFeqt77N&md5=7ccb4c3860b4612b2e81fab02d15907a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1517%2F14656566.8.14.2359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.8.14.2359%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DSunitinib%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2007%26volume%3D8%26spage%3D2359%26epage%3D2369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Roccaro, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribatti, D.</span><span> </span><span class="NLM_article-title">Bortezomib in the treatment of cancer</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=397-403&author=A.+M.+Roccaroauthor=A.+Vaccaauthor=D.+Ribatti&title=Bortezomib+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoccaro%26aufirst%3DA.%2BM.%26aulast%3DVacca%26aufirst%3DA.%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DBortezomib%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26volume%3D1%26spage%3D397%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Rini, B. I.</span><span> </span><span class="NLM_article-title">Temsirolimus, an inhibitor of mammalian target of rapamycin</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1286</span><span class="NLM_x">–</span> <span class="NLM_lpage">1290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-07-4719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18316545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislSku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1286-1290&author=B.+I.+Rini&title=Temsirolimus%2C+an+inhibitor+of+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin</span></div><div class="casAuthors">Rini, Brian I.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1286-1290</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Temsirolimus, an inhibitor of mammalian target of rapamycin, a mol. implicated in multiple tumor-promoting intracellular signaling pathways is discussed.  A brief description of temsirolimus and mTOR as well as the different studies regarding the field of interest are presented.  Results from these studies validated mTOR as a relevant therapeutic target in renal cell carcinoma (RCC), at least in the subset of patients with multiple adverse risk features.  The temsirolimus-related adverse events and the other rapamycin analog inhibitors of mTOR currently clin. testing are also given.  Still, more potent mTOR inhibition, simultaneous inhibition of multiple signaling pathways, and/or more precise mol. phenotyping of tumors to define mTOR pathway reliance are needed to build on the obsd. clin. benefits of temsirolimus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgD87VNVhdWLVg90H21EOLACvtfcHk0lipU1yTEIyy-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislSku7Y%253D&md5=b2abad3901820fc28b06254e12b7666c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-4719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-4719%26sid%3Dliteratum%253Aachs%26aulast%3DRini%26aufirst%3DB.%2BI.%26atitle%3DTemsirolimus%252C%2520an%2520inhibitor%2520of%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1286%26epage%3D1290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Deeken, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loscher, W.</span><span> </span><span class="NLM_article-title">The blood-brain barrier and cancer: transporters, treatment, and Trojan horses</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-06-2854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17363519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1663-1674&author=J.+F.+Deekenauthor=W.+Loscher&title=The+blood-brain+barrier+and+cancer%3A+transporters%2C+treatment%2C+and+Trojan+horses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses</span></div><div class="casAuthors">Deeken, John F.; Loescher, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1663-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite scientific advances in understanding the causes and treatment of human malignancy, a persistent challenge facing basic and clin. investigators is how to adequately treat primary and metastatic brain tumors.  The blood-brain barrier is a physiol. obstruction to the delivery of systemic chemotherapy to the brain parenchyma and central nervous system (CNS).  A no. of physiol. properties make the endothelium in the CNS distinct from the vasculature found in the periphery.  Recent evidence has shown that a crit. aspect of this barrier is composed of xenobiotic transporters which extrude substrates from the brain into the cerebrospinal fluid and systemic circulation.  These transporters also extrude drugs and toxins if they gain entry into the cytoplasm of brain endothelial cells before they enter the brain.  This review highlights the properties of the blood-brain barrier, including the location, function, and relative importance of the drug transporters that maintain this barrier.  Primary and metastatic brain malignancy can compromise this barrier, allowing some access of chemotherapy treatment to reach the tumor.  The responsiveness of brain tumors to systemic treatment found in past clin. research is discussed, as are possible explanations as to why CNS tumors are nonetheless able to evade therapy.  Finally, strategies to overcome this barrier and better deliver chemotherapy into CNS tumors are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxa44seefNF7Vg90H21EOLACvtfcHk0lipU1yTEIyy-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivV2gtrg%253D&md5=dc7ea92d49779b99871f98a5e2b59858</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2854%26sid%3Dliteratum%253Aachs%26aulast%3DDeeken%26aufirst%3DJ.%2BF.%26aulast%3DLoscher%26aufirst%3DW.%26atitle%3DThe%2520blood-brain%2520barrier%2520and%2520cancer%253A%2520transporters%252C%2520treatment%252C%2520and%2520Trojan%2520horses%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1663%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Broniscer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panetta, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shaughnessy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gajjar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, C. F.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1511</span><span class="NLM_x">–</span> <span class="NLM_lpage">1515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-06-2372" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17332296" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1511-1515&author=A.+Broniscerauthor=J.+C.+Panettaauthor=M.+O%E2%80%99Shaughnessyauthor=C.+Fragaauthor=F.+Baiauthor=M.+J.+Krasinauthor=A.+Gajjarauthor=C.+F.+Stewart&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+erlotinib+and+its+active+metabolite+OSI-420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420</span></div><div class="casAuthors">Broniscer, Alberto; Panetta, John C.; O'Shaughnessy, Melinda; Fraga, Charles; Bai, Feng; Krasin, Matthew J.; Gajjar, Amar; Stewart, Clinton F.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1511-1515</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">To report cerebrospinal fluid (CSF) penetration of erlotinib and its metabolite OSI-420.  Pharmacokinetic measurements were done in plasma (days 1, 2, 3, and 8 of therapy) and, concurrently, in plasma and CSF (before and at 1, 2, 4, 8, and 24 h after dose on day 34 of therapy) in an 8-yr-old patient diagnosed with glioblastoma who received local irradn. and oral erlotinib in a phase I protocol.  CSF samples were collected from a ventriculoperitoneal shunt, which was externalized because of infection.  Erlotinib concns. were detd. by liq. chromatog./mass spectrometry.  CSF penetration of erlotinib and OSI-420 were estd. by a compartmental model and by calcg. the ratio of CSF to plasma 24-h area under concn.-time curve (AUC0-24).  This patient was assigned to receive erlotinib at a dose level of 70 mg/m2, but the actual daily dose was 75 mg (78 mg/m2).  Erlotinib and OSI-420 plasma pharmacokinetic variables on days 8 and 34 overlapped to suggest that steady state had been reached.  Whereas erlotinib and OSI-420 AUC0-24 in plasma on day 34 were 30,365 and 2,527 ng h/mL, resp., the correspondent AUC0-24 in the CSF were 2,129 and 240 ng h/mL, resp.  Erlotinib and OSI-420 CSF penetration were 7% and ∼9%, resp., using both est. methods.  The max. steady-state CSF concn. of erlotinib was ∼130 ng/mL (325 nmol/L).  The plasma pharmacokinetics of erlotinib in this child overlapped with results described in adults.  Oral administration of erlotinib achieves CSF concns. comparable with those active against several cancer cell lines in preclin. models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoldU23ij5mgLVg90H21EOLACvtfcHk0lgWxNFogVFmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXitlSjt7Y%253D&md5=9b1e3b0a3d448075085ee7fd38ca635e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2372%26sid%3Dliteratum%253Aachs%26aulast%3DBroniscer%26aufirst%3DA.%26aulast%3DPanetta%26aufirst%3DJ.%2BC.%26aulast%3DO%25E2%2580%2599Shaughnessy%26aufirst%3DM.%26aulast%3DFraga%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DKrasin%26aufirst%3DM.%2BJ.%26aulast%3DGajjar%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DC.%2BF.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520erlotinib%2520and%2520its%2520active%2520metabolite%2520OSI-420%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Franceschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magrini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosso, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scopece, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbini, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pession, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tallini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crinò, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandes, A. A.</span><span> </span><span class="NLM_article-title">Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1038%2Fsj.bjc.6603669" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17353924" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsleksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=1047-1051&author=E.+Franceschiauthor=G.+Cavalloauthor=S.+Lonardiauthor=E.+Magriniauthor=A.+Tosoniauthor=D.+Grossoauthor=L.+Scopeceauthor=V.+Blattauthor=B.+Urbiniauthor=A.+Pessionauthor=G.+Talliniauthor=L.+Crin%C3%B2author=A.+A.+Brandes&title=Gefitinib+in+patients+with+progressive+high-grade+gliomas%3A+a+multicentre+phase+II+study+by+Gruppo+Italiano+Cooperativo+di+Neuro-Oncologia+%28GICNO%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)</span></div><div class="casAuthors">Franceschi, E.; Cavallo, G.; Lonardi, S.; Magrini, E.; Tosoni, A.; Grosso, D.; Scopece, L.; Blatt, V.; Urbini, B.; Pession, A.; Tallini, G.; Crino, L.; Brandes, A. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1047-1051</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">To investigate the role of gefitinib in patients with high-grade gliomas (HGGs), a phase II trial (1839IL/0116) was conducted in patients with disease recurrence following surgery plus radiotherapy and first-line chemotherapy.  Adult patients with histol. confirmed recurrent HGGs following surgery, radiotherapy and first-line chemotherapy, were considered eligible.  Patients were treated with gefitinib (250 mg day-1) continuously until disease progression.  The primary end point was progression-free survival at 6 mo progression-free survival at 6 mo (PFS-6).  Tissue biomarkers (epidermal growth factor receptor (EGFR) gene status and expression, phosphorylated Akt (p-Akt) expression) were assessed.  Twenty-eight patients (median age, 55 years; median ECOG performance status, 1) were enrolled; all were evaluable for drug activity and safety.  Sixteen patients had glioblastoma, three patients had anaplastic oligodendrogliomas and nine patients had anaplastic astrocytoma.  Five patients (17.9%, 95% CI 6.1-36.9%) showed disease stabilization.  The overall median time to progression was 8.4 (range 2-104+) weeks and PFS-6 was 14.3% (95% CI 4.0-32.7%).  The median overall survival was 24.6 wk (range 4-104+).  No grade 3-4 gefitinib-related toxicity was found.  Gefitinib showed limited activity in patients affected by HGGs.  Epidermal growth factor receptor expression or gene status, and p-Akt expression do not seem to predict activity of this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYiU3YpISpS7Vg90H21EOLACvtfcHk0lgWxNFogVFmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsleksLw%253D&md5=bb2c9941b1869d9cc98bb04d339e6f77</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6603669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6603669%26sid%3Dliteratum%253Aachs%26aulast%3DFranceschi%26aufirst%3DE.%26aulast%3DCavallo%26aufirst%3DG.%26aulast%3DLonardi%26aufirst%3DS.%26aulast%3DMagrini%26aufirst%3DE.%26aulast%3DTosoni%26aufirst%3DA.%26aulast%3DGrosso%26aufirst%3DD.%26aulast%3DScopece%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DV.%26aulast%3DUrbini%26aufirst%3DB.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DTallini%26aufirst%3DG.%26aulast%3DCrin%25C3%25B2%26aufirst%3DL.%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26atitle%3DGefitinib%2520in%2520patients%2520with%2520progressive%2520high-grade%2520gliomas%253A%2520a%2520multicentre%2520phase%2520II%2520study%2520by%2520Gruppo%2520Italiano%2520Cooperativo%2520di%2520Neuro-Oncologia%2520%2528GICNO%2529%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2007%26volume%3D96%26spage%3D1047%26epage%3D1051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reardon, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peery, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dowell, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penne, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrand, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Duyn, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dancey, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenzel, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed Rasheed, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourt-Uhlig, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herndon, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vredenburgh, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span> </span><span class="NLM_article-title">Phase II trial of gefitinib in recurrent glioblastoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1200%2FJCO.2004.08.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=14638850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVKhsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=133-142&author=J.+N.+Richauthor=D.+A.+Reardonauthor=T.+Peeryauthor=J.+M.+Dowellauthor=J.+A.+Quinnauthor=K.+L.+Penneauthor=C.+J.+Wikstrandauthor=L.+B.+Van+Duynauthor=J.+E.+Danceyauthor=R.+E.+McLendonauthor=J.+C.+Kaoauthor=T.+T.+Stenzelauthor=B.+K.+Ahmed+Rasheedauthor=S.+E.+Tourt-Uhligauthor=J.+E.+Herndonauthor=J.+J.+Vredenburghauthor=J.+H.+Sampsonauthor=A.+H.+Friedmanauthor=D.+D.+Bignerauthor=H.+S.+Friedman&title=Phase+II+trial+of+gefitinib+in+recurrent+glioblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II trial of gefitinib in recurrent glioblastoma</span></div><div class="casAuthors">Rich, Jeremy N.; Reardon, David A.; Peery, Terry; Dowell, Jeannette M.; Quinn, Jennifer A.; Penne, Kara L.; Wikstrand, Carol J.; van Duyn, Lauren B.; Dancey, Janet E.; McLendon, Roger E.; Kao, James C.; Stenzel, Timothy T.; Rasheed, B. K. Ahmed; Tourt-Uhlig, Sandra E.; Herndon, James E., II; Vredenburgh, James J.; Sampson, John H.; Friedman, Allan H.; Bigner, Darell D.; Friedman, Henry S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">133-142</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">The aim was to evaluate the efficacy and tolerability of gefitinib (ZD1839, Iressa; AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.  This was an open-label, single-center phase II trial.  Fifty-seven patients with first recurrence of a glioblastoma who were previously treated with surgical resection, radiation, and usually chemotherapy underwent an open biopsy or resection at evaluation for confirmation of tumor recurrence.  Each patient initially received 500 mg of gefitinib orally once daily; dose escalation to 750 mg then 1,000 mg, if a patient received enzyme-inducing antiepileptic drugs or dexamethasone, was allowed within each patient.  Although no objective tumor responses were seen among the 53 assessable patients, only 21% of patients (11 of 53 patients) had measurable disease at treatment initiation.  Seventeen percent of patients (nine of 53 patients) underwent at least six 4-wk cycles, and the 6-mo event-free survival (EFS) was 13% (seven of 53 patients).  The median EFS time was 8.1 wk, and the median overall survival (OS) time from treatment initiation was 39.4 wk.  Adverse events were generally mild (grade 1 or 2) and consisted mainly of skin reactions and diarrhea.  Drug-related toxicities were more frequent at higher doses.  Withdrawal caused by drug-related adverse events occurred in 6% of patients (three of 53 patients).  Although the presence of diarrhea pos. predicted favorable OS from treatment initiation, epidermal growth factor receptor expression did not correlate with either EFS or OS.  Gefitinib is well tolerated and has activity in patients with recurrent glioblastoma.  Further study of this agent at higher doses is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVwxzaQ62e7Vg90H21EOLACvtfcHk0lgWxNFogVFmjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVKhsr8%253D&md5=4477591e92c2ce1272a21b1bbf8e451a</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1200%2FJCO.2004.08.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2004.08.110%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DJ.%2BN.%26aulast%3DReardon%26aufirst%3DD.%2BA.%26aulast%3DPeery%26aufirst%3DT.%26aulast%3DDowell%26aufirst%3DJ.%2BM.%26aulast%3DQuinn%26aufirst%3DJ.%2BA.%26aulast%3DPenne%26aufirst%3DK.%2BL.%26aulast%3DWikstrand%26aufirst%3DC.%2BJ.%26aulast%3DVan%2BDuyn%26aufirst%3DL.%2BB.%26aulast%3DDancey%26aufirst%3DJ.%2BE.%26aulast%3DMcLendon%26aufirst%3DR.%2BE.%26aulast%3DKao%26aufirst%3DJ.%2BC.%26aulast%3DStenzel%26aufirst%3DT.%2BT.%26aulast%3DAhmed%2BRasheed%26aufirst%3DB.%2BK.%26aulast%3DTourt-Uhlig%26aufirst%3DS.%2BE.%26aulast%3DHerndon%26aufirst%3DJ.%2BE.%26aulast%3DVredenburgh%26aufirst%3DJ.%2BJ.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26atitle%3DPhase%2520II%2520trial%2520of%2520gefitinib%2520in%2520recurrent%2520glioblastoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2004%26volume%3D22%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brandes, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franceschi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tosoni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegi, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupp, R.</span><span> </span><span class="NLM_article-title">Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-07-1810" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18281526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12c&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvF2ntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=957-960&author=A.+A.+Brandesauthor=E.+Franceschiauthor=A.+Tosoniauthor=M.+E.+Hegiauthor=R.+Stupp&title=Epidermal+growth+factor+receptor+inhibitors+in+neuro-oncology%3A+hopes+and+disappointments"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12cR"><div class="casContent"><span class="casTitleNuber">12c</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and Disappointments</span></div><div class="casAuthors">Brandes, Alba A.; Franceschi, Enrico; Tosoni, Alicia; Hegi, Monika E.; Stupp, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">957-960</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Despite advances in diagnosis and treatment made over the past two decades, high-grade gliomas are still incurable neoplasms.  Moreover, after failing adjuvant therapy, few active treatments are available.  In this setting, novel agents, such as new chemotherapy compds. and anticancer agents against specific mol. targets, have therefore been investigated.  Epidermal growth factor receptor (EGFR) is an intriguing target in high-grade gliomas because it is frequently overexpressed due to amplification of the EGFR gene.  Gefitinib and erlotinib act as ATP mimetic agents, binding to the cytoplasmic ATP pocket domain and blocking receptor phosphorylations and, thereby, EGFR-mediated activation of downstream pathways.  These drugs have been evaluated in several clin. trials treating recurrent high-grade gliomas with contrasting results.  Retrospective correlative analyses generated a plethora of putative predictive factors of activity of EGFR tyrosine kinase inhibitors.  The first generations of studies on EGFR inhibitors have not found significant activity of these agents in high-grade gliomas.  Furthermore, no clear mol. or clin. predictors have been identified.  As with other targeted agents, prospective trials using specific criteria and standardized methods to evaluate tissue biomarkers are required to find predictors of EGFR inhibitors activity in high-grade glioma patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPxtOeDUc1zLVg90H21EOLACvtfcHk0li--F_M4a8lng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvF2ntL0%253D&md5=20ae26e0f0b80bcfe55be0fcd52bc66b</span></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1810%26sid%3Dliteratum%253Aachs%26aulast%3DBrandes%26aufirst%3DA.%2BA.%26aulast%3DFranceschi%26aufirst%3DE.%26aulast%3DTosoni%26aufirst%3DA.%26aulast%3DHegi%26aufirst%3DM.%2BE.%26aulast%3DStupp%26aufirst%3DR.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520inhibitors%2520in%2520neuro-oncology%253A%2520hopes%2520and%2520disappointments%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D957%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Polli, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmon, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Mara, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">John-Williams, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serabjit-Singh, C. J.</span><span> </span><span class="NLM_article-title">The role of efflux and uptake transporters in N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=695-701&author=J.+W.+Polliauthor=J.+E.+Humphreysauthor=K.+A.+Harmonauthor=S.+Castellinoauthor=M.+J.+O%E2%80%99Maraauthor=K.+L.+Olsonauthor=L.+S.+John-Williamsauthor=K.+M.+Kochauthor=C.+J.+Serabjit-Singh&title=The+role+of+efflux+and+uptake+transporters+in+N-%7B3-chloro-4-%5B%283-fluorobenzyl%29oxy%5Dphenyl%7D-6-%5B5-%28%7B%5B2-%28methylsulfonyl%29ethyl%5Damino%7Dmethyl%29-2-furyl%5D-4-quinazolinamine+%28GW572016%2C+lapatinib%29+disposition+and+drug+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DHarmon%26aufirst%3DK.%2BA.%26aulast%3DCastellino%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Mara%26aufirst%3DM.%2BJ.%26aulast%3DOlson%26aufirst%3DK.%2BL.%26aulast%3DJohn-Williams%26aufirst%3DL.%2BS.%26aulast%3DKoch%26aufirst%3DK.%2BM.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520role%2520of%2520efflux%2520and%2520uptake%2520transporters%2520in%2520N-%257B3-chloro-4-%255B%25283-fluorobenzyl%2529oxy%255Dphenyl%257D-6-%255B5-%2528%257B%255B2-%2528methylsulfonyl%2529ethyl%255Damino%257Dmethyl%2529-2-furyl%255D-4-quinazolinamine%2520%2528GW572016%252C%2520lapatinib%2529%2520disposition%2520and%2520drug%2520interactions%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lukas, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boire, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, M. K.</span><span> </span><span class="NLM_article-title">Emerging therapies for malignant glioma</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_elocation-id">S29−36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&author=R.+V.+Lukasauthor=A.+Boireauthor=M.+K.+Nicholas&title=Emerging+therapies+for+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukas%26aufirst%3DR.%2BV.%26aulast%3DBoire%26aufirst%3DA.%26aulast%3DNicholas%26aufirst%3DM.%2BK.%26atitle%3DEmerging%2520therapies%2520for%2520malignant%2520glioma%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2007%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fischer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze-Osthoff, K.</span><span> </span><span class="NLM_article-title">New approaches and therapeutics targeting apoptosis in disease</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2005&pages=187-215&author=U.+Fischerauthor=K.+Schulze-Osthoff&title=New+approaches+and+therapeutics+targeting+apoptosis+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DU.%26aulast%3DSchulze-Osthoff%26aufirst%3DK.%26atitle%3DNew%2520approaches%2520and%2520therapeutics%2520targeting%2520apoptosis%2520in%2520disease%26jtitle%3DPharmacol.%2520Rev.%26date%3D2005%26volume%3D57%26spage%3D187%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">O’Driscoll, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linehan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, M.</span><span> </span><span class="NLM_article-title">Survivin: role in normal cells and in pathological conditions</span> <span class="citation_source-journal">Curr. Cancer Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F1568009033482038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=12678716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=131-152&author=L.+O%E2%80%99Driscollauthor=R.+Linehanauthor=M.+Clynes&title=Survivin%3A+role+in+normal+cells+and+in+pathological+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Survivin: Role in normal cells and in pathological conditions</span></div><div class="casAuthors">O'Driscoll, L.; Linehan, R.; Clynes, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Cancer Drug Targets</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-152</span>CODEN:
                <span class="NLM_cas:coden">CCDTB9</span>;
        ISSN:<span class="NLM_cas:issn">1568-0096</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Survivin, an inhibitor of apoptosis (IAP) contg. one baculovirus IAP repeat (BIR) domain, has been reported to be capable of regulating both cellular proliferation and apoptotic cell death.  Survivin splice variants, survivin-ΔEx3 and survivin-2B, have apparently retained and lost anti-apoptotic potential, resp.  As survivin was first discovered due to its high homol. with effector cell protease receptor (EPR-1), a protein involved in blood coagulation, it has been suggested (but not proven) that EPR-1 may act as a natural anti-sense to survivin in cells.  Survivin homologs have been found in non-human species.  Survivin expression has been described during embryonic development and in adult cancerous tissues, with greatly reduced expression in adult normal differentiated tissues, particularly if their proliferation index is low.  Survivin has been defined as a universal tumor antigen and as the fourth most significant transcriptosome expressed in human tumors.  Although survivin is usually located in the cell cytoplasmic region and assocd. with poor prognosis in cancer, nuclear localization, indicative of favorable prognosis, has also been reported.  Survivin expression has also been reported in a no. of proliferating normal adult tissues.  Extensive research has been conducted, aimed at increasing our understanding of survivin, by detg. its sub-cellular structure and location, mechanism(s) of action and control of expression.  While much important information on this mol. has been accumulated, there are still many areas of controversy or limited information.  Further research may enable exploitation of survivin overexpression in cancer compared to normal tissues, making survivin a potentially attractive target for cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTyDh2jQIlKLVg90H21EOLACvtfcHk0lhWWMtPFtSxsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1alt7s%253D&md5=444e29c17b6ad4954f8a1a8e182850af</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1568009033482038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568009033482038%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Driscoll%26aufirst%3DL.%26aulast%3DLinehan%26aufirst%3DR.%26aulast%3DClynes%26aufirst%3DM.%26atitle%3DSurvivin%253A%2520role%2520in%2520normal%2520cells%2520and%2520in%2520pathological%2520conditions%26jtitle%3DCurr.%2520Cancer%2520Drug%2520Targets%26date%3D2003%26volume%3D3%26spage%3D131%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Grivicich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">da Rocha, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayser, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartsmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriques, J. A.</span><span> </span><span class="NLM_article-title">Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines</span> <span class="citation_source-journal">Oncol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16491956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOjsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=385-392&author=I.+Grivicichauthor=A.+Regnerauthor=A.+B.+da+Rochaauthor=L.+B.+Grassauthor=P.+A.+Alvesauthor=G.+B.+Kayserauthor=G.+Schwartsmannauthor=J.+A.+Henriques&title=Irinotecan%2F5-fluorouracil+combination+induces+alterations+in+mitochondrial+membrane+potential+and+caspases+on+colon+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Irinotecan/5-fluorouracil combination induces alterations in mitochondrial membrane potential and caspases on colon cancer cell lines</span></div><div class="casAuthors">Grivicich, Ivana; Regner, Andrea; da Rocha, Adriana B.; Grass, Luciano B.; Alves, Pedro A. G.; Kayser, Guilherme B.; Schwartsmann, Gilberto; Henriques, Joao A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7/8</span>),
    <span class="NLM_cas:pages">385-392</span>CODEN:
                <span class="NLM_cas:coden">ONREE8</span>;
        ISSN:<span class="NLM_cas:issn">0965-0407</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">The combination of irinotecan (CPT-11) and 5-fluorouracil (5-FU) is currently used in the treatment of advanced colorectal carcinoma.  When compared to both agents alone, CPT-11 followed by 5-FU treatment demonstrated a synergistic effect.  This observation can be related to increased in apoptosis induction after caspase activation.  Several studies have demonstrated that changes in mitochondrial membrane potential occur earlier in apoptosis.  In this study, we verified whether the collapse in mitochondrial membrane and the activation of caspases is responsible for increased apoptosis obsd. with CPT-11/5-FU treatment.  Thus, HT-29 and SNU-C4 human colon carcinoma cell lines were exposed for 24 h to each drug alone, and to various combinations and treatment sequences, and assessed for colony formation, changes in the mitochondrial membrane potential, and the activities of caspase-3, -8, and -9.  The CPT-11/5-FU treatment induced apoptosis in both cell lines; however, the most pronounced effect was obsd. in HT-29 cells.  In these cells, both caspase-3 and -9 were involved in the activation of apoptosis after CPT-11/5-FU treatment.  Moreover, in these cells, a redn. of 50% in mitochondrial membrane potential was obsd. with this treatment.  On the other hand, in the SNU-C4 cell line in addn. to caspase-3 and -9, caspase-8 seems to be important to apoptosis after CPT-11/5-FU treatment.  Furthermore, in this cell line we did not observe alterations in mitochondrial membrane potential.  In spite of the differences among the cell lines, these results indicated that the increase in apoptosis in HT-29 cells obsd. with CPT-11 followed by 5-FU treatment could be explained by a disruption in mitochondria membrane potential that induced caspases activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHbrkcrRK3ubVg90H21EOLACvtfcHk0lhWWMtPFtSxsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOjsL4%253D&md5=191ee04e5ee6876e035f2947746ba2f4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrivicich%26aufirst%3DI.%26aulast%3DRegner%26aufirst%3DA.%26aulast%3Dda%2BRocha%26aufirst%3DA.%2BB.%26aulast%3DGrass%26aufirst%3DL.%2BB.%26aulast%3DAlves%26aufirst%3DP.%2BA.%26aulast%3DKayser%26aufirst%3DG.%2BB.%26aulast%3DSchwartsmann%26aufirst%3DG.%26aulast%3DHenriques%26aufirst%3DJ.%2BA.%26atitle%3DIrinotecan%252F5-fluorouracil%2520combination%2520induces%2520alterations%2520in%2520mitochondrial%2520membrane%2520potential%2520and%2520caspases%2520on%2520colon%2520cancer%2520cell%2520lines%26jtitle%3DOncol.%2520Res.%26date%3D2005%26volume%3D15%26spage%3D385%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kolomeichuk, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bene, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upreti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyle, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajasekaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. C.</span><span> </span><span class="NLM_article-title">Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=128-136&author=S.+N.+Kolomeichukauthor=A.+Beneauthor=M.+Upretiauthor=R.+A.+Dennisauthor=C.+S.+Lyleauthor=M.+Rajasekaranauthor=T.+C.+Chambers&title=Induction+of+apoptosis+by+vinblastine+via+c-Jun+autoamplification+and+p53-independent+down-regulation+of+p21WAF1%2FCIP1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolomeichuk%26aufirst%3DS.%2BN.%26aulast%3DBene%26aufirst%3DA.%26aulast%3DUpreti%26aufirst%3DM.%26aulast%3DDennis%26aufirst%3DR.%2BA.%26aulast%3DLyle%26aufirst%3DC.%2BS.%26aulast%3DRajasekaran%26aufirst%3DM.%26aulast%3DChambers%26aufirst%3DT.%2BC.%26atitle%3DInduction%2520of%2520apoptosis%2520by%2520vinblastine%2520via%2520c-Jun%2520autoamplification%2520and%2520p53-independent%2520down-regulation%2520of%2520p21WAF1%252FCIP1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D128%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kolenko, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzzo, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukowski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, J. H.</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kolenko%2C+V.+M.%3B+Uzzo%2C+R.+G.%3B+Bukowski%2C+R.%3B+Finke%2C+J.+H.Apoptosis+2000%2C+5%2C+17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolenko%26aufirst%3DV.%2BM.%26aulast%3DUzzo%26aufirst%3DR.%2BG.%26aulast%3DBukowski%26aufirst%3DR.%26aulast%3DFinke%26aufirst%3DJ.%2BH.%26jtitle%3DApoptosis%26date%3D2000%26volume%3D5%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Promoting apoptosis as a strategy for cancer drug discovery</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">885</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1038%2Fnrc1736" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=16239906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=876-885&author=S.+W.+Fesik&title=Promoting+apoptosis+as+a+strategy+for+cancer+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Promoting apoptosis as a strategy for cancer drug discovery</span></div><div class="casAuthors">Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">876-885</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Apoptosis is deregulated in many cancers, making it difficult to kill tumors.  Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive.  Apoptosis targets that are currently being explored for cancer drug discovery include the tumor-necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors, the BCL2 family of anti-apoptotic proteins, inhibitor of apoptosis (IAP) proteins and MDM2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOkjz2FXKfBbVg90H21EOLACvtfcHk0ljbx_kPH13GBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Witb7J&md5=0976f3fb83374260702a71fd856a4834</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrc1736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1736%26sid%3Dliteratum%253Aachs%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPromoting%2520apoptosis%2520as%2520a%2520strategy%2520for%2520cancer%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2005%26volume%3D5%26spage%3D876%26epage%3D885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0ljbx_kPH13GBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okawa, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb600276q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=525-533&author=K.+Zobelauthor=L.+Wangauthor=E.+Varfolomeevauthor=M.+C.+Franklinauthor=L.+O.+Elliottauthor=H.+J.+Wallweberauthor=D.+C.+Okawaauthor=J.+A.+Flygareauthor=D.+Vucicauthor=W.+J.+Fairbrotherauthor=K.+Deshayes&title=Design%2C+synthesis%2C+and+biological+activity+of+a+potent+Smac+mimetic+that+sensitizes+cancer+cells+to+apoptosis+by+antagonizing+IAPs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1021%2Fcb600276q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb600276q%26sid%3Dliteratum%253Aachs%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DFranklin%26aufirst%3DM.%2BC.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DOkawa%26aufirst%3DD.%2BC.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520activity%2520of%2520a%2520potent%2520Smac%2520mimetic%2520that%2520sensitizes%2520cancer%2520cells%2520to%2520apoptosis%2520by%2520antagonizing%2520IAPs%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2006%26volume%3D1%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shangary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pienta, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">3933</span><span class="NLM_x">–</span> <span class="NLM_lpage">3938</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1073%2Fpnas.0708917105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=18316739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Ohtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=3933-3938&author=S.+Shangaryauthor=D.+Qinauthor=D.+McEachernauthor=M.+Liuauthor=R.+S.+Millerauthor=S.+Qiuauthor=Z.+Nikolovska-Coleskaauthor=K.+Dingauthor=G.+Wangauthor=J.+Chenauthor=D.+Bernardauthor=J.+Zhangauthor=Y.+Luauthor=Q.+Guauthor=R.+B.+Shahauthor=K.+J.+Pientaauthor=X.+Lingauthor=S.+Kangauthor=M.+Guoauthor=Y.+Sunauthor=D.+Yangauthor=S.+Wang&title=Temporal+activation+of+p53+by+a+specific+MDM2+inhibitor+is+selectively+toxic+to+tumors+and+leads+to+complete+tumor+growth+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21cR"><div class="casContent"><span class="casTitleNuber">21c</span><div class="casTitle"><span class="NLM_cas:atitle">Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition</span></div><div class="casAuthors">Shangary, Sanjeev; Qin, Dongguang; McEachern, Donna; Liu, Meilan; Miller, Rebecca S.; Qiu, Su; Nikolovska-Coleska, Zaneta; Ding, Ke; Wang, Guoping; Chen, Jianyong; Bernard, Denzil; Zhang, Jian; Lu, Yipin; Gu, Qingyang; Shah, Rajal B.; Pienta, Kenneth J.; Ling, Xiaolan; Kang, Sanmao; Guo, Ming; Sun, Yi; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3933-3938</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We have designed MI-219 as a potent, highly selective and orally active small-mol. inhibitor of the MDM2-p53 interaction.  MI-219 binds to human MDM2 with a Ki value of 5 nM and is 10,000-fold selective for MDM2 over MDMX.  It disrupts the MDM2-p53 interaction and activates the p53 pathway in cells with wild-type p53, which leads to induction of cell cycle arrest in all cells and selective apoptosis in tumor cells.  MI-219 stimulates rapid but transient p53 activation in established tumor xenograft tissues, resulting in inhibition of cell proliferation, induction of apoptosis, and complete tumor growth inhibition.  MI-219 activates p53 in normal tissues with minimal p53 accumulation and is not toxic to animals.  MI-219 warrants clin. investigation as a new agent for cancer treatment.+.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQBsJgWWIJ-LVg90H21EOLACvtfcHk0lhyVPZ2qJlsLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Ohtb4%253D&md5=cf97e00f9748744da7617491da96f37e</span></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0708917105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0708917105%26sid%3Dliteratum%253Aachs%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DR.%2BS.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DQ.%26aulast%3DShah%26aufirst%3DR.%2BB.%26aulast%3DPienta%26aufirst%3DK.%2BJ.%26aulast%3DLing%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DTemporal%2520activation%2520of%2520p53%2520by%2520a%2520specific%2520MDM2%2520inhibitor%2520is%2520selectively%2520toxic%2520to%2520tumors%2520and%2520leads%2520to%2520complete%2520tumor%2520growth%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D3933%26epage%3D3938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, E.</span><span> </span><span class="NLM_article-title">Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=39-42&author=S.+X.+Caiauthor=H.-Z.+Zhangauthor=J.+Guastellaauthor=J.+Dreweauthor=W.+Yangauthor=E.+Weber&title=Design+and+synthesis+of+rhodamine+110+derivative+and+caspase-3+substrate+for+enzyme+and+cell-based+fluorescent+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DWeber%26aufirst%3DE.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520rhodamine%2520110%2520derivative%2520and%2520caspase-3%2520substrate%2520for%2520enzyme%2520and%2520cell-based%2520fluorescent%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D39%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2627</span><span class="NLM_x">–</span> <span class="NLM_lpage">2644</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.2174%2F092986706778201521" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17017915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=2627-2644&author=S.+X.+Caiauthor=J.+Dreweauthor=S.+Kasibhatla&title=A+chemical+genetics+approach+for+the+discovery+of+apoptosis+inducers%3A+from+phenotypic+cell+based+HTS+assay+and+structure-activity+relationship+studies%2C+to+identification+of+potential+anticancer+agents+and+molecular+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A chemical genetics approach for the discovery of apoptosis inducers: from phenotypic cell based HTS assay and structure-activity relationship studies, to identification of potential anticancer agents and molecular targets</span></div><div class="casAuthors">Cai, Sui Xiong; Drewe, John; Kasibhatla, Shailaja</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2627-2644</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The approach of chem. genetics has been widely used to study biol. systems and to discover new drugs, signaling pathways and targets.  The current review focuses on the development and utilization of a cell- and caspase-based apoptosis induction assay for the discovery of apoptosis inducers.  We began with the development of a cell based phenotypic assay, which was used for the identification of small mols. that exhibit apoptosis inducing activities, including N-Ph nicotinamides, gambogic acid, indole-2-carboxylic acid benzylidene-hydrazides, 4-aryl-4H-chromenes and 3-aryl-5-aryl-1,2,4-oxadiazoles.  Through medicinal chem. and biol. studies, in vivo active compds. were identified, such as MX116407 as a tumor vascular disrupting agent with potent in vivo anticancer activity.  The mol. targets of in vivo active compds. were identified using reagents designed and synthesized based on the SAR, including the identification of tail-interacting protein 47 (TIP47), an insulin-like growth factor II (IGF II) receptor binding protein, as the mol. target of 3-aryl-5-aryl-1,2,4-oxadiazoles; and Transferrin receptor I (TfR), a transmembrane protein that interacts with transferrin (Tf) for the transport of iron into cells, as the mol. target of gambogic acid.  We demonstrated that chem. genetics is a very useful approach for anticancer drug research, from the discovery of potential drugs, to the understanding of signaling pathways and identification of druggable targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bmsD_VBUGLVg90H21EOLACvtfcHk0lhyVPZ2qJlsLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1SktbY%253D&md5=d4ca29e8367b8dd6a882df747760c9a2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.2174%2F092986706778201521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986706778201521%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DA%2520chemical%2520genetics%2520approach%2520for%2520the%2520discovery%2520of%2520apoptosis%2520inducers%253A%2520from%2520phenotypic%2520cell%2520based%2520HTS%2520assay%2520and%2520structure-activity%2520relationship%2520studies%252C%2520to%2520identification%2520of%2520potential%2520anticancer%2520agents%2520and%2520molecular%2520targets%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2006%26volume%3D13%26spage%3D2627%26epage%3D2644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span> </span><span class="NLM_article-title">Discovery of substituted <i>N</i>-phenyl nicotinamides as potent inducers of apoptosis using a cell- and caspase-based high throughput screening assay</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2474</span><span class="NLM_x">–</span> <span class="NLM_lpage">2481</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0205200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2474-2481&author=S.+X.+Caiauthor=B.+Nguyenauthor=S.+Jiaauthor=J.+Herichauthor=J.+Guastellaauthor=S.+Reddyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+Kasibhatla&title=Discovery+of+substituted+N-phenyl+nicotinamides+as+potent+inducers+of+apoptosis+using+a+cell-+and+caspase-based+high+throughput+screening+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm0205200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205200%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DKasibhatla%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520substituted%2520N-phenyl%2520nicotinamides%2520as%2520potent%2520inducers%2520of%2520apoptosis%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2474%26epage%3D2481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guastella, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=309-317&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=Y.+Wangauthor=J.+Herichauthor=J.+Guastellaauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery%2C+characterization+and+SAR+of+gambogic+acid+as+a+potent+apoptosis+inducer+by+a+HTS+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DGuastella%26aufirst%3DJ.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%252C%2520characterization%2520and%2520SAR%2520of%2520gambogic%2520acid%2520as%2520a%2520potent%2520apoptosis%2520inducer%2520by%2520a%2520HTS%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meerovitch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouffard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rej, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blais, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6299</span><span class="NLM_x">–</span> <span class="NLM_lpage">6310</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049640t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6299-6310&author=W.+Kemnitzerauthor=S.+Kasibhatlaauthor=S.+Jiangauthor=H.+Zhangauthor=Y.+Wangauthor=J.+Zhaoauthor=S.+Jiaauthor=J.+Herichauthor=D.+Labrequeauthor=R.+Storerauthor=K.+Meerovitchauthor=D.+Bouffardauthor=R.+Rejauthor=R.+Denisauthor=C.+Blaisauthor=S.+Lamotheauthor=G.+Attardoauthor=H.+Gourdeauauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+1.+Structure-activity+relationships+of+the+4-aryl+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1021%2Fjm049640t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049640t%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DJia%26aufirst%3DS.%26aulast%3DHerich%26aufirst%3DJ.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DMeerovitch%26aufirst%3DK.%26aulast%3DBouffard%26aufirst%3DD.%26aulast%3DRej%26aufirst%3DR.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DBlais%26aufirst%3DC.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25201.%2520Structure-activity%2520relationships%2520of%2520the%25204-aryl%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6299%26epage%3D6310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 3. Structure-activity relationships of fused rings at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2858</span><span class="NLM_x">–</span> <span class="NLM_lpage">2864</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070216c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2858-2864&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=J.+Zhaoauthor=C.+Crogan-Grundyauthor=L.+Xuauthor=S.+Lamotheauthor=H.+Gourdeauauthor=R.+Denisauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high-throughput+screening+assay.+3.+Structure-activity+relationships+of+fused+rings+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.1021%2Fjm070216c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070216c%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high-throughput%2520screening%2520assay.%25203.%2520Structure-activity%2520relationships%2520of%2520fused%2520rings%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2858%26epage%3D2864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labreque, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bubenick, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamothe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gourdeau, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 4-aryl-4<i>H</i>-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of <i>N</i>-alkyl substituted pyrrole fused at the 7,8-positions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7010657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=417-423&author=W.+Kemnitzerauthor=J.+Dreweauthor=S.+Jiangauthor=H.+Zhangauthor=C.+Crogan-Grundyauthor=D.+Labrequeauthor=M.+Bubenickauthor=G.+Attardoauthor=R.+Denisauthor=S.+Lamotheauthor=H.+Gourdeauauthor=B.+Tsengauthor=S.+Kasibhatlaauthor=S.+X.+Cai&title=Discovery+of+4-aryl-4H-chromenes+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+4.+Structure-activity+relationships+of+N-alkyl+substituted+pyrrole+fused+at+the+7%2C8-positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=10.1021%2Fjm7010657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7010657%26sid%3Dliteratum%253Aachs%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DLabreque%26aufirst%3DD.%26aulast%3DBubenick%26aufirst%3DM.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DDenis%26aufirst%3DR.%26aulast%3DLamothe%26aufirst%3DS.%26aulast%3DGourdeau%26aufirst%3DH.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25204-aryl-4H-chromenes%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25204.%2520Structure-activity%2520relationships%2520of%2520N-alkyl%2520substituted%2520pyrrole%2520fused%2520at%2520the%25207%252C8-positions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D417%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuemmerle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemnitzer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliis-Mason, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogran-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5215</span><span class="NLM_x">–</span> <span class="NLM_lpage">5223</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050292k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5215-5223&author=H.-Z.+Zhangauthor=S.+Kasibhatlaauthor=J.+Kuemmerleauthor=W.+Kemnitzerauthor=K.+Oliis-Masonauthor=L.+Quiauthor=C.+Crogran-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+3-aryl-5-aryl-1%2C2%2C4-oxadiazoles+as+a+new+series+of+apoptosis+inducers+and+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm050292k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050292k%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DKuemmerle%26aufirst%3DJ.%26aulast%3DKemnitzer%26aufirst%3DW.%26aulast%3DOliis-Mason%26aufirst%3DK.%26aulast%3DQui%26aufirst%3DL.%26aulast%3DCrogran-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%25203-aryl-5-aryl-1%252C2%252C4-oxadiazoles%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520and%2520potential%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5215%26epage%3D5223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claassen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of substituted 4-anilino-2-(2-pyridyl)pyrimidines as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 1. Structure-activity relationships of the 4-anilino group</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">7761</span><span class="NLM_x">–</span> <span class="NLM_lpage">7773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=7761-7773&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=B.+Nguyenauthor=A.+Pervinauthor=Y.+Wangauthor=G.+Claassenauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+substituted+4-anilino-2-%282-pyridyl%29pyrimidines+as+a+new+series+of+apoptosis+inducers+using+a+cell-+and+caspase-based+high+throughput+screening+assay.+1.+Structure-activity+relationships+of+the+4-anilino+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DClaassen%26aufirst%3DG.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%2520substituted%25204-anilino-2-%25282-pyridyl%2529pyrimidines%2520as%2520a%2520new%2520series%2520of%2520apoptosis%2520inducers%2520using%2520a%2520cell-%2520and%2520caspase-based%2520high%2520throughput%2520screening%2520assay.%25201.%2520Structure-activity%2520relationships%2520of%2520the%25204-anilino%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D7761%26epage%3D7773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Zhang, H.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claassen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crogan-Grundy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery and structure activity relationship of <i>N</i>-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]quinolin-4-amines as a new series of potent apoptosis inducers</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=222-231&author=H.-Z.+Zhangauthor=G.+Claassenauthor=C.+Crogan-Grundyauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+and+structure+activity+relationship+of+N-phenyl-1H-pyrazolo%5B3%2C4-b%5Dquinolin-4-amines+as+a+new+series+of+potent+apoptosis+inducers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.-Z.%26aulast%3DClaassen%26aufirst%3DG.%26aulast%3DCrogan-Grundy%26aufirst%3DC.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520and%2520structure%2520activity%2520relationship%2520of%2520N-phenyl-1H-pyrazolo%255B3%252C4-b%255Dquinolin-4-amines%2520as%2520a%2520new%2520series%2520of%2520potent%2520apoptosis%2520inducers%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D18%26spage%3D222%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span> </span><span class="NLM_article-title">Discovery of 2-chloro-<i>N</i>-(4-methoxyphenyl)-<i>N</i>-methylquinazolin-4-amine (EP128265, MPI-0441138) as a potent inducer of apoptosis with high in vivo activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4771</span><span class="NLM_x">–</span> <span class="NLM_lpage">4779</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8003653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4771-4779&author=N.+Sirisomaauthor=S.+Kasibhatlaauthor=A.+Pervinauthor=H.+Zhangauthor=S.+Jiangauthor=J.+A.+Willardsenauthor=M.+Andersonauthor=V.+Baichwalauthor=G.+G.+Matherauthor=K.+Jessingauthor=R.+Hussainauthor=K.+Hoangauthor=C.+M.+Pleimanauthor=B.+Tsengauthor=J.+Dreweauthor=S.+X.+Cai&title=Discovery+of+2-chloro-N-%284-methoxyphenyl%29-N-methylquinazolin-4-amine+%28EP128265%2C+MPI-0441138%29+as+a+potent+inducer+of+apoptosis+with+high+in+vivo+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm8003653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8003653%26sid%3Dliteratum%253Aachs%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMather%26aufirst%3DG.%2BG.%26aulast%3DJessing%26aufirst%3DK.%26aulast%3DHussain%26aufirst%3DR.%26aulast%3DHoang%26aufirst%3DK.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DS.%2BX.%26atitle%3DDiscovery%2520of%25202-chloro-N-%25284-methoxyphenyl%2529-N-methylquinazolin-4-amine%2520%2528EP128265%252C%2520MPI-0441138%2529%2520as%2520a%2520potent%2520inducer%2520of%2520apoptosis%2520with%2520high%2520in%2520vivo%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4771%26epage%3D4779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Connolly, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiry, P. J.</span><span> </span><span class="NLM_article-title">Preparation and resolution of a modular class of axially chiral quinazoline-containing ligands and their application in asymmetric rhodium-catalyzed olefin hydroboration</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6572</span><span class="NLM_x">–</span> <span class="NLM_lpage">6589</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo049195%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=6572-6589&author=D.+J.+Connollyauthor=P.+M.+Laceyauthor=M.+McCarthyauthor=C.+P.+Saundersauthor=A.-M.+Carrollauthor=R.+Goddardauthor=P.+J.+Guiry&title=Preparation+and+resolution+of+a+modular+class+of+axially+chiral+quinazoline-containing+ligands+and+their+application+in+asymmetric+rhodium-catalyzed+olefin+hydroboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjo049195%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049195%252B%26sid%3Dliteratum%253Aachs%26aulast%3DConnolly%26aufirst%3DD.%2BJ.%26aulast%3DLacey%26aufirst%3DP.%2BM.%26aulast%3DMcCarthy%26aufirst%3DM.%26aulast%3DSaunders%26aufirst%3DC.%2BP.%26aulast%3DCarroll%26aufirst%3DA.-M.%26aulast%3DGoddard%26aufirst%3DR.%26aulast%3DGuiry%26aufirst%3DP.%2BJ.%26atitle%3DPreparation%2520and%2520resolution%2520of%2520a%2520modular%2520class%2520of%2520axially%2520chiral%2520quinazoline-containing%2520ligands%2520and%2520their%2520application%2520in%2520asymmetric%2520rhodium-catalyzed%2520olefin%2520hydroboration%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26spage%3D6572%26epage%3D6589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kasibhatla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirisoma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pervin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span> </span><span class="NLM_article-title">MPC-6827: a small molecule inhibitor of microtubule formation that is not a substrate for multi-drug resistance pumps</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5865</span><span class="NLM_x">–</span> <span class="NLM_lpage">5871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5865-5871&author=S.+Kasibhatlaauthor=V.+Baichwalauthor=S.+X.+Caiauthor=B.+Rothauthor=I.+Skvortsovaauthor=S.+Skvortsovauthor=P.+Lukasauthor=N.+M.+Englishauthor=N.+Sirisomaauthor=J.+Dreweauthor=A.+Pervinauthor=B.+Tsengauthor=R.+O.+Carlsonauthor=C.+M.+Pleiman&title=MPC-6827%3A+a+small+molecule+inhibitor+of+microtubule+formation+that+is+not+a+substrate+for+multi-drug+resistance+pumps"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DCai%26aufirst%3DS.%2BX.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DSkvortsov%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DP.%26aulast%3DEnglish%26aufirst%3DN.%2BM.%26aulast%3DSirisoma%26aufirst%3DN.%26aulast%3DDrewe%26aufirst%3DJ.%26aulast%3DPervin%26aufirst%3DA.%26aulast%3DTseng%26aufirst%3DB.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26atitle%3DMPC-6827%253A%2520a%2520small%2520molecule%2520inhibitor%2520of%2520microtubule%2520formation%2520that%2520is%2520not%2520a%2520substrate%2520for%2520multi-drug%2520resistance%2520pumps%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5865%26epage%3D5871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Neville, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parise, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleksic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egorin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuffey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, S. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2525</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-03-0155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=15073132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFSqsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=2525-2529&author=K.+Nevilleauthor=R.+A.+Pariseauthor=P.+Thompsonauthor=A.+Aleksicauthor=M.+J.+Egorinauthor=F.+M.+Balisauthor=L.+McGuffeyauthor=C.+McCullyauthor=S.+L.+Bergauthor=S.+M.+Blaney&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+imatinib+after+administration+to+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of imatinib after administration to nonhuman primates</span></div><div class="casAuthors">Neville, Kathleen; Parise, Robert A.; Thompson, Patrick; Aleksic, Alexander; Egorin, Merrill J.; Balis, Frank M.; McGuffey, Leticia; McCully, Cynthia; Berg, Stacey L.; Blaney, Susan M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2525-2529</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Imatinib mesylate (Gleevec, Glivec, STI571, imatinib) is a potent tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors.  The role of imatinib in the treatment of malignant gliomas and other solid tumors is being evaluated.  We used a nonhuman primate model that is highly predictive of the cerebrospinal fluid penetration of drugs in humans to study the pharmacokinetics of imatinib in plasma and cerebrospinal fluid (CSF) after i.v. and p.o. administration.  Imatinib, 15 mg/kg i.v. over 30 min (n = 3) or 30 mg/kg p.o. (n = 3), was administered to nonhuman primates.  Imatinib was measured in serial samples of plasma and CSF using high-pressure liq. chromatog. with UV absorbance or mass spectroscopic detection.  Pharmacokinetic parameters were estd. using model-independent methods.  Peak plasma imatinib concns. ranged from 6.4 to 9.5 μM after i.v. dosing and 0.8 to 2.8 μM after p.o. dosing.  The mean ±SD area under the plasma concn. vs. time curve was 2480 ±1340 μM·min and 1191 ±146 μM·min after i.v. and p.o. dosing, resp.  The terminal half-life was 529 ±167 min after i.v. dosing and 266 ±88 min after p.o. dosing.  After i.v. dosing the steady state vol. of distribution was 5.9 ±2.8 L/kg, and the total body clearance was 12 ±5 mL/min/kg.  The mean peak CSF concn. was 0.25 ±0.07 μM after i.v. dosing and 0.07 ±0.04 μM after p.o. dosing.  The mean CSF:plasma area under the plasma concn. vs. time curve ratio for all of the animals was 5% ±2%.  There is limited penetration of imatinib into the CSF of nonhuman primates after i.v. and p.o. administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMPjbJK4TVxrVg90H21EOLACvtfcHk0lj7iV8acKMjZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFSqsbo%253D&md5=1849626bb417a9aaa5b6b6e13c45bc5c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0155%26sid%3Dliteratum%253Aachs%26aulast%3DNeville%26aufirst%3DK.%26aulast%3DParise%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DP.%26aulast%3DAleksic%26aufirst%3DA.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26aulast%3DMcGuffey%26aufirst%3DL.%26aulast%3DMcCully%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DS.%2BL.%26aulast%3DBlaney%26aufirst%3DS.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520imatinib%2520after%2520administration%2520to%2520nonhuman%2520primates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D2525%26epage%3D2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Heimberger, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Learn, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Archer, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chewning, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuck, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pracyk, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigner, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, J. H.</span><span> </span><span class="NLM_article-title">Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa)</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3496</span><span class="NLM_x">–</span> <span class="NLM_lpage">3502</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=12429640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVCgtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=3496-3502&author=A.+B.+Heimbergerauthor=C.+A.+Learnauthor=G.+E.+Archerauthor=R.+E.+McLendonauthor=T.+A.+Chewningauthor=F.+L.+Tuckauthor=J.+B.+Pracykauthor=A.+H.+Friedmanauthor=H.+S.+Friedmanauthor=D.+D.+Bignerauthor=J.+H.+Sampson&title=Brain+tumors+in+mice+are+susceptible+to+blockade+of+epidermal+growth+factor+receptor+%28EGFR%29+with+the+oral%2C+specific%2C+EGFR-tyrosine+kinase+inhibitor+ZD1839+%28iressa%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (Iressa)</span></div><div class="casAuthors">Heimberger, Amy B.; Learn, Chris A.; Archer, Gary E.; McLendon, Roger E.; Chewning, Tracy A.; Tuck, Frank L.; Pracyk, John B.; Friedman, Allan H.; Friedman, Henry S.; Bigner, Darell D.; Sampson, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3496-3502</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Iressa (ZD 1839) is a p.o.-active, selective, epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) that blocks signal transduction pathways implicated in cancer cell proliferation, survival, and host-dependent processes promoting cancer growth.  EGFR is up-regulated in primary malignant tumors of the central nervous system (CNS) and in many systemic tumors that metastasize to the CNS.  The purpose of our study was to evaluate the efficacy and toxicity of p.o.-administered ZD 1839 for the treatment of established intracerebral (i.c.) tumors expressing EGFR or the tumorigenic mutated variant EGFRvIII, which is constitutively phosphorylated.  Oral administration of ZD 1839 at 50 or 100 mg/kg/day for 3 wk in athymic mice with established i.c. A431 human epidermoid carcinoma expressing EGFR increased median survival by 88% and 105%, resp.  Addnl., there was no evidence of systemic or CNS toxicity.  However, ZD 1839 failed to inhibit either s.c. or i.c. in vivo tumor growth when tumorigenicity was conferred by EGFRvIII.  Western blotting revealed that treatment with ZD 1839 virtually ablated phosphorylation of EGFR Tyr-1173 in A431 tumors.  However, treatment of NR6M tumors with ZD 1839 only partially decreased phosphorylation of EGFRvIII Tyr-1173 while up-regulating overall expression, suggesting that EGFRvIII may not be susceptible to the same mol. mechanisms of tyrosine kinase inhibition as EGFR.  In conclusion, ZD 1839 is active in a brain tumor model expressing EGFR, but not EGFRvIII, as EGFR mutations may lead to relative therapeutic resistance.  On the basis of these observations, we believe that clin. trials of ZD 1839 against brain tumors expressing EGFR are warranted, but that special consideration should be given to tumors that coexpress EGFRvIII.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoodn9-INoJ17Vg90H21EOLACvtfcHk0lj7iV8acKMjZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVCgtLs%253D&md5=fffc5229788f76544cc97e65708914ce</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeimberger%26aufirst%3DA.%2BB.%26aulast%3DLearn%26aufirst%3DC.%2BA.%26aulast%3DArcher%26aufirst%3DG.%2BE.%26aulast%3DMcLendon%26aufirst%3DR.%2BE.%26aulast%3DChewning%26aufirst%3DT.%2BA.%26aulast%3DTuck%26aufirst%3DF.%2BL.%26aulast%3DPracyk%26aufirst%3DJ.%2BB.%26aulast%3DFriedman%26aufirst%3DA.%2BH.%26aulast%3DFriedman%26aufirst%3DH.%2BS.%26aulast%3DBigner%26aufirst%3DD.%2BD.%26aulast%3DSampson%26aufirst%3DJ.%2BH.%26atitle%3DBrain%2520tumors%2520in%2520mice%2520are%2520susceptible%2520to%2520blockade%2520of%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520with%2520the%2520oral%252C%2520specific%252C%2520EGFR-tyrosine%2520kinase%2520inhibitor%2520ZD1839%2520%2528iressa%2529%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2002%26volume%3D8%26spage%3D3496%26epage%3D3502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cho, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates</span> <span class="citation_source-journal">Cancer Chemother. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1007%2Fs00280-006-0402-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=17187251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnvFKntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2007&pages=563-567&author=S.+Y.+Choauthor=E.+Foxauthor=C.+McCullyauthor=J.+Bauchauthor=K.+Marshauthor=F.+M.+Balis&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+intravenously+administered+ABT-751+in+non-human+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates</span></div><div class="casAuthors">Cho, Steve Y.; Fox, Elizabeth; McCully, Cynthia; Bauch, Joy; Marsh, Kennan; Balis, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">563-567</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: ABT-751 is an orally bioavailable sulfonamide that binds to the colchicine binding site on β-tubulin and inhibits microtubule polymn.  The plasma and cerebrospinal fluid (CSF) pharmacokinetics of ABT-751, after a short i.v. infusion, were evaluated in a non-human primate (Macaca mulatta) model that is highly predictive of the CSF penetration of drugs in humans.  Materials and methods: Plasma and CSF samples were collected over 24 h after 7.5 mg/kg (150 mg/m2) ABT-751 infused over 0.25-0.70 h, and ABT-751 concns. in plasma and CSF were quantified using a validated HPLC-MS/MS assay.  Pharmacokinetic parameters in plasma and CSF were derived using non-compartmental methods.  Results and conclusion: Plasma disappearance was bi-exponential with a terminal half-life of 13 h.  The mean ± SD clearance was 100 ± 18 mL/min m2, the mean ± SD vol. of distribution at steady state was 1.3 ± 0.5 l/kg, and the mean ± SD mean residence time was 4.6 ± 1.8 h.  The mean ± SD peak ABT-751 concn. in CSF was 0.26 ± 0.08 μM, and the mean ± SD CSF half-life of 1.3 ± 0.3 h.  CSF penetration was limited (mean ± SD AUCCSF:AUCplasma, 1.1 ± 0.3%) relative to total (protein-bound + free) plasma drug concns., but the CSF concns. approximated the estd. free drug concns. in plasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYdC0MjbKyHbVg90H21EOLACvtfcHk0liZ1fvSr4wGnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnvFKntr0%253D&md5=50e5747b8835e1b986f4e742522f6b74</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs00280-006-0402-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-006-0402-7%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BY.%26aulast%3DFox%26aufirst%3DE.%26aulast%3DMcCully%26aufirst%3DC.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520intravenously%2520administered%2520ABT-751%2520in%2520non-human%2520primates%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2007%26volume%3D60%26spage%3D563%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jacobs, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCully, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balis, F. M.</span><span> </span><span class="NLM_article-title">Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1158%2F1078-0432.CCR-04-1807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=15746072" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhvVSrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1669-1674&author=S.+S.+Jacobsauthor=E.+Foxauthor=C.+Dennieauthor=L.+B.+Morganauthor=C.+L.+McCullyauthor=F.+M.+Balis&title=Plasma+and+cerebrospinal+fluid+pharmacokinetics+of+intravenous+oxaliplatin%2C+cisplatin%2C+and+carboplatin+in+nonhuman+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates</span></div><div class="casAuthors">Jacobs, Shana S.; Fox, Elizabeth; Dennie, Christopher; Morgan, Lindsey B.; McCully, Cynthia L.; Balis, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1669-1674</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Describe and compare the central nervous system pharmacol. of the platinum analogs, cisplatin, carboplatin, and oxaliplatin and develop a pharmacokinetic model to distinguish the disposition of active drug from inert platinum species.  Oxaliplatin (7 or 5 mg/kg), cisplatin (2 mg/kg), or carboplatin (10 mg/kg) was given i.v.  Serial plasma and cerebrospinal fluid (CSF) samples were collected over 24 h.  Plasma ultrafiltrates were prepd. immediately.  Platinum concns. were measured using at. absorption spectrometry.  Areas under the concn. x time curve were derived using the linear trapezoidal method.  CSF penetration was defined as the CSF AUC0-24/plasma ultrafiltrate AUC0-24 ratio.  A four-compartment model with first-order rate consts. was fit to the data to distinguish active drug from inactive metabolites.  The mean ± SD AUCs in plasma ultrafiltrate for oxaliplatin, cisplatin, and carboplatin were 61 ± 22, 18 ± 6, and 211 ± 64 μmol/L hour, resp.  The AUCs in CSF were 1.2 ± 0.4 μmol/L hour for oxaliplatin, 0.56 ± 0.08 μmol/L hour for cisplatin, and 8 ± 2.2 μmol/L hour for carboplatin, and CSF penetration was 2.0%, 3.6%, and 3.8%, resp.  For oxaliplatin, cisplatin, and carboplatin, the pharmacokinetic model estd. that active drug accounted for 29%, 79%, and 81% of platinum in plasma ultrafiltrate, resp., and 25%, 89%, and 56% of platinum in CSF, resp.  The CSF penetration of active drug was 1.6% for oxaliplatin, 3.7% for cisplatin, and 2.6% for carboplatin.  The CSF penetration of the platinum analogs is limited.  The pharmacokinetic model distinguished between active drug and their inactive (inert) metabolites in plasma and CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_OFcn4uU-KLVg90H21EOLACvtfcHk0liZ1fvSr4wGnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhvVSrt7s%253D&md5=1aafc40d922a2ccc7104e9e995f1a0b4</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1807%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DS.%2BS.%26aulast%3DFox%26aufirst%3DE.%26aulast%3DDennie%26aufirst%3DC.%26aulast%3DMorgan%26aufirst%3DL.%2BB.%26aulast%3DMcCully%26aufirst%3DC.%2BL.%26aulast%3DBalis%26aufirst%3DF.%2BM.%26atitle%3DPlasma%2520and%2520cerebrospinal%2520fluid%2520pharmacokinetics%2520of%2520intravenous%2520oxaliplatin%252C%2520cisplatin%252C%2520and%2520carboplatin%2520in%2520nonhuman%2520primates%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1669%26epage%3D1674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0liZ1fvSr4wGnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Norinder, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haeberlein, M.</span><span> </span><span class="NLM_article-title">Computational approaches to the prediction of the blood-brain distribution</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">313</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm801315b&amp;key=10.1016%2FS0169-409X%2802%2900005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm801315b&amp;key=11922949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm801315b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=291-313&author=U.+Norinderauthor=M.+Haeberlein&title=Computational+approaches+to+the+prediction+of+the+blood-brain+distribution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Computational approaches to the prediction of the blood-brain distribution</span></div><div class="casAuthors">Norinder, Ulf; Haeberlein, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-313</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  This review attempts to summarize present knowledge related to the theor. modeling of drug transport across the blood-brain barrier.  Several computational protocols are described ranging from quantum mechanics-based approaches through mol. mechanics-related techniques to simple and fast procedures based on only the 2-D graph of the investigated structures.  Amazingly, few descriptors have been shown to influence the derived relationships in a significant manner and a cornerstone in most of the described models are terms describing hydrogen bonding.  A very quick quant. assessment of the brain partitioning of a compd. has also been devised using the following two rules: If N+O (the no. of nitrogen and oxygen atoms) in a mol. is less than or equal to five, it has a high chance of entering the brain.  The second rule predicts that if log P-(N+O) is pos. then log BB is pos.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy9Yd_Pc0M07Vg90H21EOLACvtfcHk0liZ1fvSr4wGnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlartbg%253D&md5=cc689594714a0afb9f67917c77530d8c</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900005-4%26sid%3Dliteratum%253Aachs%26aulast%3DNorinder%26aufirst%3DU.%26aulast%3DHaeberlein%26aufirst%3DM.%26atitle%3DComputational%2520approaches%2520to%2520the%2520prediction%2520of%2520the%2520blood-brain%2520distribution%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D291%26epage%3D313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm801315b">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26482"></div></div></div></div></div><hr /></hr><p class="last">Table of elemental analysis and HPLC data for the targeted compounds <b>6c</b>−<b>6m</b>, <b>7a</b>−<b>7s</b> and <b>9a</b>. Caspase activation assays, growth inhibition assays, tubulin inhibition assay, cell cycle analysis, MX-1 tumor model studies of <b>6h</b>, and determination of brain/plasma AUC ratio of <b>6h</b> and related analogues. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm801315b/suppl_file/jm801315b_si_001.pdf">jm801315b_si_001.pdf (61.17 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm801315b&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm801315b%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-8%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm801315b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                471KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ac7496efe227f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
